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PREFACE 
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Infectious Diseases (Chancellor’s Building, Little France, Edinburgh), The 
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Work has been concerned with research into improving our understanding of the role 
of Staphylococcus aureus toxins in the pathogenesis of septic arthritis.   
 
The experimental work was carried out personally under the supervision of Dr 
Andrew Hall, Professor Hamish Simpson and Professor Sebastian Amyes who 
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ABSTRACT 
Septic arthritis has the potential to be a highly destructive joint disease.  Although 
numerous bacterial species are capable of inducing septic arthritis, Staphylococcus 
aureus is most commonly implicated, accounting for up to 65% of cases.  Whilst this 
organism is known to produce a diverse array of potential virulence factors, studies 
investigating a variety of S. aureus-related infections have implicated alpha(Hla)-, 
beta(Hlb)- and gamma(Hlg)-haemolysins as key damaging toxins, with the ‘pore-
forming’ Hla considered to be the most potent.  The work presented in this study 
focused on gaining further insight into the interaction between S. aureus toxins and 
in situ chondrocytes during an episode of septic arthritis. 
 
An in vitro bovine osteochondral explant model of S. aureus-induced septic arthritis 
was developed in this study.  Utilising fluorescence-mode confocal laser scanning 
microscopy (CLSM), the model, which avoided the complexities of a host immune 
response, permitted an assessment of the following: (1) the spatial and temporal 
quantification of in situ chondrocyte viability following exposure to both a 
laboratory ‘wild-type’ (S. aureus 8325-4) and clinical strains of S. aureus; (2) the 
influence of Hla, Hlb and Hlg on in situ chondrocyte viability through the use of 
specific ‘haemolysin-knockout’ mutant strains; (3) the influence of altered culture 
medium osmolarity and extracellular Ca2+ on Hla-induced in situ chondrocyte death; 
and (4) dynamic changes in intracellular Ca2+ within in situ chondrocytes following 
Hla exposure.  
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S. aureus 8325-4 and S. aureus clinical strains rapidly reduced in situ chondrocyte 
viability (>45% chondrocyte death at 40hrs).  The increased acidity, observed during 
bacterial culture, had a minimal effect on chondrocyte viability.  Chondrocyte death 
commenced within the superficial zone (SZ) of cartilage and rapidly progressed to 
the deep zone (DZ).  Simultaneous exposure of SZ and DZ chondrocytes to S. aureus 
8325-4 toxins (achieved with the use of subchondral bone-free explants) 
demonstrated that SZ chondrocytes were more susceptible to the toxins than DZ 
chondrocytes.  
 
When explants were cultured in the presence of a selection of isogenic S. aureus 
mutants, with varying Hla, Hlb and Hlg production capabilities (all originating from 
S. aureus 8325-4), Hla-producing mutants induced significant in situ chondrocyte 
death compared to toxin deficient controls (Hla-Hlb-Hlg-).  In contrast, mutants 
producing Hlb and Hlg in the absence of Hla were unable to induce significant 
chondrocyte death.  Hla alone was therefore identified as the key damaging toxin to 
in situ chondrocyte viability. 
 
Raised culture medium osmolarity had no influence on Hla-induced in situ 
chondrocyte death.  In the absence of Hla, a high extracellular Ca2+ concentration 
(20mM) had no influence on chondrocyte viability during the experimental period.  
Hla-induced chondrocyte death increased in the presence of raised extracellular Ca2+ 
concentrations thereby confirming a role of Ca2+ in the chondrocyte death pathway. 
There was no significant difference between S. aureus growth in high and low Ca2+ 
culture media. 
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Finally, when live osteochondral explants stained with the Ca2+-sensitive fluorophore 
Fluo-4 were cultured with an Hla-containing S. aureus supernatant (S. aureus 8325-4 
(Hla+Hlb+Hlg+)) there was a significant rise in intracellular Ca2+ in comparison to 
those explants exposed to a non-Hla-containing supernatant (S. aureus DU5938 (Hla-
Hlb-Hlg-)).  The Hla-induced Ca2+ transients were always followed by chondrocyte 
death.  Thus, it is likely that Hla-induced chondrocyte death was associated with a 
rise in intracellular Ca2+. 
 
These findings are of translational relevance.  Firstly, toxins released by S. aureus 
have a rapid and fatal action on in situ chondrocytes, thereby advocating the prompt 
and thorough removal of bacteria and their toxins during the treatment of septic 
arthritis.  Secondly, the identification of Hla alone as the key damaging toxin to in 
situ chondrocyte viability, with its destructive action being associated with a rise in 
intracellular Ca2+, may enable the development of future targeted therapeutic 
strategies in order to reduce the extent of cartilage destruction during and after an 
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1.1 Prelude  
Articular cartilage is a unique tissue that allows the smooth motion of a joint whilst 
withstanding considerable forces.  Unfortunately, for individuals affected by a 
variety of joint pathology the loss of cartilage is a common end pathway that results 
in pain, loss of joint function and subsequent disability.  Exciting and challenging 
aspects of cartilage research may focus on (1) identifying factors that result in 
cartilage damage and subsequent loss or (2) mechanisms of cartilage regeneration 
and repair.  All basic research in these areas is directed, ultimately, to future clinical 
benefit.  This study focuses on the former by investigating the influence of defined 
Staphylococcus aureus toxins on in situ viability of chondrocytes (the sole cell type 
of articular cartilage).  In this thesis, S. aureus is exclusively studied, as it is the most 
commonly implicated organism in septic arthritis, a potentially highly destructive 
joint disease that arises as a result of bacterial infection.  In order to interpret the 
immediate and long-term effects of S. aureus and its toxins on articular cartilage, it is 
important, firstly, to appreciate the normal structure and physiology of this highly 
specialised connective tissue.  
 
1.2 Articular Cartilage 
Articular cartilage, a form of hyaline cartilage, is the smooth, glistening white 
material covering the articulating bone ends that serves to provide joint movement 
with minimal friction i.e. it is the bearing material of synovial joints.  It is 
remarkably resilient to compressive forces, which can exceed 100 atmospheres 
during standing (Hodge et al., 1986; Afoke et al., 1987; Urban, 1994), yet allows 
controlled deformation in order to distribute loads.  Articular cartilage is alymphatic, 
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aneural, and avascular (Buckwalter et al., 2005) and its nutrition is entirely reliant on 
the diffusion of nutrients from the synovial fluid and subchondral bone (Malinin and 
Ouellette, 2000; Wang et al., 2013). 
 
1.2.1 Composition 
Chondrocytes are the only cellular component of articular cartilage.  Despite their 
undistinguished rounded appearance, chondrocytes are highly differentiated and 
specialised mesenchymal cells that are central to the survival of cartilage (Muir, 
1995).  In humans, articular cartilage is 65-80% water by wet weight (Pearle et al., 
2005; Bhosale and Richardson, 2008) and chondrocytes comprise less than 10% of 
the structure of cartilage and contribute approximately 1% of its volume (Urban et 
al., 1993; Buckwalter and Mankin, 1997a).  Each cell is therefore embedded within a 
relatively large volume of extracellular matrix (ECM).   
 
Cartilage can be considered a biphasic structure comprising (1) a fluid phase of water 
and ions and (2) a solid phase consisting of collagen and proteoglycans (Mow et al., 
1984; Athanasiou et al., 1991; Zhu et al., 1993; Pearle et al., 2005).  The solid phase 
has low permeability, primarily as a result of the high frictional resistance 
established by the dense collagen-proteoglycan matrix (Mow et al., 1984).  When a 
load is applied to cartilage, the interstitial fluid is displaced but due to the low 
permeability of the solid phase there is resultant high interstitial fluid pressurisation 
(Soltz and Ateshian, 2000).  It has been demonstrated that this fluid pressurisation 
contributes in excess of 90% of the load support (Park et al., 2003), shielding the 
collagen-proteoglycan matrix from excessive stresses and reducing friction at the 
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articular surfaces (Ateshian et al., 1994; Ateshian and Wang, 1995; Soltz and 
Ateshian, 1998).  The low permeability of the solid phase and the subsequent 
pressurisation of the fluid phase give rise to both the stiffness and resilience 
properties of articular cartilage (Muir, 1995; Buckwalter et al., 2005).  
 
Water is the most abundant component of articular cartilage, contributing 65 to 80% 
of its volume (Linn and Sokoloff, 1965).  Approximately 30% of this water is 
associated with the intrafibrillar space (i.e. within the collagen fibers) and a small 
percentage is within the intracellular space (Loret and Simões, 2004).  The remainder 
is contained in the interfibrillar space (i.e. between the collagen fibers- the pore 
space of the ECM), where it appears to exist as a gel (Pearle et al., 2005).  Dissolved 
within the water are gases, small proteins, metabolites and inorganic ions such as 
Na+, K+, Ca2+ and Cl- (Linn and Sokoloff, 1965; Buckwalter and Mankin, 1997a).  
The water concentration varies throughout the depth of cartilage, decreasing from 
80% at the articular surface to 65% in the region of the bone-cartilage interface 
(osteochondral junction) (Venn and Maroudas, 1977; Bhosale and Richardson, 
2008).  The interaction between water and the structural macromolecules of cartilage 
substantially influences the mechanical properties of the tissue (Buckwalter et al., 
2005).  In addition, the flow of water through the cartilage and across the articular 
surface delivers nutrition to chondrocytes whilst also providing a medium for 
lubrication (Bhosale and Richardson, 2008).  
 
The solid phase of articular cartilage is comprised of three distinct classes of 
structural macromolecules: (1) collagens, (2) proteoglycans and (3) non-collagenous 
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proteins and glycoproteins.  Together, these macromolecules contribute 20-40% of 
the wet weight of cartilage (Buckwalter et al., 2005; Bhosale and Richardson, 2008).  
However, they differ both in their concentrations within articular cartilage and in 
their contributions to its properties.  Collagens contribute approximately 60% of the 
dry weight (solid phase) of articular cartilage, proteoglycans contribute 25 to 30%, 
and non-collagenous proteins and glycoproteins contribute 15 to 20% (Buckwalter et 
al., 2005).  The collagens, which have a half-life in excess of 100 years (Verzijl et 
al., 2000), form a fibrillar meshwork giving cartilage its form and tensile strength.  
The proteoglycans, which have a half-life between 3 and 25 years (Maroudas et al., 
1998), and non-collagenous proteins either bind to the fibrillar meshwork or become 
entrapped within it and act to maintain the macromolecular structure of the matrix.  
 
Type II collagen accounts for 90-95% of the total collagen found within the solid 
phase of cartilage.  Like all collagens, Type II collagen is composed of three 
polypeptide chains (α-chains), which are tightly wound together into a triple helix 
structure (Buckwalter and Mankin, 1997a).  This ‘rope-like’ structure is stabilised 
through a combination of hydrogen bonds and cross-links involving lysine residues 
(Muir, 1995), and provides articular cartilage with important shear and tensile 
properties (Zhu et al., 1993; LeRoux et al., 2000).  The collagen molecules orientate 
themselves in a staggered end-to-end and side-to-side fashion to form fibrils 
containing a multitude of holes and overlaps (Pearle et al., 2005), thereby forming a 
framework that has a ‘mesh-like’ appearance.  Type I, IV, V, VI, IX and XI 
collagens are also found in cartilage and principally serve to stabilise the type II 
collagen fibrillar network (Buckwalter et al., 2005; Sophia Fox et al., 2009).   
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Proteoglycans are the second largest group of macromolecules within the ECM.  
They are responsible for the turgid nature of cartilage and provide the osmotic 
properties needed to resist compressive loads (Roughley, 2006).  Proteoglycans are 
heavily glycosolated protein monomers consisting of a protein core with one or more 
covalently attached glycosaminoglycan chains.  Glycosaminoglycans are long 
unbranched polysaccharide chains consisting of repeating disaccharides that contain 
an amino sugar (Buckwalter and Mankin, 1997a; Roughley, 2006).  Each 
disaccharide unit contains at least one negatively charged carboxylate or sulphate 
group.  Glycosaminoglycans therefore form strings of negative charges that repel 
other negative charges i.e. Cl-, and attract cations i.e. Na+ and Ca2+.  
Glycosaminoglycans found in articular cartilage include chondroitin sulfate, keratin 
sulfate, dermatin sulfate and hyaluronic acid (Poole et al., 1996).  The attraction of 
cations results in an increase in total tissue inorganic ion concentration, which in turn 
results in an increase in the tissue osmolarity.  This creates a so-called ‘Donnan 
effect’ (raised extra-osmotic pressure that is attributable to cations attached to 
negatively charged proteins).  However, the resulting influx of water into the ECM is 
restricted by the surrounding collagen network (Buckwalter et al., 2005). 
 
Articular cartilage contains a variety of proteoglycans that are essential for normal 
function.  These proteoglycans can be divided into two major classes: (1) large 
aggregating proteoglycan monomers, otherwise known as aggrecans, and (2) small 
proteoglycans, which include biglycan, fibromodulin and decorin (Buckwalter and 
Mankin, 1997a).  The predominant proteoglycan in articular cartilage, accounting for 
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approx. 90% of the total ECM proteoglycan mass, is aggrecan (Buschmann et al., 
1996; Buckwalter and Mankin, 1997a; Pearle et al., 2005; Sophia Fox et al., 2009).  
Aggrecan is the largest proteoglycan in cartilage, possessing more than 100 
chondroitin sulphate and keratin sulfate chains (Roughley et al., 1995).  It fills most 
of the interfibrillar spaces within the collagen network (Buckwalter and Mankin, 
1997a) and is characterised by its ability to associate with hyaluronic acid 
(hyaluronan) non-covalently to form large proteoglycan aggregates, an association 
that is stabilised by link proteins (small non-collagenous proteins) (Buckwalter and 
Mankin, 1997a; Pearle et al., 2005; Sophia Fox et al., 2009).  In the constrained 
environment of the collagen fibrillar network, which itself endows cartilage with its 
mechanical strength in tension, the electrically charged and ‘gel-like’ aggrecan 
provides resistance to compression.  The importance of aggrecan to the resistance of 
compressive loads has been illustrated in animal studies whereby it has been 
demonstrated that aggrecan concentration is frequently higher in areas of habitually 
loaded cartilage (Slowman and Brandt, 1986; Kiviranta et al., 1988).  Conversely, it 
is reduced in concentration within experimentally immobilised animal joints 
(Palmoski et al., 1979; Kiviranta et al., 1987). 
 
In comparison to aggrecan, the small non-aggregating proteoglycans, the most 
common of which are decorin, biglycan and fibromodulin (Roughley et al., 1995), 
have shorter protein cores, occupy a small tissue volume and do not contribute to the 
mechanical behaviour of cartilage (Buckwalter et al., 2005).  Despite being the 
products of distinct genes, the non-aggregating proteoglycans have similar protein 
structures (Fisher et al., 1989; Oldberg et al., 1989).  However, they differ in 
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glycosaminoglycan composition and function.  Although termed ‘non-aggregating’, 
these proteoglycans are thought to interact with other matrix components.  Decorin 
and fibromodulin interact with type II collagen fibrils and are believed to play a role 
in organising and stabilising the type II collagen meshwork (Roughley et al., 1995).  
Biglycan is primarily found in the pericellular matrix where it is thought to interact 
with type VI collagen (Wiberg et al., 2001; Wiberg et al., 2002).  
 
A number of non-collagenous proteins and glycoproteins have been identified within 
articular cartilage, but few have been studied in detail (Roughley, 2001; Buckwalter 
et al., 2005).  Whilst the specific function of the vast majority of these molecules 
thus remains unknown, it is believed that they have regulatory roles with regard to 
the structure and function of the cartilage matrix, including matrix assembly, cell-cell 
and cell-matrix interactions, and matrix metabolism (Chevalier et al., 1994).  
Anchorin CII, cartilage oligomeric matrix protein (COMP), fibronectins and tenascin 
have been the most widely studied, yet remain to be characterised fully.  Anchorin 
CII is a collagen binding glycoprotein that is found on the surface of chondrocytes 
and is thought to aid in the anchorage of chondrocytes to the collagen fibrils of the 
ECM (Mollenhauer et al., 1984).  COMP is a cartilage specific protein that has a 
preferential localisation to the territorial matrix and also the capacity to bind to 
chondrocytes (Hedbom et al., 1992; DiCesare et al., 1994).  It may have value as a 
marker of cartilage turnover and has therefore been investigated as a potential 
indicator of progressive cartilage degeneration in patients with osteoarthritis and 
rheumatoid arthritis (Saxne and Heinegård, 1992; Lohmander et al., 1994; Sharif et 
al., 1995).  Fibronectins are believed to play an important role in chondrocyte 
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adhesion, migration and de-differentiation (Chevalier, 1993) while tenascin 
influences the interaction between chondrocytes and the pericellular matrix by 
interacting with fibronectin (Chiquet-Ehrismann et al., 1988; Lotz et al., 1989; 
Chevalier et al., 1994). 
  
1.2.2 Chondrocytes 
Chondrocytes are the only cells found within articular cartilage and are embedded 
within a large volume of ECM (Goldring, 2012).  They are surrounded by a 
specialised microenvironment that effectively insulates the chondrocyte and protects 
it from the bulk of the load-bearing matrix (Poole et al., 1992).  Each chondrocyte is 
linked at its surface to a proteoglycan and glycoprotein-rich ‘pericellular’ matrix 
(sometimes referred to as the glycocalyx), which itself is enclosed by a compacted 
fibrous pericellular capsule (Poole et al., 1984; Chang and Poole, 1997).  There is a 
close interaction between chondrocytes and their surrounding ECM, with regard to 
both attachment and communication, and this is primarily achieved through a family 
of transmembrane receptors known as integrins (Loeser, 2002).  Integrins bind to 
ligands within the ECM to form signalling complexes, which play a key role in 
chondrocyte survival, proliferation, differentiation, migration and remodelling  
mechanotransduction, chondrocyte growth, differentiation, migration and 
proliferation (Adams and Watt, 1993; Salter et al., 1995; Svoboda, 1998; Loeser, 
2000; Millward-Sadler and Salter, 2004; Gao et al., 2014).  
 
Collectively, the chondrocyte and its pericellular microenvironment represent the 
‘chondron’ (Poole et al., 1992).  These microanatomical units, which can be 
	   10	  
visualised under low power light microcopy, either exist as single, double or linear 
chondron columns (Poole, 1997) (Figure 1.1).  Immediately surrounding the 
chondron is the ‘territorial’ matrix (Poole et al., 1984).  This region is primarily 
composed of fine collagen fibrils, which form a basket-like network around the cells 
(Sophia Fox et al., 2009).  The matrix that occupies the majority of space between 
chondrocytes is referred to as the ‘interterritorial’ matrix and contributes the most to 
the biomechanical properties of articular cartilage (Guilak et al., 1999; Mow and 
Guo, 2002).  It is characterised by bundles of large collagen fibrils that are arranged 
parallel to the articular surface within the most superficial zone and perpendicular to 
the surface within deeper regions.  
 
 
Figure 1.1: Chondron units 
A 10µm thick coronal section of haematoxylin and eosin stained bovine articular cartilage, as viewed 
under a x20 objective, demonstrating the presence of chondrons, which physically separate the 
chondrocytes from the surrounding ECM.  These microanatomical units exist as either single (*), 
double (**) or linear (***) chondron columns (scale bar = 100µm).  Image kindly provided by Dr 
Asima Karim, Centre for Integrative Physiology, The University of Edinburgh. 
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Although chondrocytes are the only cells within cartilage they exhibit morphological 
heterogeneity throughout the depth of cartilage ranging from flattened at the surface 
to larger and rounder in deeper regions (Goldring, 2012) (Figure 1.2).  Due to the 
avascular nature of cartilage, chondrocytes primarily derive their nutrition from 
nutrient solutes in the synovial fluid.  It has been hypothesised that chondrocytes 
within deeper regions may also rely, to some extent, on the diffusion of nutrients 
across the osteochondral junction i.e. from the subchondral bone (Malinin and 
Ouellette, 2000; Wang et al., 2013).  Despite the low oxygen tension in articular 
cartilage, which ranges from 7% O2 at the articular surface to <1% O2 within deeper 
regions (Zhou et al., 2004; Cernanec et al., 2007), individual chondrocytes are 
actually quite metabolically active, having a glycolytic rate per cell similar to that of 
cells in well-vascularised tissues (Buckwalter and Mankin, 1997a).  However, due to 
the low cell density the total metabolic activity of the tissue is low. 
 
The primary role of the chondrocyte is to synthesise the macromolecular components 
that constitute the ECM whilst also regulating matrix metabolism (Muir, 1995; 
Buckwalter and Mankin, 1997a; Bhosale and Richardson, 2008).  Throughout their 
lifespan, chondrocytes have an intimate relationship with the ECM.  Alterations in 
the macromolecular composition of the ECM are closely monitored by the 
chondrocytes and, when necessary, controlled matrix synthesis or breakdown is 
initiated.  Matrix breakdown is mediated through the release of a variety of 
proteolytic enzymes including matrix metalloproteinases and aggrecanases 
(Buckwalter and Mankin, 1997a; Goldring and Marcu, 2009; Struglics and Hansson, 
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2012).   Chondrocytes can therefore be considered both the architects and cellular 
building blocks of articular cartilage. 
 
Chondrocytes are regarded as post-mitotic cells, in so much that once skeletal 
maturity is reached there is no further cell division detectable in healthy adult 
articular cartilage (Muir, 1995; Goldring and Marcu, 2009).  Mature chondrocytes 
therefore have a long life span and are generally expected to remain viable as long as 
their host.  However, once chondrocytes are lost they are not replaced, and when 
they are lost in large numbers their importance in the maintenance of cartilage 
integrity is illustrated: Simon et al. (1976) investigating the long-term effect of 
chondrocyte death induced by localised cryotherapy on rabbit articular cartilage in 
vivo, demonstrated, through histological staining coupled with both normal and 
polarised light microscopy, that the cartilage was structurally intact at 6 months 
despite the absence of living chondrocytes.  However, by 12 months extensive 
cartilage fibrillation and softening was evident, changes that were considered to be 
amongst the first macroscopic appearances associated with degenerative joint disease 
(Pearle et al., 2005). 
 
Whilst no studies have specifically investigated cartilage degeneration following 
catastrophic loss of chondrocyte viability in humans, a case report by van Huyssteen 
and Bracey (1999) possibly highlights the consequences of such an occurrence.  
Extensive chondrolysis, as evidenced by radiographical loss of joint space, was 
identified in three consecutive patients 2 to 4 months post anterior cruciate ligament 
reconstruction.  Throughout each of the three procedures, the knee joints were 
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mistakenly irrigated with 0.2% chlorhexidine instead of the standard 0.02%.  In a 
subsequent study by Campbell et al. (2014) osteochondral allografts were exposed to 
varying concentrations of chlorhexidine and chondrocyte viability assessed.  7 days 
post-pulse lavage with 0.25% chlorhexidine, which is comparable to the 
concentration administered to the above patients, chondrocyte viability was 10±19%.  
In comparison, chondrocyte viability in those allografts pulse lavaged with 0.002% 
chlorhexidine ranged from 67±4% to 81±22%.  It is therefore extremely important to 
preserve chondrocyte viability during both acute and chronic pathology, and also 
during surgical instrumentation in order to maintain cartilage integrity. 
 
1.2.3 Articular cartilage structure  
The structure of articular cartilage is both complex and heterogeneous.  The 
thickness, cell density, matrix composition and mechanical properties of articular 
cartilage vary within the same joint, between joints in the same individual and 
between species (Buckwalter et al., 2005).  The full thickness of cartilage extends 
from the articular surface to the osteochondral junction (bone-cartilage interface) 
(Figure 1.2).  Between these two points, articular cartilage is loosely divided into 
four distinct zones on the basis of depth-associated variation in cell morphology and 
ECM properties: [1] the superficial (tangential) zone (SZ), [2] the middle zone (MZ), 
[3] the deep zone (DZ) and [4] the zone of calcification (ZC), otherwise known as 
the zone of calcified cartilage (Figure 1.2) (Buckwalter and Mankin, 1997a; Poole, 
1997; Pearle et al., 2005).  The demarcation between each zone however can often 
be difficult to define. 
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In most species, including humans, the SZ is the smallest zone, accounting for 
approximately 0-10% depth from the articular surface (Pedersen et al., 2013) and 
typically consists of two layers (Figure 1.2) (Buckwalter et al., 2005).  The first of 
these layers is an acellular sheet of fine fibrils that is known as the lamina splendens 
(Buckwalter and Mankin, 1997a; Bhosale and Richardson, 2008).  Deep to this layer, 
flattened ellipsoid-shaped chondrocytes lie within a matrix that has a low 
proteoglycan and high collagen content (Poole et al., 1984).  The dense network of 
collagen fibres, which, along with the chondrocytes, are orientated parallel to the 
articular surface, provide the tissue with tensile strength, stiffness and durability 
(Clark, 1990; Wu et al., 2008; Mansfield et al., 2009).  This arrangement is also 
considered to act as a sieve by allowing the passage of nutrients from the synovial 
fluid into the cartilage whilst, at the same time, preventing the ingress of larger and 
potentially damaging molecules of the immune system (Buckwalter and Mankin, 
1997a). 
 
The MZ provides a functional and anatomical bridge between the SZ and DZ and 
extends from approx. 10-40% depth from the articular surface (Jadin, 2005; Pedersen 
et al., 2013) (Figure 1.2).  The chondrocytes within this zone are at lower density 
and are more spherical in shape in comparison to the SZ.  The collagen fibres have a 
greater diameter and, in contrast to the SZ, arch obliquely in relation to the articular 
surface (Poole, 1997).  Furthermore, there is a greater concentration of proteoglycans 
within the matrix of this zone but, conversely, there is a lower water and collagen 
content (Buckwalter et al., 2005).  Functionally, the MZ offers the first line of 
resistance to compressive forces and thereby acts as a ‘shock absorber’. 
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Immediately below the MZ lies the DZ, which extends from approx. 40-100% depth 
from the articular surface (Figure 1.2) (Pedersen et al., 2013).  It is characterised by 
spherical chondrocytes that organise themselves into columns as a result of the 
vertically orientated collagen fibres in this zone (Pearle et al., 2005).  These collagen 
fibres have the widest diameter of all collagen fibres embedded within articular 
cartilage and extend into the tidemark, the boundary between uncalcified and 
calcified cartilage (Buckwalter and Mankin, 1997a).  The main function of the DZ, 
which contains the highest concentration of proteoglycans and the lowest water 
content, is to provide the maximum resistance to compressive forces (Buckwalter 
and Mankin, 1997a; Pearle et al., 2005). 
 
The deepest layer of cartilage is the ZC and it is this layer that separates articular 
cartilage from subchondral bone (Figure 1.2).  The zone is characterised by a sparse 
population of spherical chondrocytes that are of a lower volume than those from the 
DZ (Buckwalter and Mankin, 1997a).  The chondrocytes are surrounded by 
uncalcified lacunae and radial collagen fibres that are anchored within a calcified 
matrix in which there is an absence of proteoglycans (Poole, 1997).  The ZC plays a 
crucial role in tethering cartilage to bone (Keinan-Adamsky et al., 2005; Sophia Fox 
et al., 2009). 
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Figure 1.2: Zonal heterogeneity of articular cartilage 
Full-thickness coronal section of 5-chloromethylfluorescein diacetate (CMFDA) and propidium 
iodide (PI) labelled bovine articular cartilage (CMFDA stains the cytoplasm of viable chondrocytes 
green while PI stains the nuclei of dead or dying cells red; staining was conducted post-cartilage 
trimming, hence a small number of cells died as a result of the scalpel blade-induced mechanical 
trauma), acquired using an upright confocal laser scanning microscope coupled with a x10 dry 
objective, displaying the superficial (SZ), middle (MZ) and deep zones of cartilage along with the 
zone of calcification (ZC).  Note the altered chondrocyte organisation with increasing depth from the 
articular surface: cells in the SZ are oval, flattened and orientated parallel to the articular surface, 
whereas those chondrocytes in the MZ and DZ are rounder and arch to orientate more obliquely (MZ) 
and perpendicular to the articular surface.  Important histological/microscopic landmarks are also 
illustrated (scale bar = 100µm). 
 
1.2.4 Cartilage repair  
In 1743 William Hunter stated ‘from Hippocrates to the present age it is universally 
allowed that ulcerated cartilage is a troublesome problem and once destroyed, it 
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never repairs’.  It has therefore long been established that articular cartilage has a 
very poor regenerative capacity following injury.  There are at least two possible 
explanations for this phenomenon.  Firstly, as mentioned previously, the literature to 
date suggests that cellular division does not take place in healthy articular cartilage 
once skeletal maturity has been reached (Muir, 1995; Goldring and Marcu, 2009).  
Chondrocyte loss, as a consequence of injury or disease, in adulthood is therefore not 
replaced.  Secondly, cartilage is an avascular tissue.  In well vasularised tissues such 
as skin and liver, the healing process follows an established pattern of necrosis, 
inflammation and repair (Mankin, 1982).  An adequate blood supply is essential for 
the inflammation and repair phases of the response.  Necrosis has been shown to be 
present in partial thickness articular cartilage injuries but no healing process has 
subsequently been identified (Mankin, 1982).  However, if the injury extends beyond 
the zone of calcification, blood seeps into the wound from the vascularised 
subchondral bone thereby delivering the necessary inflammatory mediators, growth 
factors and reparative cells, such as fibroblasts and mesenchymal stem cells, for 
healing to occur.  Unfortunately however, the healing process that ensues is 
rudimentary and the defect, at best, is filled with mechanically inferior fibrocartilage 
(Bhosale and Richardson, 2008; Kang et al., 2008).  This suboptimal tissue has been 
shown to degenerate quickly once mechanical load is applied with the eventual 
formation of an isolated osteoarthritic lesion that may subsequently result in pain and 
disability (Mankin, 1982; Hunziker, 2002).  It is therefore of critical importance that 
ongoing research should focus on attempts to reduce the extent of cartilage 
destruction during episodes of pathology and following trauma. 
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1.2.5 Experimental study of articular cartilage 
The assessment of articular cartilage following experimental challenge has largely 
been conducted on animal models, isolated chondrocytes or cartilage explants.  
Animal models have the advantage of allowing the analysis of cartilage within a 
living joint.  Thus, the results obtained from such studies reflect a closer correlation 
and relevance to the clinical setting.  Nevertheless, there are disadvantages to the use 
of live animal models.  In some circumstances, the strong and often complex host 
immune response, inherent in an animal model, can make the assessment of 
experimental variables difficult.  For example, when assessing the impact of a 
particular bacterial strain on cartilage in an animal model of septic arthritis, it is 
difficult to distinguish what proportion of the resulting cartilage damage is due to the 
bacterial toxins and what proportion is due to the host immune response.  Albeit, 
some of these difficulties can be overcome with the use of animals bred with the 
selective absence of various components of the immune response.  In addition, 
animals are expensive to purchase and maintain, which is a not inconsiderable factor.  
Animal studies also necessitate the acquisition of animal handling licenses and 
ethical approval.   
 
In some research circumstances, it is important to remove the host immune response 
from the experimental environment in order to evaluate the primary effect of 
particular ‘challenges’ on articular cartilage more accurately.  Accordingly, it is 
necessary to distance the research model from the living animal.  One such model is 
the use of isolated chondrocytes.  In the absence of a host immune response, isolated 
chondrocytes have the advantage of allowing easier control of experimental 
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variables. However, in relative comparison to other isolated cell types, chondrocytes 
are challenging.  Despite their apparently stable appearance within healthy living 
cartilage for many decades, once chondrocytes are isolated within an experimental 
vessel such as a Petri dish (i.e. taken out of their native environment), they rapidly 
change their phenotype (i.e. de-differentiate).  They develop a ‘fibroblast-like’ 
flattened and elongated shape, enter a proliferative cycle and alter the characteristics 
of the synthesised collagen, producing predominantly type I collagen (Gargiulo et 
al., 2002).  The isolation of ‘pure’ chondrocytes is thus challenging.  However, one 
experimental method commonly employed to prevent the undesirable change in 
phenotype is the isolation chondrocytes within agarose constructs (Buschmann et al., 
1992).  
 
Articular cartilage explants are simply pieces of cartilage of variable size that are 
extracted from a synovial joint.  When subchondral bone is attached to the cartilage 
they are referred to as osteochondral explants (Figure 1.3).  In comparison to 
isolated chondrocytes, they allow the assessment of cartilage as a tissue, intact with 
its cellular and matrix components, whilst also permitting tight control of 
experimental variables in the absence of a host immune response.  Cartilage explants, 
sourced from various animals have frequently been used for research purposes.  
Some studies have utilised human cartilage explants.  However, there are several 
potential problems associated with their use.  Similar to live animal studies, ethical 
permission is required and, additionally, patient consent is mandatory.  Human 
cartilage is traditionally obtained from the femoral condyles or tibial plateaus of 
patients undergoing total knee joint replacement (Amin et al., 2011) or the femoral 
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heads of patients either undergoing total hip replacement or hemiarthroplasty for 
osteoarthritis and femoral neck fracture, respectively (Démarteau et al., 2006).  As 
these patients are invariably elderly, the common pathology is osteoarthritis and it is 
often difficult to source healthy non-degenerate cartilage from such surgical discard.  
In a study by Amin et al. (2011), which investigated the chondroprotective effect of 
raised irrigation solution osmolarity in a human cartilage explant model of sharp 
mechanical trauma, the femoral condyles of only four patients out of a total of 30 
(87% rejection rate) recruited for the study were deemed non-degenerate and suitable 
for experimental purposes.  A further consideration against the use of human 
cartilage is that studies have demonstrated similar responses by bovine and human 




Figure 1.3: Osteochondral explant 
Cartilage explants are defined as harvested pieces of articular cartilage, of variable size, for the 
purpose of in vitro experimentation.  In comparison to isolated chondrocytes, they permit the study of 
cartilage as a tissue i.e. with intact cellular and matrix components and thus more accurately mimic 
the in vivo environment (scale bar = 0.5cm). 
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1.3 Septic Arthritis 
One condition that has the potential to cause rapid joint destruction, and thus injury 
to articular cartilage, is septic arthritis.  Septic arthritis, which is considered a 
rheumatological and orthopaedic emergency, is defined as joint inflammation 
secondary to bacterial infection (Mathews et al., 2008).  The destructive effects of 
sepsis on articular cartilage were described several centuries ago by William Hunter 
(1743) who stated: “when a cartilage is inflamed and soaked in a purulent material, 
the connecting fibres will be the soonest to give way and the cartilage will become 
soft and red”.  Patients with septic arthritis typically present with a red, hot and 
swollen joint that is extremely painful, especially upon movement.  Commonly, there 
are associated features of systemic upset including generalised malaise and a marked 
pyrexia.  
 
The management of septic arthritis has remained a challenge for centuries.  In 1819, 
Sir Benjamin Brodie wrote of the difficulties in draining a septic joint, advocating 
“removal of limb by amputation” in patients presenting with septic arthritis 
(Buchanan, 2003; Nade, 2003).  Whilst amputation is fortunately very rarely 
associated with septic arthritis in the present medical era, some patients, despite 
current therapeutic strategies, still remain inadequately treated (Goldenberg, 1998).  
Consequently, these patients may be left with devastating lifelong problems such as 
pain, disfigurement and disability (Weston et al., 1999; Shirtliff and Mader, 2002; 
Nunn et al., 2007; Mathews et al., 2008).  The work presented in this thesis focused 
on improving our knowledge of the interaction between bacteria and articular 
cartilage with the hope of developing novel chondroprotective treatments.  
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1.3.1 Epidemiology 
Septic arthritis affects all age groups.  However, there are incidence peaks in the very 
young and the elderly (Shetty and Gedalia, 2004).  Although any joint can be 
affected, there is a propensity for lower limb involvement, with the knee and hip 
most commonly implicated (Shirtliff and Mader, 2002) followed by the shoulder, 
wrist, elbow and ankle in varying orders depending on the particular case series 
assessed (Morgan et al., 1996; Kaandorp et al., 1997a; Weston et al., 1999; Gupta et 
al., 2001; Abid et al., 2006).  Septic arthritis is not exclusively monoarticular with 
polyarticular involvement being seen in approximately 20% of cases (Dubost et al., 
1993; Kaandorp et al., 1997a; Mateo Soria et al., 2009).   
 
In developed countries, the incidence of septic arthritis ranges from 2-10 
cases/100,000 persons (Morgan et al., 1996; Weston et al., 1999; Levine and Siegel, 
2003; Mathews et al., 2010; Chander and Coakley, 2011) rising to 30-70 
cases/100,000 persons in patients who have had prior joint disease i.e. rheumatoid 
arthritis (Goldenberg, 1998).  There is an estimated case fatality rate of 11%, the 
majority of which are elderly patients with multiple co-morbidities (Gupta et al., 
2001; Shirtliff and Mader, 2002; Mathews et al., 2008).  Since a significant 
proportion of cases (approx. 30%) are never confirmed bacteriologically (Nduati and 
Wamola, 1991; Weston et al., 1999; Mathews et al., 2010), epidemiological studies 
may underestimate the incidence of septic arthritis and its burden of morbidity and 
mortality.  Risk factors for the development of septic arthritis have been identified 
from several retrospective and prospective studies and include the following: 
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rheumatoid arthritis, osteoarthritis, gout, diabetes mellitus, oral corticosteroids, intra-
articular steroid injections, cytotoxic therapy, previous joint surgery, recent joint 
trauma, underlying carcinoma, upper respiratory tract infection, skin ulceration, 
cellulitis, intravenous drug abuse and alcohol excess (Morgan et al., 1996; Weston et 
al., 1999; Gupta et al., 2001).      
 
Worldwide, the prevalence of septic arthritis increases in populations from poorer 
socioeconomic backgrounds.  For example, in Northern Australia the incidence of 
septic arthritis amongst Aboriginal Australians, an impoverished population, was 29 
cases/100,000 persons in comparison to 9 cases/100,000 persons in non-Aboriginal 
Australians (Morgan et al., 1996).  Whilst septic arthritis in infants is rare in Western 
societies, it is more common in sub-Saharan Africa (Nduati and Wamola, 1991; 
Smith et al., 2002; Akinyoola et al., 2006; Lavy, 2007; Nunn et al., 2007) and can 
have potentially devastating consequences.  Septic arthritis in infants can lead to 
permanent cartilage damage, osteomyelitis, avascular necrosis of the femoral head 
(in cases of septic arthritis of the hip) and destruction of the epiphyseal growth plate, 
leaving the child with permanent joint deformity and thus disability (Lavy, 2007; 
Nunn et al., 2007).  
 
1.3.2 Diagnosis  
Septic arthritis is typically diagnosed on the basis of patient history, clinical 
examination and laboratory investigations.  A positive synovial fluid gram stain or 
culture confirms the diagnosis and it is therefore imperative that the joint in question 
is aspirated without delay if septic arthritis is suspected.  However, a negative result 
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cannot exclude a diagnosis of septic arthritis as, disappointingly, synovial fluid gram 
staining and culture are positive in only 50% and 70% of cases, respectively 
(Mathews et al., 2010).  Blood cultures may aid the diagnosis as a retrospective 
study by Weston et al. (1999) investigating 462 cases demonstrated that 24% of the 
patients studied had positive blood cultures.  Interestingly, in 9% of the patients with 
confirmed septic arthritis in this particular case series, blood cultures were the only 
source of a positive microbiological diagnosis. 
 
In addition to gram stain and culture, initial synovial fluid analysis at the bedside 
may arise suspicion of a diagnosis of septic arthritis.  Synovial fluid from a septic 
joint typically has a turbid and yellow appearance, in some cases appearing as ‘frank 
pus’, which is considerably different to the often clear and straw-coloured fluid 
associated with a reactive effusion secondary to osteoarthritis.  Even if subsequent 
gram stain and culture are negative, the number of white blood cells (leukocytes) in a 
defined volume (white cell count (WCC)) of synovial fluid is considered helpful 
(Shirtliff and Mader, 2002).  In a retrospective study by Coutlakis et al. (2002), the 
records of 202 consecutive patients with synovial WCCs >2000/mm3 were reviewed.  
Septic arthritis was diagnosed in 77% of patients with counts >100,000/mm3, 47% in 
the 50,000-100,000/mm3 range and 5% with counts <50,000/mm3.   Thus, the 
diagnosis of septic arthritis is unlikely in those patients with a WCC<50,000/mm3, 
although it still cannot be excluded.  
 
Further laboratory tests that may guide the clinician to a diagnosis of septic arthritis 
include an assessment of inflammatory markers.  In the blood samples of patients 
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with septic arthritis, erythrocyte sedimentation rate and C-reactive protein level are 
usually elevated (Mathews et al., 2010).  However, normal values for these 
parameters have been reported (Li, 2004), especially in malnourished, anaemic and 
underweight children (Lavy, 2007), and thus an absence of an acute phase response 
does not exclude a diagnosis of septic arthritis.  Nevertheless, once a diagnosis has 
been established, serial measurements of inflammatory markers, if elevated at 
presentation, are useful to monitor the response to treatment.  
 
In current clinical practice, imaging studies are neither sensitive nor specific for the 
diagnosis of septic arthritis (Shirtliff and Mader, 2002; Chander and Coakley, 2011) 
but are nevertheless useful to either support or dissuade a clinical suspicion of the 
disease.  Plain radiographs frequently appear normal during the first few days of 
infection.  They may also demonstrate the presence of co-existent osteomyelitis or 
changes consistent with pre-existing joint disease i.e. osteoarthritis.  In some cases, 
fat pad displacement (typically seen in radiographs of the knee and elbow) and joint 
space widening due to localised oedema and effusion may be evident (Shirtliff and 
Mader, 2002; Nunn et al., 2007).  Plain radiographs however are perhaps most useful 
as a baseline for future comparison.  As the infection progresses, changes such as 
acute joint space narrowing, indicative of catastrophic articular cartilage destruction, 
may be become evident.  Indeed, the sequelae of an episode of septic arthritis may 
only become evident months to years post-sepsis.  Examples of potential late 
radiographic changes include secondary osteoarthritis and joint fusion in adults and 
joint subluxation/dislocation and avascular necrosis of the femoral head in children. 
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Ultrasonography is a useful investigative tool for identifying intra- and extra-
articular abnormalities that may not be evident on plain radiographs.  It enables 
assessment of the intra-articular compartment, joint capsule, and surrounding soft 
tissues.  Its main strength however is the detection of early fluid collections both 
within and outwith the joint, for which it has both a high specificity and sensitivity 
(Shirtliff and Mader, 2002).  Collections as small as 1-2ml have been shown to be 
accurately detected (Zieger et al., 1987).  It is therefore particularly useful for the 
detection of effusions and juxta-articular collections in deep joints such as the hip.  
In addition, it can also be used to guide initial joint aspiration and subsequent 
drainage procedures in such joints.  Given the non-invasive nature of 
ultrasonography and the lack of ionising radiation, it is a popular investigative 
technique for the assessment of children with suspected septic arthritis. 
 
When a diagnosis of septic arthritis remains ambiguous or the extent of surrounding 
bone and soft tissue infection is questioned, computed tomography (CT), magnetic 
resonance imaging (MRI) or radionuclide scans may be helpful.  During the early 
stages of septic arthritis, CT shares some of the limitations of plain radiographs 
(Chander and Coakley, 2011).  However, CT scans may enable the visualisation of 
soft tissue swellings, para-articular abscess formation, and the presence of joint 
effusion that may not be evident on plain radiographs.  In addition, a CT scan may be 
useful for the investigation of joints that are difficult to assess on plain radiographs 
such as the sacro-iliac and sternoclavicular joints.  Like Ultrasonography, CT may 
also be used to guide the initial aspiration of deep joints. 
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Although MRI provides a lower resolution of calcified bone structures, it displays 
considerably greater resolution for soft tissue (Shirtliff and Mader, 2002).  Soft tissue 
abnormalities such as joint effusions, abscesses and tissue oedema are particularly 
evident on T2 weighted images whereby oedema and fluid are projected ‘bright’ and 
fat is ‘dark’.  However, as with plain radiography, CT and Ultrasonography, MRI is 
non-specific and is unable to differentiate between infectious and non-infectious 
arthropathies (Graif et al., 1999).  Interestingly, a recent animal study by Lefevre et 
al. (2011) has identified a potential future role for MRI in monitoring the in vivo 
response to antibiotic therapy in patients with septic arthritis.  Septic arthritis was 
induced in rabbits through the intra-articular inoculation of S. aureus.  Thereafter, the 
ensuing infection and subsequent response to antibiotic treatment was assessed using 
MRI coupled with ‘ultrasmall superparamagnetic iron oxide’ (USPIO) particles.  
Following injection, USPIO particles are phagocytosed by macrophages, which then 
become amenable to MR imaging.  Macrophages are recruited during the early 
stages of joint infection and then dissipate with the resolution of infection.   Thus, the 
signal intensity changes according to the extent of USPIO-loaded macrophage 
infiltration, thereby providing a means of monitoring the response to antibiotic 
treatment.  
 
Radionuclide scans (otherwise known as bone scans or skeletal scintigraphy), 
commonly utilising either gallium-67-citrate (67Ga), technetium-99m (99mTc) or 
indium-111 (111In)-labelled polyclonal human immunoglobulins or 99mTc or 111In-
labelled autologous leukocytes (Lupetti et al., 2003), are helpful in establishing a 
diagnosis of infection.  Unlike MRI and CT, they permit whole-body imaging and 
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are therefore extremely useful for the assessment of patients with ‘sepsis of unknown 
origin’ i.e. they can be used to localise sepsis.  They are also useful for confirming 
that an abnormality identified on CT or MRI is indeed infectious in origin.  In 
orthopaedic practice, 99mTc  and 111In leukocyte scans are routinely employed during 
the assessment of patients with painful joint prostheses in order to help distinguish 
between infection and aseptic loosening (Johnson et al., 1988).  Unfortunately 
however, current radiopharmaceuticals accumulate in both infected and inflamed 
areas due to non-specific mechanisms of accumulation (Becker and Meller, 2001). 
Thus, at present, radionuclide scans lack the specificity to differentiate between 
active infection and inflammation and are therefore not commonly utilised for the 
diagnosis of septic arthritis.   
 
1.3.3 Management 
A joint affected by septic arthritis contains both pus and bacteria and it has long been 
established that this combination is highly destructive to articular cartilage (Hunter, 
1743).  Clinical and experimental research to date has demonstrated an undisputed 
relationship between early and aggressive initiation of joint lavage and a successful 
outcome (Jackson, 1985; Lane et al., 1990; Jerosch et al., 1995; Stutz et al., 2000; 
Seara et al., 2002; Ateschrang et al., 2011).  Septic arthritis is therefore considered a 
rheumatological or orthopaedic emergency and current treatment is focused on early 
institution of appropriate antibiotics and prompt removal of purulent synovial fluid 
(pus) from the infected joint.  
 
	   29	  
There are a number of ways of removing pus from a septic joint ranging from simple 
needle aspiration, through tidal irrigation (a technique whereby the joint is aspirated 
to dryness i.e. no more fluid can be aspirated, followed by the flushing of lavage 
fluid in and out of the joint through wide bore needles), to invasive surgery, which 
may take the form of minimally invasive arthroscopy or open arthrotomy.  Despite 
advocates of their own methods making claims for their preferred techniques, there 
is, at present, no prospective evidence to suggest that any joint irrigation strategy is 
superior (Manadan and Block, 2004; Ravindran et al., 2009).  The preferred method 
of pus removal therefore tends to be dependent upon local guidelines (Coakley et al., 
2006).  
 
Following the initial aspiration of synovial fluid for microbiological analysis, there 
may be a delay of several hours before the gram stain result is communicated to the 
clinician and a further 24-48hrs may lapse before the results of the cultures, 
including antibiotic sensitivities, are available.  In addition, for a variety of reasons 
there may a considerable delay between initial joint aspiration and formal joint 
lavage i.e. lack of operating theatre availability.  It is therefore important that 
antibiotics are commenced without delay.  Which antibiotics, how they are 
administered and for how long are questions that have not been addressed in any 
particular studies (Lavy, 2007).  A large meta-analysis and systematic review of 
antibiotic treatment for septic arthritis conducted by Stengel et al. (2001) failed to 
show an advantage of any one antibiotic regime over another.  At present, antibiotic 
regimes are therefore chosen on the basis of the most likely causative organisms and 
altered accordingly following the acquisition of culture sensitivities.  Given the 
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strong association of S. aureus and Streptococci with septic arthritis (Chander and 
Coakley, 2011), antibiotics are usually empirically selected to cover these pathogens 
(Goldenberg, 1998).   
 
Regardless of antibiotic regime, the general consensus among clinicians is that 
intravenous antibiotics are advised in the early stages, with a move to oral antibiotics 
when the patient demonstrates clear signs of clinical improvement coupled with 
falling inflammatory markers.  The majority of clinicians continue with the 
administration of antibiotics for 4-6 weeks although there is no compelling scientific 
backing for this duration (Lavy, 2007).  Despite previously held historical views that 
rest after joint infection should be ‘uninterrupted and prolonged’ (Salter et al., 1981), 
there is no evidence to suggest that patient immobilisation aids joint recovery 
following septic arthritis.  Indeed, this was confirmed in a lapine study by Salter et 
al. (1981) whereby continuous passive motion gave improved clinical and 
pathological results following joint infection and injury.  Mobilisation is therefore 
actively encouraged in patients with septic arthritis. 
 
There is evidence from animal studies that the simultaneous administration of 
systemic antibiotics and intra-articular steroids may have a protective effect in 
reducing the extent of articular cartilage destruction (Wysenbeek et al., 1998; Lavy, 
2007).  In a communication by Lane (2000), the successful treatment of a 62 year old 
man and an 87 year woman, who had ongoing pain and persisting synovitis despite 
antibiotics and bedside joint lavage, with a single intra-articular steroid 
administration was described.  The return of both patients to a full and independent 
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life with no sequelae is reported.  However, the administration of intra-articular 
steroids in humans with acute septic arthritis is not common practice, primarily 
through a fear of provoking overwhelming and unrestrained bacterial sepsis within 
the joint. 
 
Despite current treatment strategies, some individuals develop an aggressive form of 
septic arthritis that results in rapid and catastrophic cartilage breakdown.  It is all the 
more devastating for these individuals as subsequent joint replacement in this group is 
bedeviled by a greater risk of periprosthetic sepsis (Jerry et al., 1988).  Worryingly, 
retrospective studies suggest that some degree of permanent joint damage, involving 
direct cartilage injury, develops in up to 50% of cases (Kaandorp et al., 1997b; 
Goldenberg, 1998; Krieg, 1999).  This suggests that chondrocyte death may occur 
during septic arthritis, as these cells are, as previously mentioned, the only living 
agents capable of cartilage maintenance (Muir, 1995).  However, the loss of 
chondrocytes, which are irreplaceable after skeletal maturity (Goldring and Marcu, 
2009), and subsequent loss of cartilage integrity may not be clinically evident for 
years.  Given the lack of long-term prospective studies following-up patients with 
septic arthritis, it is thus possible that supposedly treated episodes of septic arthritis 
may have seeded the foundations for future problems such as early onset osteoarthritis. 
 
1.3.4 Pathogenesis 
Septic arthritis ensues when bacteria colonise a synovial joint in sufficient numbers 
to trigger an acute inflammatory reaction.  The pathogenesis is multifactorial and 
depends upon interactions between host joint tissues, the invading bacteria and the 
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host immune response.  There are three defined stages during the development of 
septic arthritis: (1) bacterial joint colonisation, (2) establishment of infection and (3) 
induction of the host inflammatory response. 
 
In the majority of cases, bacterial colonisation of a synovial joint arises through the 
haematogenous spread of bacteria (Goldenberg, 1998; Shirtliff and Mader, 2002; 
Lavy, 2007).  The synovial membrane has no limiting basement plate under the well-
vascularised synovium (Shirtliff and Mader, 2002; Lavy, 2007) thereby allowing the 
easy haematogenous entry of bacteria into the joint.  It is unsurprising therefore that 
septic arthritis is commonly associated with a bacteraemic episode arising from a 
distant source, typically the chest or urinary tract.  In addition, bacteria may also gain 
access to a joint from an infectious focus within adjacent structures.  For example, in 
infants with metaphyseal osteomyelitis, the presence of small blood vessels crossing 
the epiphyseal growth plate may permit the extension of infection into the epiphysis 
and the joint space thereafter (Jackson et al., 1992; De Boeck, 2005).   
 
Rarely, direct joint colonisation may occur following intra-articular injections, 
surgical instrumentation or penetrating trauma.  It has also been suggested that 
closed injury to a joint may predispose an individual to septic arthritis, the current 
hypothesis being that capillary blood stasis arising as a result of trauma creates a 
potential nidus for the development of infection (Lavy, 2007).  It has also been 
postulated that microtrauma at the capillary level may reduce oxygen tension locally, 
thereby decreasing the efficiency of the host immune response (Shirtliff and Mader, 
2002).  This may explain why there is a higher incidence of septic arthritis of the 
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shoulder in children from sub-Saharan Africa (Smith et al., 2002), as children in this 
part of the world are traditionally ‘swung’ onto the mother’s back by holding the 
child’s arm, thereby causing repeated episodes of minor injury to the shoulder joint.  
The association between microtrauma and the development of septic arthritis is 
indeed supported by a lapine study conducted by Olney et al. (1987), whereby 
microtrauma in the presence of bacteraemia was found to render joints susceptible to 
infection.  
 
Once bacteria gain entry to the closed joint space, low fluid shear conditions within 
the joint promote bacterial adherence and the establishment of infection (Shirtliff and 
Mader, 2002).  Some bacterial species, such as S. aureus, also have a variety of 
surface receptors for host proteins, termed ‘microbial surface components 
recognising adhesive matrix molecules’ (MSCRAMMs), that mediate adherence to 
host matrix components including fibronectin, laminin, elastin, collagen and 
hyaluronic acid (Shirtliff and Mader, 2002).  Once the joint is colonised, bacteria 
rapidly proliferate and trigger an acute inflammatory response.  During the early 
stages of infection, the inflammatory cytokines interleukin 1-β (IL-1β) and 
interleukin 6 (IL-6) are released into the synovial fluid by synovial cells, which 
subsequently activate the release of acute-phase proteins, for example CRP, from the 
liver (Lowy, 1998; Osiri et al., 1998).  There is also an accompanying influx of host 
inflammatory cells.  The acute-phase proteins bind to the bacteria, promoting 
opsonisation and activation of the complement system.  Phagocytosis of the bacteria 
is conducted by macrophages, synoviocytes and polymorphonuclear neutrophils and 
is associated with the further release of inflammatory cytokines including tumour 
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necrosis factor alpha (TNF-α), granulocyte-macrophage colony-stimulating factor 
(GMCSF) and interleukin 8 (IL-8) (Shirtliff and Mader, 2002).  In addition, there is 
the further release of IL-1β and IL-6. 
 
At a later stage, cells of the adaptive immune response (CD4+ T cells) enter the joint 
and may aid bacterial clearance.   Adaptive immunity consists of T-cell mediated (T-
helper 1 (Th1)) and humoral (T-helper 2 (Th2)) responses but its role in septic 
arthritis remains to be fully defined.  The cytokine gamma interferon (IFN-γ), 
produced by activated CD4+ Th1 cells, has been shown to reduce mortality and the 
level of joint destruction in a murine model of Group B Streptococcus-induced septic 
arthritis.  This is supported by Puliti et al. (2002) who identified that interleukin 12 
(IL-12), a heterodimeric cytokine produced mainly by mononuclear phagocytes and 
B cells, reduced the extent of articular cartilage lesions and that this protective effect 
was mediated through IL-12 induced release of IFN-γ.  In contrast however, a murine 
study of S. aureus-induced septic arthritis conducted by Zhao et al. (1998), identified 
that IFN-γ increased both the frequency and severity of septic arthritis whilst 
simultaneously, and paradoxically, protecting the mice from overwhelming 
septicaemia.  In a further S. aureus murine study by Sasaki et al. (2000) investigating 
interleukin 4 (IL-4) and interleukin 10 (IL-10), cytokines produced by CD4+ Th2 
cells, both IL-4 and IL-10 were found to play a role in host resistance to infection 
through the regulation of IFN-γ.  From the experimental studies to date it would 
therefore appear that particular components of the T-cell mediated immune response 
are beneficial for some bacterial species while destructive for others. 
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In the event that the host immune response is unable to contain the infection quickly, 
a fierce inflammatory response, associated with high levels of cytokines and reactive 
oxygen species, along with the release of bacterial virulence factors may rapidly 
cause cartilage destruction (Riegels-Nielsen et al., 1989; Wysenbeek et al., 1998; 
Shirtliff and Mader, 2002).  Elevated cytokine levels stimulate the release of host 
matrix metalloproteinases, including stromelysin and gelatinase A & B, in addition 
to other collagen-degrading enzymes (Williams et al., 1990; Williams et al., 1991; 
García-Arias et al., 2011).  Furthermore, inflammatory cells, synovial cells and 
invading bacteria all release proteolytic enzymes that are capable of degrading the 
ECM, which may initiate within 8hrs of infection (Smith et al., 1987).  Cartilage 
integrity may be further compromised by the presence of a large joint effusion, 
which arises as a result of inflammation of the synovium and altered synovial fluid 
dynamics (Nade, 2003).  The joint effusion increases intra-articular pressure, which 
mechanically impedes the blood and nutrient supply to the joint with subsequent 
destruction of the synovium and cartilage. 
 
ECM degradation within septic joints is characterised by a rapid reduction in matrix 
proteoglycans, which typically occurs within 48hrs of infection (Smith and 
Schurman, 1983).  This is followed by a more prolonged period of collagen loss, 
prior to the emergence of gross morphological changes over the articular surface 
(Smith et al., 1987).  In experimental models, at least 10 days must lapse before loss 
of collagen is detectable (Smith et al., 1987).  
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Worryingly, an in vivo lapine study of S. aureus-induced septic arthritis by Smith et 
al. (1987) identified that some degree of cartilage destruction was still evident 
regardless of when antibiotics were commenced.  Discouragingly, further studies on 
experimentally-induced S. aureus septic arthritis have confirmed the finding that 
continued cartilage destruction is a common occurrence in spite of joint lavage and 
the administration of antibiotics (Bobechko and Mandell, 1975; Salter et al., 1981; 
Smith et al., 1987).  These experimental findings are corroborated by more recent 
retrospective clinical studies, which highlight some degree of joint destruction in up 
to 50% of patients with septic arthritis despite current treatment strategies (Kaandorp 
et al., 1997b; Goldenberg, 1998; Krieg, 1999).  To conclude, there is scientific 
evidence to suggest that both bacterial virulence factors and components of the host 
immune response play an important role in the overall cartilage destruction but it is 
not yet known what contribution each of these play in the destructive process.  
 
1.3.5 Microbiology 
Numerous bacterial species have been implicated in the development of septic 
arthritis.  In adults, the most commonly isolated organism in adults is S. aureus, 
accounting for 40 to 65% of cases (Kaandorp et al., 1997a; Gupta et al., 2001).  This 
increases further to 80% in patients with diabetes or rheumatoid arthritis 
(Goldenberg, 1998).  Over the past decade, there has been concern over the 
increasing incidence of methicllin-resistant S. aureus (MRSA) (Cunningham et al., 
1996).  Streptococci are also commonly implicated in septic arthritis, with 
Streptococcus pyogens, Streptococcus pneumoniae and group A β-haemolytic 
Streptococci being most frequently isolated (Goldenberg, 1998).  Group B, C, G and 
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F Streptococci are also not infrequently involved, especially in immunocompromised 
patients or patients with either diabetes, malignancy or serious genitourinary or 
gastrointestinal infections (Morgan et al., 1996; Ryan et al., 1997; Schattner and 
Vosti, 1998).  Gram-negative bacilli are identified in up to 20% of cases of septic 
arthritis and are commonly associated with intravenous drug abuse, the extremes of 
age, and immunocompromised patients (Morgan et al., 1996; Dubost et al., 2002).  
Of the gram-negative organisms, Pseudomonas aeruginosa and Escherichia coli are 
most frequently isolated (Shirtliff and Mader, 2002). 
 
In neonates under the age of 2 months, the most common organisms associated with 
community-acquired septic arthritis are group B Streptococci followed by S. aureus 
and gram-negative bacilli (Lavy, 2007).  Between the ages of 2 months and 4 years, 
Haemophilus influenzae has historically been most frequently implicated (Wilson 
and Di Paola, 1986; Peltola et al., 1998).  However, the overall incidence of H. 
influenzae septic arthritis has reduced considerably following the advent, and 
subsequent widespread administration, of the H. influenzae type b (Hib) vaccine 
(Peltola et al., 1998).  In a study by Bowerman et al. (1997), 165 cases of acute 
haematogenous osteomyelitis or septic arthritis presenting both before and after the 
introduction of the Hib vaccine were retrospectively analysed.  In those patients 
presenting in the post-Hib vaccine era, H. influenzae was virtually non-existent. 
 
In the absence of H. influenzae, S. aureus and group B Streptococci are now the most 
causative organisms in children of all ages (Dagan, 1993; Luhmann and Luhmann, 
1999; De Boeck, 2005).  In addition, some studies have reported an increased 
	   38	  
incidence of joint infections by Kingella kingae (Yagupsky et al., 1992).  K. kingae 
is a normal oropharyngeal commensal in young children and its increasing 
association with septic arthritis is thought to mirror the decline of H. influenzae 
(Shirtliff and Mader, 2002).   
 
Although S. aureus and Streptococci are the organisms most commonly implicated 
with septic arthritis in most countries, there are nevertheless some geographical 
variations.  In the USA, the most common cause of septic arthritis in young healthy 
adults is the diplococcus gram-negative bacterial species Neisseria gonorrhoeae 
(Shirtliff and Mader, 2002).  It is an uncommon cause of septic arthritis in Europe 
however.  In sub-Saharan Africa, there is a high prevalence of Salmonella-induced 
septic arthritis in children.  In a Malawian case series by Molyneux and French 
(1982) Salmonellae were the causative organisms in 23% of cases.  This increased 
further to 59% in a Zambian case series by Lavy (2007).   
 
1.4 Staphylococcus aureus 
Given the destructive nature of S. aureus-induced septic arthritis and its high 
prevalence in all age groups, the work presented in this thesis exclusively focuses on 
this organism.  Following a series of clinical observations approximately 140 years 
ago, Ogston described staphylococcal disease and its role in sepsis and abscess 
formation (cited by Lowy (1998)).  Today, S. aureus remains a highly versatile and 
dangerous pathogen in humans.  It is implicated in numerous serious pathologies 
including pneumonia and toxic shock syndrome.  Despite recent advances in 
antimicrobial treatments, the frequencies of both community- and hospital-acquired 
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staphylococcal infections have steadily risen, with minimal change in the overall 
mortality (Kaech et al., 2006; Stahl, 2009).  S. aureus is therefore a highly adaptive 
organism, mutating with ease to overcome any obstacles in its path (Prunier et al., 
2003; Trong et al., 2005; McAdam et al., 2011). 
 
S. aureus is a gram positive organism that is spherical in shape when viewed under 
the microscope.  It is a facultative anaerobe that can grow by either aerobic 
respiration or through lactic acid fermentation of glucose (Fuchs et al., 2007).  When 
grown on agar plates, the bacteria cluster into small colonies that are golden in 
colour, thereby giving rise to the name ‘aureus’ (latin for golden), which distinguish 
S. aureus from other staphylococcal species (Figure 1.4).  A further distinguishing 
feature is the ability of S. aureus to produce ‘clumping factor’ (Moreillon et al., 
1995; Palmqvist et al., 2004).  This unique feature forms the basis of the ‘latex 
agglutination test’, which is routinely used in clinical practice.  In the presence of S. 
aureus clumping factor, previously invisible latex particles clump together to the 
extent that they become visible to the naked eye (Figure 1.4).  The test has a 
sensitivity and specificity of approximately 98% (van Griethuysen et al., 2001) and 
is therefore an extremely reliable test for the identification of S. aureus.   
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Figure 1.4: Staphylococcus aureus – typical appearance and positive identification 
(A) When grown on agar plates S. aureus forms clusters of small round colonies that appear golden in 
colour (arrow).  (B) The latex agglutination is used to confirm the presence of S. aureus.  The 
clumping factor secreted by S. aureus results in the visible agglutination of small latex particles 
contained within the test solution (*).  In comparison, there is no latex agglutination identified in the 
control sample (**). 
 
S. aureus is known to produce a diverse array of potential virulence factors.  
Virulence factors are those bacterial components and products that enable the 
organism to both establish infection and enhance its potential to cause disease 
(Cunningham et al., 1996).  It is a commensal that colonises the axillae, groin, 
vagina, anterior nares, gastrointestinal tract, pharynx and broken skin surfaces 
(Noble et al., 1967; Casewell and Hill, 1986).  The moist squamous epithelium of the 
anterior nares is the main ecological reservoir however, with approximately 20% of 
individuals being persistently nasally colonised with S. aureus and a further 60% 
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being transiently colonised (Foster, 2005; Gordon and Lowy, 2008).  Infections are 
initiated when a breach of the skin or mucosal barrier permits the access of S. aureus 
to adjacent tissues or the blood stream.  Whether an infection is contained or spreads 
depends on a complex interplay between S. aureus virulence factors and host defense 
mechanisms.  Individuals with S. aureus infections are commonly infected with their 
colonising strain (Williams et al., 1959).  In a multicentre study of S. aureus 
bacteraemia by von Eiff et al. (2001), the blood isolates were identical to those from 
the anterior nares in 82% of patients.  
 
The armamentarium of S. aureus virulence factors is extensive, with both structural 
and secreted products playing a role in the pathogenesis of infection (Lowy, 1998).  
In order to establish infection, S. aureus must firstly adhere to host tissues (Edwards 
et al., 2010).  This is achieved through numerous surface receptors for host proteins, 
collectively referred to as ‘microbial surface components recognising adhesive 
matrix molecules’ (MSCRAMMS) (Gordon and Lowy, 2008).  S. aureus may 
simultaneously express MSCRAMMS, otherwise known as adhesins, binding many 
different ECM proteins including collagen, fibronectin, fibrinogen, vitronectin, 
thrombospondin, elastin, laminin, bone sialoprotein, hyaluronic acid and osteopontin 
(Switalski et al., 1993; Shirtliff and Mader, 2002).  A number of adhesin genes have 
been identified and include genes encoding fibronectin binding proteins (fnbA and 
fnbB) (Jönsson et al., 1991), fibrinogen binding proteins (fib, cflA, and fbpA) (Bodén 
and Flock, 1994), a collagen receptor (cna) (Patti et al., 1992) and an elastin binding 
protein (ebpS) (Rosenbloom, 1996).  A broad specificity adhesin (map) mediating 
low-level binding of several proteins including osteopontin, collagen, bone 
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sialoprotein, vitronectin, fibronectin and fibrinogen has also been identified 
(McGavin et al., 1993).  Collagen adhesin is considered to be particularly important 
in the pathogenesis of septic arthritis through its promotion of bacterial adherence to 
articular cartilage.  An in vitro study by Switalski et al. (1993) identified that 
collagen receptor-positive strains adhered to both isolated type II collagen and 
cartilage explants in a time-dependent process.  However, in the presence of blocking 
collagen receptor-specific antibodies bacterial adherence was inhibited. 
 
Once S. aureus adheres to host tissues it is able to grow and persist through the use 
of a variety of evasive strategies.  Firstly, S. aureus can form biofilms on both host 
and prosthetic tissue surfaces, which essentially shield the bacteria from the host 
immune response and antimicrobials (Donlan and Costerton, 2002).  It is for this 
reason that infected joint prostheses are particularly difficult to treat.  Secondly, in 
vitro studies have demonstrated that S. aureus can invade and subsequently survive 
within the immune privileged intracellular compartment of a variety of mammalian 
cells (Hudson et al., 1995; Lammers et al., 1999).   Menzies and Kourteva (1998) 
and Kahl et al. (2000) have further demonstrated that whilst within this compartment 
they may also induce apoptosis of the host cell, thus enhancing the overall tissue 
destruction through the process of host cell internalisation (Menzies and Kourteva, 
1998; Kahl et al., 2000).  Thirdly, S. aureus is able to form small-colony variants 
(SCVs), which are believed to play a key role in persistent and recurrent infections.  
S. aureus can produce a variant population that may be phenotypically very different 
to the parent strain, thereby conferring great survival flexibility (Proctor and Peters, 
1998).   
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SCVs represent naturally occurring subpopulations of S. aureus that typically grow 
slowly and produce small non-pigmented and non-haemolytic colonies that 
demonstrate a number of other atypical characteristics including reduced coagulase 
production and increased resistance to both aminoglycosides and cell wall active 
antibiotics (Proctor et al., 1995; Proctor and Peters, 1998).  In vitro studies have 
demonstrated that SCVs can hide within host cells, where they are relatively 
protected form the host immune response and antibiotics (Kahl et al., 1998; Gordon 
and Lowy, 2008).  Once the host immune response has abated and antibiotic therapy 
has been completed, SCVs may revert to the highly virulent and rapidly growing 
parent form, lyse the host cell and re-establish infection (Proctor and Peters, 1998).  
The presence of quiescent intracellular SCVs may explain why S. aureus has the 
ability to lie dormant following an episode of infection, sometimes for many 
decades, prior to re-emergence as clinical disease in exactly the same location.  
 
S. aureus displays many other characteristics that help it evade the host immune 
response during an infection.  Firstly, neutrophil chemotaxis (the migration of 
neutrophils from the blood stream to the site of infection) is inhibited through the 
secretion of ‘chemotaxis inhibitory protein of staphylococci’ (CHIPS), which is 
produced by approximately 60% of S. aureus strains (de Haas et al., 2004).  
Secondly, S. aureus demonstrates resistance to phagocytosis through the avoidance 
of opsonins (molecules that mark a cell for phagocytosis) present in normal serum, 
which include antibodies recognising cell surface components such as peptidoglycan 
and teichoic acid (Foster, 2005).  This is achieved through the expression of surface-
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associated anti-opsonic proteins and a polysaccharide capsule, both of which 
interfere with the deposition of antibodies and complement formation or their access 
to neutrophil complement receptor and Fc receptor.  S. aureus phagocytosis by 
neutrophils is therefore compromised as it requires the recognition of bound 
complement and antibody.  For example, protein A, a MSCRAMM, is a wall-
anchored protein that binds the Fc region of the immunoglobulin IgG in an 
orientation that prevents its recognition by the corresponding neutrophil Fc receptor 
(Uhlén et al., 1984; Foster, 2005; Gordon and Lowy, 2008).  In addition, the majority 
of S. aureus clinical isolates express a thin microcapsular layer that is composed of 
serotype 5, 8 or 336 capsular polysaccharide (O'Riordan and Lee, 2004; Roghmann 
et al., 2005).  Animal infection models have identified that expression of type 5 and 
8 capsular polysaccharide is associated with increased virulence (Luong and Lee, 
2002).  Studies conducting in vitro phagocytosis assays have identified that, in the 
presence of normal serum opsonins, the presence of the capsule reduced the uptake 
of S. aureus by neutrophils, indicating that the capsule is anti-opsonic (Nilsson et al., 
1997; Thakker et al., 1998).  
 
1.4.1 S. aureus toxins 
In addition to immune evasion strategies, S. aureus may also indirectly attack the 
cells of the innate immune response through the release of toxins that specifically 
target and lyse leukocytes.  These toxins are collectively referred to as leukotoxins 
and contribute to abscess formation through the widespread killing of neutrophils 
attempting to engulf and kill bacteria (Foster, 2005).  Indeed, abscess formation is a 
typical feature of S. aureus infection (Cheng et al., 2009).  Four key leukotoxins 
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have been identified: Panton-Valentine leukocidin (PVL), gamma-haemolysin, 
leukocidin E/D and leukocidin M/F-PV-like (Menestrina et al., 2003).  Arguably the 
most widely studied leukotoxin is PVL, which is a two-component pore-forming 
toxin (i.e. it destroys host cells through the formation of cell membrane pores) that 
has a high affinity for neutrophils and macrophages (Lina et al., 1999; Lipinska et 
al., 2011).  It is implicated in a rapidly growing number of serious skin infections 
(Diep et al., 2004), severe necrotising pneumonia (Gillet et al., 2002) and necrotising 
fasciitis (Miller et al., 2005).    
 
Another toxin that is frequently associated with S. aureus is toxic shock syndrome 
toxin-1 (TSST-1).  This toxin first came to light as a result of a well-defined clinical 
syndrome in menstruating females associated with the use of high-absorbency 
tampons.  Toxic shock syndrome (TSS) comprises fever, an erythematous rash, skin 
desquamation and hypotension, frequently associated with multi-organ failure 
(Cunningham et al., 1996).  Most cases have no associated bacteraemia, thereby 
implicating that TSS results from the systemic intoxication with a product or 
products elaborated by S. aureus (Dinges et al., 2000).  The gene for TSST-1 is 
found in 20% of S. aureus isolates (Lowy, 1998).  In contrast, TSST-1 is detected in 
all S. aureus isolates from patients with TSS (Cunningham et al., 1996).  TSST-1 is a 
22kDa protein and is regarded as a superantigen, stimulating non-specific T-cell 
proliferation by interacting directly with major histocompatibility complex class II 
molecules (Cunningham et al., 1996).  This leads to the massive systemic release of 
inflammatory cytokines and, ultimately, circulatory collapse. 
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1.4.2 S. aureus haemolysins 
One of the cardinal features of S. aureus is its ability to secrete toxins that damage 
the membranes of host cells and not just cells of the innate immune response. It has 
been hypothesised that the purpose of destructive S. aureus toxins is to convert local 
host tissues into nutrients required for bacterial growth (Dinges et al., 2000).  Whilst 
S. aureus produces a diverse array of toxins that may contribute to host tissue 
destruction including, in addition to those already mentioned, proteolytic enzymes, 
enterotoxins A-E, and exfoliative toxins (ETA and ETB) (Tomita and Kamio, 1997; 
Dinges et al., 2000), it is a group of exotoxins known as ‘haemolysins’ that are 
believed to be key virulence factors.  This knowledge has been obtained from studies 
investigating a variety of S. aureus-related infections (O'Callaghan et al., 1997; 
Schmitz et al., 1997; Dajcs et al., 2002; Hayashida et al., 2009).  
 
The haemolysins, so-called because of their ability to lyse erythrocytes, consist of 
four toxins: alpha(Hla)-, beta(Hlb)-, gamma(Hlg)- and delta(Hld)-haemolysin 
(otherwise known as alpha(α)-, beta(β)-, gamma(γ)- and delta(δ)-toxin).   
 
1.4.2.1 Alpha-haemolysin 
Hla is a 33kDa pore-forming toxin that is secreted by the majority of S. aureus 
clinical isolates and is believed to play a major role in the pathogenesis of S. aureus 
infections including pneumonia (Bubeck-Wardenburg et al., 2007), sepsis (Patel et 
al., 1987), brain abscess (Kielian et al., 2001) and corneal infections (Callegan et al., 
1994; Hume et al., 2000).  Hla is encoded by the gene hla, which was sequenced by 
Gray and Kehoe (1984), and is released by the bacteria in a monomer form before 
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integrating into the host cell membrane and organising with other membrane-bound 
Hla monomers into cylindrical heptamers (Figure 1.5) (Gouaux, 1998).  It is in this 
oligomeric form that Hla is capable of inducing eukaryotic cell death.  Once the 
cylindrical heptamer has formed on the cell membrane, a 1- to 2-nm transmembrane 
pore is established (Figure 1.5) that permits both the influx and efflux of ions and 
small molecules that ultimately results in the disruption of the ionic equilibrium, 
osmotic swelling and cellular demise (Dinges et al., 2000).  Hla is active against a 
wide variety of mammalian cells but has extraordinarily marked activity against 
rabbit (lapine) erythrocytes, a feature that permits its laboratory identification on 
rabbit blood agar plates.  In addition to its pore-forming abilities, Hla has also been 
shown to induce the release of pro-inflammatory cytokines and chemokines 
including IL-6, IL-1β, IL-1α, IL-8, TNF-α, KC and MIP-2 (Bhakdi et al., 1989; 
Dragneva et al., 2001; Onogawa, 2002; Bartlett et al., 2008; Hruz et al., 2009), 
thereby potentially further enhancing tissue destruction.   
 
 
Figure 1.5: Formation of the Hla heptameric pore in a eukaryotic cell membrane 
Hla is released from S. aureus in a monomer form.  The rim domain of the toxin adheres to the plasma 
membrane and subsequent intertwining of the stem regions results in the formation of a 
transmembrane pore.  Diagram taken from Dinges et al. (2000). 
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1.4.2.2 Beta-haemolysin 
Hlb is a 35kDa toxin that was first identified in 1935 (cited by Dinges et al. (2000)).  
It is encoded by the hlb gene, a gene that was cloned and sequenced by Projan et al. 
(1989) and Coleman et al. (1986) and, in contrast to Hla, is highly haemolytic for 
sheep but not rabbit erythrocytes (Huseby et al., 2007; Burnside et al., 2010).  Hlb is 
a Mg2+ dependent sphingomyelinase C that degrades sphingomyelin in the outer 
phospholipid layer of the erythrocyte membrane (Coleman et al., 1986).  The varied 
interspecies sensitivity to erythrocyte lysis by this toxin correlates with the 
sphingomyelin content in the erythrocyte outer membrane (Dinges et al., 2000).  The 
extremely high content of sphingomyelin in sheep erythrocytes thus renders them 
highly susceptible to lysis in the presence of Hlb.  The haemolytic activity of Hlb is 
enhanced when erythrocytes incubated (37°C) in the presence of this toxin are 
chilled for a short period bellow 10°C (Wiseman, 1975; Coleman et al., 1986; 
Huseby et al., 2007).  It is therefore frequently referred to as the ‘hot-cold’ 
haemolysin.   
 
Hlb has been shown to play an important role in S. aureus-induced mastitis (Bramley 
et al., 1989), pneumonia (Hayashida et al., 2009) and corneal infections (bacterial 
keratitis) (O'Callaghan et al., 1997).  In addition, experimental studies have 
suggested that Hlb may play a role in the establishment of S. aureus-induced sinusitis 
through the impairment of nasal epithelial cell ciliary function (Kim et al., 2000).  
Furthermore, a study by Katayama et al. (2013) investigating S. aureus murine ear 
colonisation demonstrated that the colonisation efficiency of a Hlb-producing mutant 
	   49	  
was 50-fold greater than that of a Hlb-deficient mutant, thereby concluding that Hlb 
plays a major role in skin colonisation.  This finding was further strengthened 
through the subsequent observation that Hlb had elevated cytotoxicity for human 
primary keratinocytes.  
 
1.4.2.3 Gamma-haemolysin 
Hlg is similar in both structure and function to PVL in that it is a bicomponent pore-
forming toxin that has a high affinity for leukocytes (Dinges et al., 2000; Yamashita 
et al., 2011) i.e. it is a leukocidin.  Together, they belong to a group of toxins known 
as the syrengohymenotropic toxins (Prévost et al., 1995).  Whilst PVL is only made 
by 2 to 3% of S. aureus strains, Hlg is secreted by virtually every strain (Siqueira et 
al., 1997).  Unlike PVL however, Hlg is able to lyse other mammalian cells, in 
particular erythrocytes.  Hlg can be difficult to identify on laboratory blood agar 
plates due to the inhibitory effect of impurities in the agar on toxin activity.  Hlg was 
first described in 1938 and is encoded by the hlg gene (cited by Dinges et al. (2000)).  
Together with TSST-1 it is believed to play an important role in the pathogenesis of 
toxic shock syndrome (Clyne et al., 1988).   
 
1.4.2.4 Delta-haemolysin 
The final haemolysin is Hld, a 26 amino acid peptide encoded by the hld gene and 
produced by 97% of S. aureus isolates (Wiseman, 1975; Janzon and Arvidson, 1990; 
Burnside et al., 2010).  Hld, which was first reported in 1947 (cited by Verdon et al. 
(2009)), is able to lyse erythrocytes and a variety of mammalian cells as well as 
membrane bound organelles (Dinges et al., 2000).  It is also capable of lysing 
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bacterial protoplasts, spheroplasts, lysosomes and lipid spherules (Kreger et al., 
1971).  Hld is believed to form an α-helix with hydrophobic and hydrophilic 
domains on either side and it has been proposed that it acts as a surfactant (Dinges et 
al., 2000).  At high concentrations it induces a detergent-like solubilisation of the 
plasma membrane, resulting in the formation of disc-shaped structures known as 
micelles and, ultimately, cell lysis (Verdon et al., 2009).  At present however, the 
exact contribution of Hld to S. aureus virulence in vivo remains unknown (Dinges et 
al., 2000). 
 
In summary, S. aureus is known to produce 4 haemolysins, all of which have the 
potential to induce target cell membrane damage: Hla, Hlb, Hlg and Hld (listed in 
chronological order of discovery).  Hla acts by creating heptameric pores in a target 
membrane, Hlb presents sphingomyelinase C activity, Hlg is a bicomponent toxin 
that also acts by creating membrane pores and Hld permeabilises the target 
membrane. 
 
1.4.3 Haemolysins and septic arthritis 
Despite the numerous toxins produced by S. aureus it is not yet known which of 
these are directly damaging to chondrocyte viability.  Mutant S. aureus strains with 
altered toxin profiles, established through genetic deletion or mutation, have helped 
to elucidate the roles of different virulence factors in an in vivo murine model of 
septic arthritis.  These studies suggest that Hla may act alone or in conjunction with 
either protein A or Hlg to promote erosive joint damage in septic arthritis (Gemmell 
et al., 1997; Nilsson et al., 1999).  
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1.5 Hla-induced cell death and a potential role of calcium 
A common finding of several studies investigating a variety of S. aureus-related 
pathology, including septic arthritis, is a likely central destructive role of Hla (Patel 
et al., 1987; Callegan et al., 1994; Gemmell et al., 1997; Hume et al., 2000; Kielian 
et al., 2001; Ragle and Bubeck-Wardenburg, 2009; Wilke and Bubeck-Wardenburg, 
2010).  Whilst studies conducted by Walev et al. (1993) and Valeva et al. (2000) 
suggested that the important primary trigger of Hla-induced cellular demise was the 
influx of Na+ coupled with the efflux of K+ (Walev et al., 1993; Valeva et al., 2000), 
there is growing experimental evidence supporting a key role of Ca2+ in the 
eukaryotic cell death pathway (Seeger et al., 1984; Suttorp et al., 1985; Bhakdi and 
Tranum-Jensen, 1991; Jonas et al., 1994; Kwak et al., 2012; Berube and Bubeck-
Wardenburg, 2013).   
 
In health, Ca2+ is regarded as a ubiquitous intracellular messenger responsible for the 
control of numerous physiological cellular functions including exocytosis, gene 
transcription, cell differentiation and muscle contraction (Clapham, 1995; Berridge et 
al., 1998).  Indeed, it may be argued that mammalian life would not exist without 
Ca2+ as successful fertilisation of the egg relies upon a prolonged Ca2+ oscillation that 
ultimately triggers the cell division cycle (Berridge et al., 2000).  Thereafter, Ca2+ 
continues to play an important and essential role in the development and 
maintenance of cellular life.  In chondrocytes, Ca2+ signalling has been shown to play 
an important role in ECM synthesis, cytoskeletal remodelling, and cell 
hyperpolarisation (Clark et al., 1994; Valhmu and Raia, 2002; Erickson et al., 2003; 
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Millward-Sadler and Salter, 2004; Madden et al., 2014).   Paradoxically however, a 
prolonged high intracellular Ca2+ concentration ([Ca2+]i) may lead to cell death 
(Clapham, 1995; Berridge et al., 1998; Huser and Davies, 2007).  In the majority of 
eukaryotic cells, Ca2+ exerts its major signalling function when it is transiently 
elevated within the cytosolic compartment (Huser and Davies, 2007).  These Ca2+ 
transients have been shown to take various forms including waves, global or 
localised spikes, oscillations, micro-gradients and nano-gradients (Petersen et al., 
1994).  Ca2+ transients may also spread from the cytoplasm into organelles such as 
the nucleus and mitochondria.    
 
The [Ca2+]i of most resting cells, including chondrocytes (Wilkins et al., 2000), is 
approx.100nM, which is 20 000-fold lower than the 2mM found extracellulary in 
most tissues (Clapham, 1995).  This rises to approx. 1000nM however during 
episodes of stimulation e.g. hormone stimulation, mechanical deformation or 
depolarisation (Petersen et al., 1994).  [Ca2+]i is regulated by the simultaneous 
interplay of several counteracting processes (Figure 1.6).  These can be divided into 
Ca2+ ‘on’ and ‘off’ mechanisms depending on whether they serve to increase or 
decrease [Ca2+]i (Berridge et al., 2000).  The ‘on’ mechanisms include various 
plasma membrane channels, which regulate the inexhaustible supply of extracellular 
Ca2+ and include mechanically-activated Ca2+ channels, receptor-operated Ca2+ 
channels, store-operated Ca2+ channels and the well characterised voltage-dependent 
Ca2+ channels (prevalent in excitable cells) (Petersen et al., 1994).  There are also 
channels on the endoplasmic reticulum, the organelle that harbours the major 
intracellular Ca2+ pool (Clapham, 1995), that release Ca2+ from this finite 
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intracellular store (Berridge, 1993).  Two important types of Ca2+ release channels 
have been identified within the endoplasmic reticulum, namely the ryanodine (RYR) 
and the inositol trisphosphate (IP3) receptors (Petersen et al., 1994).  Both function to 
release Ca2+ from intracellular stores into the cytoplasm.  Interestingly, the main 
activator of these channels is Ca2+ itself and this phenomenon is referred to as ‘Ca2+-
induced Ca2+ release’, a process that is believed to be central to Ca2+ signalling 
(Berridge et al., 2000).  
 
Figure 1.6: The major regulators of intracellular Ca2+ homeostasis 
Plasma membrane pumps and channels (plasma membrane Ca2+ ATPase (PMCA), Na+/Ca2+ 
exchanger (NCX) and store-operated Ca2+ channels (SOCE)) regulate the influx and efflux of Ca2+ 
from the cytoplasm.  G-protein-coupled receptors such as Ca2+-sensing receptor (CaR) initiate signals 
(e.g. inositol trisphosphate (IP3)) that modify compartmentalised Ca2+ stores.  Ca2+ ATPases on 
organelles (e.g. sarco (endo)plasmic reticulum Ca2+ ATPase (SERCA) and secretory pathway Ca2+ 
ATPase isoform 1 (SPCA1)) monitor and restore intracellular Ca2+ storage sites.  ER, endoplasmic 
reticulum; DAG, diacylglycerol; NFAT, nuclear factor of activated T cells; IP3R, inositol 
trisphosphate receptor; PKC, protein kinase C; PLC, phospholipase C; PIP2, phosphatidylinositol 4,5-
bisphosphate; STIM, stromal interaction molecule; TRPC, transient receptor potential C.  Diagram 
taken from Mascia et al. (2012). 
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The ‘off’ mechanisms are more diverse and are employed by cells to remove Ca2+ 
from the cytosolic compartment.  They include Ca2+ ATPases, located on the plasma 
membrane and endoplasmic reticulum (Carafoli, 1991; Petersen et al., 1993; 
Berridge et al., 2000), in addition to exchangers that utilise concentration gradients 
of other ions to provide the ‘driving force’ to transport Ca2+ out of the cell i.e. the 
Na+/Ca2+ exchange (Petersen et al., 1994).  Furthermore, the cytosol contains slowly 
diffusible Ca2+-binding proteins that are capable of rapidly buffering Ca2+ (Neher and 
Augustine, 1992).  It is believed that these buffers act in the immediate vicinity of 
the Ca2+ release channels and the subsequent saturation of these buffers may be 
essential for both Ca2+ spike initiation and Ca2+ wave propagation (Petersen et al., 
1993).  Finally, organelles other than the endoplasmic reticulum are believed to play 
an important role in Ca2+ homeostasis by sequestering or releasing Ca2+.  For 
example, mitochondria sequester Ca2+ rapidly during the development of the Ca2+ 
signal prior to releasing it slowly during the recovery phase (Duchen, 1999).  The 
uptake of Ca2+ by the mitochondria is believed to be important in determining both 
the amplitude and spatio-temporal patterns of Ca2+ signals (Jouaville et al., 1995; 
Budd and Nicholls, 1996; Duchen, 1999). 
 
When the Ca2+ equilibrium is disturbed through injury, the fate of the cell relies on 
its ability to restore normal [Ca2+]i through the previously described ‘off’ 
mechanisms.  If this is not achieved then the cell will ultimately die.  Persistently 
high [Ca2+]i can lead to the rapid disintegration of cells (necrotic cell death) through 
the activity of Ca2+-sensitive proteases (Trump and Berezesky, 1995; Berridge et al., 
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1998).  In addition, elevated [Ca2+]i has also been implicated in apoptotic cell death 
(Berridge et al., 1998; Duchen, 1999), a process that can be both physiological and 
pathological, and is thought to be mediated through Ca2+-induced changes in gene 
transcription (Trump and Berezesky, 1995).  Many cellular insults have the potential 
to affect [Ca2+]i rapidly through their influence on one or more of the following: 
energy metabolism, ion translocation systems, trans-membrane signalling and plasma 
membrane integrity (Berridge et al., 1998; Kristian and Siesjo, 1998; Huser and 
Davies, 2007).  In the case of Hla, it is hypothesised that, in the presence of a marked 
concentration gradient between the intra- and extracellular compartments, the 
transmembrane Hla pores established on the plasma membrane permit a rapid influx 
of Ca2+ and subsequent overwhelming rise in [Ca2+]i that is ultimately fatal to the cell 
(Berube and Bubeck-Wardenburg, 2013).   
   
1.6 Confocal laser scanning microscopy (CLSM) 
The maintenance of healthy articular cartilage is highly sophisticated and relies upon 
complex interactions between chondrocytes and the ECM (Muir, 1995).  Such 
interactions are absent when chondrocytes are removed from their native 
environment i.e. during the experimental assessment of isolated in vitro 
chondrocytes, thereby potentially altering the susceptibility of these chondrocytes to 
experimental challenge.  Thus, in order to acquire a more accurate representation of 
the in vivo situation, it would be advantageous to assess both the temporal and spatial 
responses of in situ chondrocytes following S. aureus toxin exposure.   
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Recent advances in microscopic techniques have permitted the assessment of 
undisturbed in situ cells without the need for physical sectioning.  One such 
advanced high-resolution technique is confocal laser scanning microscopy (CLSM), 
which enables the generation of 3-Dimensional (3-D) images of fluorescently 
labelled in situ tissue architecture and microstructure following laser excitation 
(Dailey et al., 1999; Klaus et al., 2003; Sorensen et al., 2003; Lin et al., 2005).  
CLSM has even enabled in vivo imaging both in animals (Unal Cevik and Dalkara, 
2003; Cockburn et al., 2013; Pérez-Alvarez et al., 2013; Williams et al., 2013; 
Vacaru et al., 2014) and in humans (Rajadhyaksha et al., 1995; Jalbert et al., 2003).  
CLSM is central to the hypotheses investigated in this thesis and an overview of its 
principles is detailed. 
 
1.6.1 Overview 
The concept of confocal microscopy was originally developed by Marvin Minsky in 
1955 while he was a post-doctoral student at Harvard University (Jones et al., 2005). 
He wished to image neural networks in unstained preparations of brain tissue and 
was driven by a desire to image biological events in situ with a clarity that exceeded 
conventional microscopes (Dailey et al., 1999).  However, due to a lack of the 
necessary intense light sources for imaging and a sufficiently powerful computer 
processor to handle large amounts of data, the idea was short lived.  It was only 30 
years later, following the development of powerful lasers and advanced computer 
processors, that confocal microscopy became an established technique within the 
scientific community.  Nevertheless, despite significant technological advances 
Minsky’s key concepts remain unchanged.  
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Unlike a conventional wide-field microscope, a confocal microscope creates a sharp 
high-resolution image of a tissue specimen by rejecting out-of-focus light from 
above and below the focal plane of interest (Figure 1.7).  The image obtained 
represents a thin cross-section section of the specimen, which is acquired without the 
need for physical sectioning.  Such a section is referred to as an ‘optical section’ and 
a series of consecutive optical sections along the vertical axis can be combined using 
imaging software to create a three-dimensional (3-D) reconstruction of the imaged 
volume of the specimen (Figure 1.8).   
 
1.6.2 Principles 
Standard wide-field fluorescent microscopy involves the simultaneous illumination 
of an entire specimen by a light source i.e. the entire specimen is flooded evenly with 
light (Combs, 2010).  Consequently, the entire specimen is excited at the same time 
and the resulting fluorescence is captured by the microscope’s photodetector or 
camera.   However, a significant proportion of the captured fluorescence is out-of-
focus (Claxton et al., 2006) i.e. it originates from above and below the focal plane of 
interest, which ultimately compromises image quality.  In contrast, CLSM permits 
the point-by-point illumination of a specimen (Semwogerere and Weeks, 2008).  
Coherent light, of known wavelength, is released from a gas or solid-state laser 
(excitation source) and passes through a spatial filter and beam expander before 
being reflected by a dichroic mirror (otherwise known as a beam splitter) and 
focused by an objective lens onto a single point (focal volume) on the specimen 
(Figure 1.7).  Thereafter, emitted light travels back along a similar path to the 
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excitation light but on this occasion, as it is of longer wavelength than the excitation 
light, it passes through the dichroic mirror and is focused onto a ‘pinhole aperture’ 
(Jones et al., 2005).   
 
The pinhole aperture is unique to confocal microscopy (Combs, 2010) and is the 
source of the term ‘confocal’.  In-focus light i.e. light from the focal plane converges 
on the pinhole and passes through it.  Conversely, out-of-focus light is unable to 
converge on the pinhole and is therefore rejected (Figure 1.7).  Upon passing 
through the pinhole, only in-focus light proceeds to the photodetector where it is 
converted to an electrical signal and ultimately a computer-generated image (Claxton 
et al., 2006).  Like conventional microscopes, the objective lens can be changed 
according to the detail of study required.   
 
The detected light originating from an illuminated volume element (single point) 
within the specimen represents one pixel in the resulting image.  As the laser scans 
over the specimen, a whole image is obtained pixel-by-pixel and line-by-line.  The 
laser beam is scanned across the sample in the horizontal plane with the use of 
motorised oscillating mirrors.  Information can be gathered from different focal 
planes by either raising or lowering the microscope stage or objective lens.  Using 
computer software, a 3-D image of the specimen can be generated by assembling a 
stack of 2-D images (optical sections) from successive focal planes.  This is 
collectively referred to as a ‘z-stack’ (North, 2006) (Figure 1.8). 
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Figure 1.7: Confocal laser scanning microscopy 
(A) Simplified diagram of the system setup of a confocal laser scanning microscope 
illustrating the principles of point-by-point illumination and the rejection of out-of-focus 
light (adapted from Jones et al. (2005)).  Light from the laser reflects off the beam splitter 
(dichroic mirror) and excites one point on the fluorescently labelled specimen.  The dye in 
the specimen is excited by the laser light and subsequently emits light of a different 
wavelength i.e. it fluoresces.  The emitted light passes through the beam splitter and is 
focused onto the detector pinhole.  Out-of-focus light is prevented from reaching the 
photomultiplier detector by the pinhole.  The entire specimen is progressively illuminated 
through the use of a set of rotating mirrors (not shown).  (B) One of the confocal microscope 
systems utilised during this study.  
	   60	  
 
Figure 1.8: CLSM optical sectioning 
Using computer software, a series of 2-D images from successive focal planes along the z-axis can be 
combined to form a 3-D image of the specimen.  This is collectively referred to as a ‘z-stack’.  Image 
kindly provided by Mr Joseph Winstanley, Centre for Integrative Physiology, The University of 
Edinburgh.  
 
In the scientific world, most confocal microscopes acquire optical sections by 
stimulating fluorescence from fluorophores embedded within various components of 
the specimen (Jones et al., 2005; Waters, 2009).  A fluorophore is defined as a 
chemical compound that emits light upon light excitation (Semwogerere and Weeks, 
2008).  There are a vast number of highly specific fluorophores available and those 
chosen will depend on the particular study.  For example, fluorophores are available 
to distinguish between living and dead/dying cells while others permit the dynamic 
assessment of alterations within the intracellular environment i.e. pH and Ca2+ 
concentration.  It is possible to label the same specimen with multiple fluorophores, 
thereby enabling several parameters to be investigated at the one time (Nwaneshiudu 
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et al., 2012).  Current advances in CLSM have primarily focused on the generation 
of novel fluorophores (Jones et al., 2005).  
 
The combination of fluorophores and CLSM is frequently referred to as 
‘fluorescence-mode’ CLSM.  The fluorophores are the only visible component with 
this particular form of confocal microscopy i.e. unstained microstructure is not 
visible.  All fluorophores have unique excitation and emitted light spectra (Tsien and 
Waggoner, 2006).  The laser light source is used to excite the fluorescently labelled 
tissue with a wavelength that is close to the peak excitation wavelength of the chosen 
fluorophore and filters are set to capture the wavelength of the emitted light, which is 
of a longer wavelength than the excitation wavelength.  With point-by-point 
illumination of the fluorophore labelled specimen a 3-D image of the emitted 
fluorescence is generated.   
 
1.6.3 CLSM and articular cartilage 
Fluorescence-mode CLSM has become a popular experimental tool in the field of 
cartilage research over the past 20 years as a result of its diversity and unprecedented 
high-resolution non-invasive imaging (Jones et al., 2005).  It has previously been 
used to characterise both healthy and non-degenerate articular cartilage (Bush and 
Hall, 2003), assess the morphology and deformation behavior of chondrocytes 
(Guilak et al., 1999), image components of the ECM (Poole et al., 1992), study the 
response of articular cartilage to mechanical trauma (Amin et al., 2008), and 
investigate cartilage repair techniques (Huntley et al., 2005).  
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1.7 Rationale and aims of the thesis 
The rationale of this work is based on gaining further insight into the interaction 
between S. aureus haemolysins and in situ chondrocytes during an episode of septic 
arthritis.  It is envisaged that the knowledge acquired during this study may be of 
translational relevance with regard to both current clinical practice and the future 
development of novel chondroprotective therapeutic strategies.  The objectives of 
this thesis may be summarised as follows: 
 
1. To develop an in vitro model of S. aureus-induced septic arthritis that, in 
conjunction with fluorescence-mode CLSM, allows the spatial and temporal 
quantification of in situ chondrocyte viability following S. aureus culture 
with bovine articular cartilage.     
 
2. Utilise this model, which avoids the complexities of a host immune response, 
to assess the influence of S. aureus haemolysins on in situ chondrocyte 
viability through the use of specific ‘haemolysin-knockout’ isogenic mutant 
strains of S. aureus (see Chapter 4).  
 
3. Assess the influence of altered culture medium osmolarity and extracellular 
Ca2+ on S. aureus haemolysin-induced in situ chondrocyte death.  The 
rationale for assessing these parameters is detailed in Chapter 5. 
 
4. To attempt to measure dynamic changes in intracellular Ca2+ concentrations 
within in situ chondrocytes using a live-cell CLSM imaging system and 
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This thesis tested the hypothesis that Hla is the key damaging S. aureus toxin to in 
situ chondrocyte viability and that its destructive action is associated with a rise in 
intracellular Ca2+. 
 
1.9 Overview of the chapters 
In Chapter 2, general methodologies relevant to all ‘results chapters’ (Chapters 3-6) 
are provided including a description of an in vitro model of S. aureus-induced septic 
arthritis.  The technique of CLSM to assess 3-D in situ chondrocyte viability 
following S. aureus haemolysin exposure and the subsequent methods for 
quantitative analyses are described.  
 
Chapters 3-6 comprise the main results section and encompass all of the objectives 
of the thesis.  Each results chapter contains a methodology section detailing 
additional methodology specific to that particular chapter.  In Chapter 3, temporal 
and spatial in situ bovine chondrocyte viability following exposure to an established 
laboratory strain and clinical strains of S. aureus is assessed.  In Chapter 4, the 
chondrocyte damaging potential of S. aureus Hla, Hlb and Hlg is investigated.  In 
Chapter 5, the influence of both altered culture medium osmolarity and extracellular 
Ca2+ concentrations on S. aureus haemolysin-induced in situ chondrocyte death is 
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studied.  In Chapter 6, alterations in intracellular Ca2+ levels within in situ 
chondrocytes during exposure to S. aureus haemolysins are examined.   
 
In Chapter 7, the merits and limitations of this work are discussed.  The translational 
relevance of the findings, with regards to both current and future clinical practice, are 
also considered.  
 
Finally, the appendix includes a copy of a peer-reviewed published paper, which is 
based on the findings presented in Chapter 3 of this thesis.  In addition, a list of 
published abstracts and presentations relating to this work is provided. 
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CHAPTER 2 
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The materials and methods presented within this chapter represent general 
methodology relevant to all ‘results’ chapters (Chapters 3-6).  Where appropriate, 
additional materials and methods specific to the individual experiments presented 
within a particular results chapter are addressed within that chapter. 
 
2.1 BIOCHEMICALS AND SOLUTIONS 
Biochemicals were obtained from Invitrogen Ltd (Paisley, UK) unless otherwise 
stated.  Formaldehyde solution (4% v/v in normal saline) was obtained from Fisher 
Scientific (Loughborough, UK) and normal saline (0.9% w/v) was obtained from 
Baxter’s Healthcare (Thetford, UK).  
 
2.1.1 Bacterial and tissue culture media 
The standard bacterial culture media were tryptone soya agar (TSA) and tryptone 
soya broth (TSB, Oxoid Ltd, Basingstoke, UK).  The standard tissue culture medium 
was serum-free Dulbecco’s Modified Eagle’s Medium (DMEM).  However, several 
distinct variants of DMEM were utilised for the experimental work presented in this 
thesis and the particular variants used for each study are detailed within the materials 
and methods section of each results chapter.  Penicillin (50 U/ml) and streptomycin 
(50µg/ml) were added to DMEM for all experiments not involving bacterial culture. 
 
2.1.2 Fluorescent probes 
A two-fluorophore cell viability assay was utilised to identify live and dead cells: 
1. LIVE CELLS: 5-chloromethylfluorescein diacetate (CMFDA) passes freely 
through the plasma membrane and is subsequently cleaved by cytosolic 
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esterases in metabolically active cells only i.e. in living cells; a process that 
removes the acetate groups (Jones et al., 2005).  The resultant molecule (5-
chloromethylfluorescein), which fluoresces green following laser excitation 
(see section 2.6 for details), is impermeable to cell membranes and is 
therefore retained within the cell where it produces a uniform cytoplasmic 
staining (Stoddart et al., 2006).  CMFDA cell tracker Green™ was prepared 
as a 1mM stock solution in the solvent dimethyl sulphoxide (DMSO). 
 
2. DEAD CELLS: Propidium iodide (PI) is impermeable to the plasma 
membrane of living cells (Krishan, 1975; Fried et al., 1976; Jones and Senft, 
1985).  Once membrane integrity is compromised however, PI passes freely 
into the cell where it binds irreversibly to nuclear DNA (Unal Cevik and 
Dalkara, 2003).  The DNA-PI complex fluoresces red following laser 
excitation (see section 2.6 for details) and therefore identifies the nuclei of 
dead or dying cells (membrane-compromised cells) only (Krishan, 1975; 
Jones and Senft, 1985; Huntley et al., 2005).  PI was used as an aqueous 
1mM stock solution that was obtained directly from the manufacturer. 
 
The use of CMFDA and PI is an accepted method utilised by many studies to label 
living and dead cells fluorescently, respectively (Jones and Senft, 1985; Bush and 
Hall, 2003; Lewis et al., 2003; Unal Cevik and Dalkara, 2003; Huntley et al., 2005; 
Jones et al., 2005; Amin et al., 2008; Bubeck-Wardenburg and Schneewind, 2008).   
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2.2 BACTERIA 
2.2.1 Bacterial storage 
For long-term storage purposes, all acquired S. aureus strains and clinical isolates 
were streaked onto TSA plates (with antibiotics where appropriate) with a sterile 
loop.  Following 24hrs incubation (37°C), ‘neat’ bacteria were harvested with a 
sterile harvesting stick and transferred to vials containing 10% v/w skimmed milk 
(Oxoid Ltd., Basingstoke, UK).  Thereafter, the vials were placed into -80°C storage.  
 
2.2.2 Preparation of defined bacterial aspirates 
When required, bacteria were thawed from -80°C storage and streaked onto TSA 
plates (with antibiotics where appropriate - see Chapter 4 for details regarding 
antibiotic resistance profiles of defined S. aureus isogenic mutant strains).  
Following 24hrs incubation (37°C), TSB (10ml), with antibiotics where appropriate, 
was inoculated with several individual bacterial colonies from the 24hr TSA plate of 
a given bacterial strain and cultured in a shaking incubator (37°C; 24hrs).  Serial 
dilutions in normal saline, to a maximum of 10-6, were performed on the 24hr TSB 
culture in order to calculate the number of colony forming units (cfu; a single cfu is 
defined as a bacterium that is capable of reproducing to form a group or ‘colony’ of 
the same bacterial sepcies; the number of cfu is therefore a measure of the number of 
active bacteria) in 1ml of 24hr TSB.  Thereafter, 100µl of 10-4, 10-5, and 10-6 
dilutions were spread evenly onto TSA plates and incubated (37°C; 24hrs) (Figure 
2.1).  Colonies, which appeared as isolated ‘islands’ of bacterial growth were then 
counted using a colony counter (Stuart®, Bibby Scientific Ltd, Stone, UK).  
Bacterial counts were performed on a number of cultures for each bacterial 
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strain/clinical isolate studied and a count of approx. 1.0x109 cfu/ml (counts ranged 
from 1.0 to 1.25x109 cfu/ml) was consistently obtained.  Based on these results, a 
24hr culture of each strain grown in 10ml TSB was diluted in DMEM to produce a 
final bacterial concentration of approx. 1.0x105 cfu/ml DMEM (Figure 2.1).  
 
2.2.3 Preparation of defined bacterial supernatants   
The 40hr cultures of a defined S. aureus strain were pooled and centrifuged (3400g; 
10mins) to separate bacteria from toxins.  The supernatant, containing the toxins, 
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Figure 2.1: Preparation of a defined bacterial aspirate 
A TSA plate was inoculated with the designated S. aureus strain and incubated (37°C; 24hrs) (A).  
Several individual colonies were then harvested from the TSA plate (B) and used to inoculate 10ml 
TSB (C).  Following 24hrs incubation (37°C) in a shaker incubator (D), serial dilutions in normal 
saline, to a maximum of 10-6, were performed on the 24hr TSB culture (E). Thereafter, 100µl of 10-4, 
10-5, and 10-6 dilutions were spread evenly onto TSA plates and incubated (37°C; 24hrs) (F).  Colonies 
were then counted using a colony counter (G).  Based on these counts, and the assumption that the 
designated S. aureus strain would have a consistent growth curve in a standardised volume of TSB, a 
second overnight TSB culture was diluted in DMEM to give a final bacterial concentration of approx. 
1.0x105 cfu/ml (H).  
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2.3 BOVINE ARTICULAR CARTILAGE EXPLANTS 
Bovine articular cartilage explants were harvested as oval osteochondral (articular 
cartilage with subchondral bone attached) blocks unless otherwise stated.  The 
technique of harvesting these explants is detailed below. 
 
2.3.1 Source of bovine tissue 
Metacarpophalangeal joints of 3-year-old cows were washed, skinned, de-hoofed and 
opened within 12hrs of slaughter (Figure 2.2).  Joints were opened within an 
extraction hood that was thoroughly cleansed with 70% ethanol spray prior to the 
commencement of each dissection i.e. an aseptic environment.  All instruments were 
sterilised in 70% ethanol.  Care was taken throughout the metacarpophalangeal joint 
exposure to prevent both contamination and iatrogenic injury (i.e. mechanical injury) 
of the articular surface.  Only healthy joints, with no evidence of cartilage 
damage/degeneration, were used. 
 
2.3.2 Cartilage explant harvesting 
Prior to release of the collateral and intra-articular ligaments, the proximal limb was 
elevated to approx. 45° with the left hand, thereby permitting posterior reflection of 
the distal limb and the drainage of synovial fluid upon their release (Figure 2.2 and 
Figure 2.3).  Osteochondral explants were harvested from the convex weight-bearing 
articular surface between the intercondylar ridges (Figure 2.2).  As the thickness, 
cell density, physical and biochemical characteristics of articular cartilage have been 
shown to vary according to mechanical load (Roberts et al., 1986a; Roberts et al., 
1986b; Castano Oreja et al., 1995; Adams, 2006; Rogers et al., 2006), explants were 
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harvested from weight-bearing surfaces only in order to permit standardisation.  
Initial attempts to harvest osteochondral explants with a number-11 scalpel were 
unsuccessful, yielding small chondral ‘flakes’ lacking subchondral bone.  The 
absence of subchondral bone also resulted in marked ‘curling’ of the explants, which 
is well characterised (Gibson and Davis, 1958; Fry and Robertson, 1967), rendering 
subsequent imaging and cell viability quantification difficult.  Internal ‘interlocked 
stresses’ exist within the matrix (Fry and Robertson, 1967), with the outer layer of 
the tissue i.e. articular surface being maintained in tension (Chappuis et al., 1983; 
Verteramo and Seedhom, 2004), and when these forces are unopposed i.e. when the 
subchondral bone anchor is removed the cartilage curls in the direction of the 
articular surface.  The problems encountered with the number-11 scalpel were 
deemed to be due to the narrow and straight nature of the blade and subsequent use 
of the broader and convex shaped number-24 scalpel blade enabled the consistent 
harvesting of osteochondral explants with approx. 0.5mm subchondral bone attached 
(Figure 2.3).  
 
Upon harvesting, each osteochondral explant was quickly transferred to a sterile 
Falcon tube containing DMEM with the harvesting scalpel blade.  Once the 
harvesting procedure was complete, the explants were thoroughly irrigated in 
DMEM in order to remove the synovial fluid and reduce the chance of unwanted 
bacterial and fungal contamination.  Thereafter, the explants were transferred to a 
sterile tissue culture flask using a ‘no-touch’ technique and re-suspended in a defined 
volume of fresh DMEM (5ml).  This was achieved by firstly draining the DMEM 
carefully from the Falcon tube in order to retain the explants within the vessel and 
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thereafter inverting the Falcon tube so that the opening of the tube aligned with the 
opening of a vertically positioned tissue culture flask.  The subsequent ‘tapping’ of 
the opening of the Flacon tube against the opening of the tissue culture flask resulted 
in the explants ‘falling’ into the tissue culture flask. 
 
 
Figure 2.2: The exposure of the bovine metacarpophalangeal (anterior approach)  
(A) Each bovine foot was washed in running water to remove excess dirt and skinned using a number-
24 scalpel. (B) The hoof was removed and the skinned specimen generously sprayed with 70% 
ethanol to reduce the risk of cartilage contamination upon subsequent exposure of the joint. (C) The 
extensor tendons were divided, revealing the underlying joint capsule. (D) The joint capsule was 
dissected at its proximal margin and reflected distally to expose the joint.  The collateral (*) and intra-
articular (**) ligaments were divided and the distal limb reflected posteriorly in order to permit 
adequate joint exposure. (E) The articular surface was carefully inspected for evidence of 
degenerative disease/cartilage injury/contamination and if present the joint was discarded. (F) If the 
articular surface appeared healthy, osteochondral explants were harvested from the weight-bearing 
regions between the intercondylar ridges (arrows) with a fresh number-24 scalpel. 
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Figure 2.3: Osteochondral explant acquisition from the bovine metacarpophalangeal 
joint 
(A) A sterile number-24 scalpel blade was engaged with the articular surface of the proximal limb at 
an angle that permitted the capture of an osteochondral explant i.e. not too steep or shallow.  (B) Due 
to the convex nature of the number-24 scalpel blade, a steady forward and backward ‘rocking’ motion 
of the blade steadily yielded an osteochondral explant with approx. 0.5mm subchondral bone attached.  
The proximal limb of the joint was stabilised with the left hand throughout the harvesting procedure 
(note- these images were taken for illustration purposes only and a sterile chainmail glove should be 
worn on the stabilising hand at all times in order to prevent scalpel injury).  (C) The explant was 
immediately transferred to a vessel containing DMEM using the harvesting blade i.e. a ‘no touch’ 
technique. (D) An example of a typical oval osteochondral explant (scale bar = 1cm). 
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2.4 INCUBATION 
2.4.1 Bacterial culture studies 
For each experiment, osteochondral explants from each foot were placed into 
separate tissue culture flasks containing DMEM (5ml).  Thereafter, 25µl (approx. 
2.5x103 cfu) of a given S. aureus aspirate was injected into each flask.  This 
concentration was chosen as it was in the range used by previous direct joint-
inoculation in vivo studies of septic arthritis (Riegels-Nielson et al., 1987; Lefevre et 
al., 2011).  In addition, preliminary experiments identified that it produced a 
measurable degree of chondrocyte death within a reasonable time period that was 
neither overwhelming nor weak.  All flasks were incubated (37°C; 5% CO2) for 
40hrs unless otherwise stated.  
 
2.4.2 Bacterial culture-supernatant studies 
Bacterial culture-supernatants were prepared as previously described (see section 
2.2.3).  Thereafter, explants were incubated (37°C; 5% CO2) with defined 
supernatants over 6hrs. 
 
2.5 CELL VIABILITY STAINING AND FIXATION 
At 0, 18, 24 and 40hrs (bacterial culture studies) or 0, 2, 4 and 6hrs (bacterial 
supernatant studies), explants were aseptically removed and trimmed so as to create 
two straight edges (Figure 2.4).  Explants were then incubated (1hr; 21°C) in 
penicillin- and streptomycin-containing DMEM with CMFDA (10µM) and PI 
(10µM), which labelled living and dead chondrocytes green and red, respectively 
(Huntley et al., 2005; Amin et al., 2008).  Explants were subsequently fixed (4% 
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formaldehyde) prior to storage (4°C) in phosphate buffered saline (PBS).  For 
CLSM, explants were secured to the base of a Petri dish with Blu-Tack (Bostik, 





Figure 2.4: The preparation of osteochondral explants for cell viability staining 
Upon retrieval from the experimental vessel, the oval osteochondral explant was trimmed, as depicted, 
with the single ‘push-through’ motion of a number-24 scalpel, establishing two straight edges (scale 
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2.6 CLSM 
An upright Zeiss LSM510 Axioskop (Carl Zeiss Ltd., Welwyn Garden City, UK) 
CLSM, fitted with a x10/0.3 dry objective, was used to acquire optical sections of 
CMFDA- and PI-labelled in situ chondrocytes using established methods (Huntley et 
al., 2005; Amin et al., 2008).  A ‘multi-track protocol’, utilising argon and helium-
neon lasers, bandpass filters (500 to 550nm) and long pass filters (>560nm), 
permitted capture and visualisation of the fluorescence emitted from CMFDA 
(excitation wavelength (λex)=488nm, emission wavelength (λem)=517nm) and PI 
(λex=543nm, λem=650nm), respectively.  Detector gain, detector sensitivity and 
laser power were adjusted to obtain optimal image quality without excessive dye 
bleaching or pixel saturation.  The pinhole diameter was set to one Airy unit in order 
to achieve the optimal balance between image resolution and signal strength (Jones 
et al., 2005). 
 
For the purpose of image analysis in the present study, articular cartilage was loosely 
characterised into three distinct zones on the basis of depth-associated variation in 
cell and ECM properties: the superficial (SZ; up to 10% depth from the articular 
surface), middle (MZ; 10-40%) and deep zones (DZ; 40-100%) (Buckwalter and 
Mankin, 1997a; Jadin, 2005) (Figure 2.5B).  Bovine cartilage is thinner than human 
cartilage (Athanasiou et al., 1991) and depending on the joint assessed, varies in 
thickness from approx. 0.8 to 2.5mm (Schinagl et al., 1997; Moo et al., 2011; 
Pedersen et al., 2013).  However, cartilage zones within bovine cartilage have been 
shown to be comparable to those in human cartilage (Pedersen et al., 2013).  
Depending on the experiment, images were obtained in either the axial or coronal 
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plane.  For axial images (Figure 2.5A), the focal plane was moved through the tissue 
at 10µm increments (i.e. in the z-direction) from the articular surface to a depth of 
100µm, thereby enabling detailed visualisation of chondrocytes within the entirety of 
the SZ and a small portion of the MZ.  Axial images were always acquired with the 
cut-edge at the margin of the field-of-view for standardisation purposes (Figure 
2.5A).  Preliminary experiments that attempted image acquisition at 5µm intervals 
resulted in the creation of large file sizes that frequently could not be handled by the 
Volocity 4 software (Improvision, Coventry, UK) used throughout this study.  In 
addition, imaging times were considerably prolonged with no apparent gain in 
cellular detail.  Furthermore, previous studies using similar experimental techniques 
utilised 10µm increments successfully for the assessment of chondrocyte viability in 
human and bovine cartilage (Huntley et al., 2005; Amin et al., 2008; Amin et al., 
2009a; Amin et al., 2009b; Amin et al., 2010; Amin et al., 2011). 
 
For coronal images (Figure 2.5B), the focal plane was moved in a similar manner 
but from the ‘cut-edge’, which was created immediately prior to explant staining, 
into the tissue (i.e. in the y-direction) to a depth of 100µm, thereby enabling 
visualisation of the full thickness of cartilage.  In both the axial and coronal plane, 
fluorescence was poor at depths greater than 100µm and therefore 100µm was set as 
the depth limit for image acquisition.  Each optical section measured 921x921µm 
and had an image resolution of 1024x1024 pixels.  
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Figure 2.5: Axial and coronal imaging of CMFDA- and PI-labelled osteochondral 
explants and the subsequent quantification of in situ chondrocyte death 
The x-, y- and z-axes of the trimmed osteochondral explants are illustrated (scale bar=0.5cm).  Axial 
imaging (A) involved the acquisition of serial optical sections at 10µm intervals from the articular 
surface into the tissue to a depth of approx. 100µm i.e. focused imaging of SZ chondrocytes.  For 
subsequent axial projections, live/dead cell counts were performed within a region of interest (ROI) 
that did not include the cut-edge shown.  Coronal imaging involved the acquisition of serial optical 
sections at 10µm intervals from the cut-edge i.e cut surface into the tissue to a depth of approx. 
100µm, thereby enabling the imaging of the the full thickness of cartilage.  For coronal projections, 
chondrocyte viability was quantified within ROIs at 100µm intervals from the articular surface to a 
depth of 400µm.  Living and dead cells were marked blue and yellow, respectively, following 
automated identification (scale bar = 100µm).  
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2.7 QUANTITATIVE ANALYSES 
2.7.1 Percentage chondrocyte death 
For reconstructed 3-D CLSM projections, the percentage chondrocyte death 
((number of dead cells/total number of living and dead cells) x 100) was calculated 
within a defined region of interest (ROI) by using Volocity 4 imaging software to 
perform automated live/dead cell counts.  The technique for automated cell counting 
within a particular ROI was based on a validated and reproducible protocol (Jomha 
et al., 2003; Lin et al., 2005; Amin et al., 2008).  Individual objects (cells) in both 
the green (living) and red (dead) channels were identified by establishing upper and 
lower limit percentage voxel (volumetric pixel) intensity thresholds (Lin et al., 
2005).  These limits were set using a histogram of measured values for all objects 
identified in each channel and enabled the exclusion of background fluorescence.  
The upper limit was set at 100% for all images.  However, the lower limits for each 
channel required minor adjustments (minimum 3% for green channel and 8% for red 
channel) in order to accommodate for variations in fluorescent dye loading and 
detector sensitivity between images.  All cells touching the margin of the ROI were 
included in the counts.  In addition, combined objects (two cells in close proximity 
incorrectly identified as single objects) within the ROI were separated using a 
dedicated feature embedded within the Volocity 4 software.  
 
The above protocol returned a list of measured objects of variable size in the green 
and red channels.  However, in order to discriminate between background noise and 
actual cells, objects were further excluded on the basis of volume.  The volume of 
healthy, living chondrocytes typically ranges from 500-1200µm3 (Bush et al., 2005).  
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Therefore, when ordered by volume, objects in the green channel <500µm3 and in the 
red channel <200µm3 were attributable to background noise and thus excluded from 
the cell counts.  The remaining objects were presented as the final automated live 
and dead cell count by the Volocity 4 software.  In order to confirm visually the 
automated capture of living and dead cells within each ROI, living and dead cells 
were marked blue and yellow, respectively (Figure 2.5).  Whilst good correlation 
between automated and manual counts has been identified, the reproducibility of the 
counts generated by the automated algorithm has been shown to be significantly 
better in comparison to human evaluation (Jomha et al., 2003). 
   
2.7.2 Axial and coronal regions of interest 
The positioning and dimension of each ROI on axial and coronal CLSM 
reconstructions was standardised as follows: 
 
1. Axial CLSM reconstructions 
For axial projections, the percentage chondrocyte death was calculated within a 50% 
field-of-view region of interest (ROI) measuring 921x461x100µm (x-y-z axes, 
respectively).  This ROI was created in order to avoid the cell death artefact induced 
by the scalpel blade at the cut-edge (Amin et al., 2008) (Figure 2.5A).   
 
2. Coronal CLSM reconstructions 
For coronal projections, percentage chondrocyte death was quantified at 100µm 
intervals, within a ROI measuring 921x100x100µm (x-y-z axis, respectively), to a 
depth of 400µm from the cartilage surface (Figure 2.5B).  Throughout this study, it 
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was observed that the thickness of bovine cartilage was usually between 600 and 
700µm.  However, in some explants the osteochondral junction was located between 
400 and 500µm and therefore to avoid potential overlap of the osteochondral 
junction, the maximum depth limit for chondrocyte viability analysis was set at 
400µm.   
 
2.8 STATISTICAL ANALYSES 
Statistical analyses were performed using SigmaPlot version 12 (Systat Software 
Inc., Chicago, USA).  N refers to the number of feet from separate animals 
(independent experiments) and n refers to the number of individual explants (i.e. 
replicates) analysed per foot for each experimental group at each experimental time 
point.  Values of all replicates were averaged to obtain a single observation for that 
animal.   
 
All the assumptions underlying the statistical analyses were fulfilled.  Normality and 
homogeneity of variance of all data were assessed using the ‘Shapiro-Wilk’ and 
‘Levene’s equality of variance’ tests, respectively.  If the experimental data sets 
passed these tests, then appropriate parametric statistical analyses were conducted 
and if not, then suitable non-parametric statistical analyses were performed.  It is 
appreciated that there are several numerical tests available to assess for normality.  
However, recent literature suggests that the Shapiro-Wilk test is the most powerful 
numerical normality test (Ghasemi and Zahediasl, 2012). 
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The specific parametric and non-parametric statistical tests used to analyse each 
experiment are detailed within each results chapter.  Data are presented as means ± 
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CHAPTER 3 
A BOVINE CARTILAGE EXPLANT MODEL OF S. 
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3.1 INTRODUCTION 
This study primarily focuses on the laboratory ‘wild-type’ strain S. aureus 8325-4, a 
well-characterised prophage-cured derivative of strain NCTC8325 (Novick, 1967; 
Gemmell et al., 1997).  It is known to produce large amounts of Hla, Hlb, Hlg, Hld, 
protein A, lipase hyalonurate, staphylokinase, metalloproteinase, serine proteinase, 
coagulase, nuclease and acid phosphatase but does not produce any enterotoxins, PVL 
or TSST-1 (O'Reilly et al., 1986; Nilsson et al., 1999; Dajcs et al., 2002; Monecke et 
al., 2013).  NCTC8325 was originally isolated from a sepsis patient in 1960 and its 
lineage remains a valuable resource for basic S. aureus research (Herbert et al., 2010).   
 
In addition to S. aureus 8325-4, this study also investigates clinical ‘isolates’ of S. 
aureus, isolated from the joint aspirates of patients presenting with S. aureus-induced 
septic arthritis.  Tenover et al. (1995) define an isolate as “a general term for a pure 
culture of bacteria obtained by subculture of a single colony from a primary 
isolation plate, presumed to be derived from a single organism, for which no 
information is available aside from its genus and species”.  They further define a 
strain as “an isolate or group of isolates that can be distinguished from other 
isolates of the same genus and species by phenotypic characteristics or genotypic 
characteristics or both.  A strain is a descriptive subdivision of a species”.  Some 
clinical infections are the result of a defined bacterial ‘strain’, which enables focused 
treatment strategies and future directed research.  For example, outbreaks of 
haemorrhagic colitis with associated haemolytic uraemic syndrome following the 
consumption of contaminated cold meat products are typically associated with the 
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bacterium Escherichia coli 0157, a specific verotoxin-producing strain of E. coli 
(Sharp et al., 1994; Waters et al., 1994; Pennington, 2010). 
 
At present, no studies have investigated whether S. aureus-induced septic arthritis is 
associated with a particular strain of S. aureus.  Thus, in order to assess whether the 
acquired S. aureus clinical isolates were indeed the same S. aureus strain, clonally 
related or independent strains, pulsed-field gel electrophoresis (PFGE) was 
conducted.  PFGE was first described by Schwartz and Cantor (1984) and is now 
considered the gold standard technique for S. aureus genotyping as it is one of the 
most reliable, discriminatory and reproducible typing procedures to enable the 
detection of a high degree of DNA polymorphism (Murchan et al., 2003; Stranden et 
al., 2003).  It is based on the digestion of bacterial genomic DNA, which is achieved 
through the use of a restriction endonuclease (Liu et al., 1996).  The restriction 
endonuclease recognises few digestion sites in the chromosome, thereby generating 
large DNA fragments that can be effectively separated by periodically shifting the 
orientation of the electrical field (Levene and Zimm, 1987; Benson and Ferrieri, 
2001). 
 
Previous work investigating bacteria and associated toxins has primarily focused on 
isolated chondrocytes, cartilage explants or animal models (Smith and Schurman, 
1983; Lee et al., 2001).  Isolated chondrocytes have the advantage of allowing easier 
control of experimental conditions but have the disadvantage of not allowing the 
study of chondrocytes in their ‘native’ extracellular environment.  In contrast, 
chondrocytes within cartilage remain within their ‘native’ environment but studies to 
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date have utilised assays for either the release of ECM components (Jasin, 1983; 
Smith and Schurman, 1983)	  or degradative enzymes (Williams et al., 1991) as 
experimental end-points.  Although these may provide an important indication of 
ECM destruction, they give no information on chondrocyte viability following 
bacterial exposure.  An in vitro model of septic arthritis whereby in situ chondrocyte 
death can be both directly visualised and quantified, whilst at the same time allowing 
better control of experimental variables in the absence of the complexities of a host 
immune response, would be highly desirable. 
 
It is likely that there are two major mechanisms to the cartilage destruction that occurs 
in septic arthritis: (1) bacteria and associated toxins, and (2) components of the host 
immune response.  However, the contribution from each of these is currently 
unknown.  This study focuses on the former and aims to provide fundamental 
information about the effect of S. aureus and its toxins on in situ chondrocyte viability 
separate from the potentially confounding effect of the host immune response present 
in in vivo animal models.  CLSM has been used to spatially define and quantify in situ 
chondrocyte death in a bovine cartilage model of septic arthritis (see Chapter 2), which 
is a novel approach in the field of septic arthritis research.  Cartilage hydration 
following bacterial exposure has also been measured in order to assess cartilage 
integrity, as increased cartilage water content is a sensitive indicator of early cartilage 
matrix disruption (Buckwalter and Mankin, 1997b; Berberat et al., 2009).   
 
This study was conducted to improve the understanding of the interaction between 
bacteria and in situ chondrocytes with a view, ultimately, to improving the treatment 
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of septic arthritis.   
 
3.2 HYPOTHESES 
The first hypothesis was that both a laboratory strain and clinical isolates of S. aureus 
have a rapid and potent effect on in situ chondrocyte viability and cartilage integrity.  
The second hypothesis was that S. aureus-induced chondrocyte death commences 
within the superficial zone (SZ) of cartilage and progresses to deeper layers.  The third 
hypothesis was that all investigated clinical isolates were independent strains of S. 
aureus. 
 
3.3 MATERIALS & METHODS 
3.3.1 Biochemicals and solutions 
The standard tissue culture medium for this study was serum-free DMEM (Catalogue 
no. 41966; 340mOsm/Kg H2O; pH7.4) with L-glutamine (4mM), D-glucose 
(25mM), sodium pyruvate (1mM) and sodium bicarbonate (44mM).  DMEM of three 
pH values was used: pH7.4, pH6.4 and pH5.4 (adjusted using HCl; measured using a 
pH meter (FiveEasy™ pH, Mettler-Toledo Ltd., Leicester, UK)).  
 
3.3.2 S. aureus strains and isolates   
S. aureus strain 8325-4 was kindly provided by Professor T.J. Foster, Dept. 
Microbiology, Trinity College, Dublin, Ireland.  A total of 5 S. aureus clinical 
isolates (Table 3.1), isolated from joint aspirates of patients presenting with S. 
aureus-induced septic arthritis, were obtained.  Isolates 36V, 28G and 12R were 
randomly selected by an impartial observer for an in situ chondrocyte viability study.  
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Isolate Gender Age Source 
36V* Male 46 Right Hip 
28G* Male 74 Right Wrist 
12R* Male 69 Left Knee 
49L Male 79 Right Hip 
78B Male 73 Right knee 
 
 
Table 3.1: Source and details of S. aureus clinical isolates utilised in this study. (*) Denotes 
isolates randomly selected by an impartial observer for in situ chondrocyte viability study.  
 
3.3.3 Pulsed-field gel electrophoresis  
The main procedural steps for PGFE subtyping of S. aureus isolates are outlined in 
Figure 3.1.  PFGE was conducted on S. aureus 8325-4 and all S. aureus clinical 
isolates (Table 1).  
 
The following buffers were obtained from Severn Biotech Ltd, Kidderminster, UK 
for PFGE: TEN buffer (0.1M Tris Cl, 0.1M EDTA, 0.15M NaCl), EC (E. coli) 
buffer (6mM Tris Cl, 1M NaCl, 0.1M EDTA, 0.5% Brij 58, 0.2% deoxycholate, 
0.5% Sarkosyl), TE buffer (10mM Tris, 5mM EDTA, pH 7.5) and 0.5X TBE buffer 
(40mM Tris Cl, 45mM Boric acid, 1mM EDTA, pH 8.3).  Several individual 
colonies of a particular test isolate were harvested from a TSA plate using a sterile 
harvesting stick and transferred to an Eppendorf tube (microcentrifuge tube) 
containing TEN buffer (1ml), thereby establishing a test isolate suspension.  The 
Eppendorf tube was then centrifuged (13 000rpm) for 2mins.  Following 
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centrifugation, the pellet was re-suspended in EC buffer (500µl).  Thereafter, 
lysostaphin (2µl of 1mg/ml solution (dissolved in 20mM sodium acetate)) and 1.2% 
low melt agarose (500µl) were added.  The entire volume of the suspension within 
the Eppendorf tube was then pipetted into a plug mould and left at room temperature 
for 15mins.  After 15mins, the plug was placed into a bijoux containing EC buffer 
(3ml), which was subsequently placed into a water bath (37°C) for 1hr.  Thereafter, 
the EC buffer was removed and replaced with TE buffer (3ml) prior to a further 1hr 
incubation (55°C) period.  Upon completion of this incubation period, the TE buffer 
was replaced with fresh TE buffer and the plug was refrigerated (4°C) until required. 
 
Following removal from refrigerated storage, a portion of the plug (approx. 2mm x 
2mm) was cut with a sterile number-11 scalpel blade and transferred to a fresh 
Eppendorf tube, to which distilled water (DW) (90µl) and reaction buffer (10µl) 
were added.  The Eppendorf tube was then placed into a refrigerator (4°C) for 
30mins.  Thereafter, the buffer was carefully removed using a fine pastette and 
replaced with DW (90µl), reaction buffer (10µl), bovine serum albumin (2µl; 
1mg/ml), dithiothreitol (2µl; 1.5mg/100µl DW) and restriction enzyme (2µl; XbaI).  
Finally, the Eppendorf tube was immersed in a water bath (25°C) for 5hrs. The above 
procedure was simultaneously conducted for each S. aureus isolate investigated. 
  
A pulsed field agarose gel was prepared by adding pulsed field agarose (1g) to 0.5X 
TBE buffer (100ml).  The liquid agarose was poured into a gel mould and allowed to 
set.  Upon setting, plugs within the Eppendorf tube (one plug per isolate 
investigated) were placed into the wells in the gel.  Thereafter, the gel was 
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transferred to the centre of a PFGE tank containing approx. 2L 0.5X TBE buffer 
(buffer continuously circulated by circulator pump).  PGFE was performed using a 
contour-clamped homogenous electric field apparatus (CHEF DRII System, BIO-
RAD Laboratories Ltd, CA, USA).  Running parameters were as follows: 14°C; 
200V (6V/cm); initial pulse time, 5secs; final pulse time, 40secs; and total time, 
20hrs. Saccharomyces cerevisiae chromosomal DNA (Mortimer and Schild, 1985) in 
1.0% low-melt agar (BIO-RAD Laboratories Ltd, CA, USA) was used as a 
molecular size standard (MSS) (DNA size marker). 
 
After the electrophoresis run was completed, the gel was stained with Gel Red (7.5µl 
in 250ml 0.1M NaCl) for 20mins in a covered container.  Thereafter, the gel was 
photographed using a gel doc system (Molecular Imager® Gel Doc™ XR System, 
BIO-RAD Laboratories Ltd, CA, USA) and visually analysed.  Strains were defined 
as either (1) representing the same strain if they possessed 100% similarity to the 
restriction fragment patterns of DNA (PFGE profile) or (2) having a clonal 
relationship if they possessed 85% similarity between PFGE profiles.  The 85% cut-
off for clonal relationship was chosen as it was considered that similarities above this 
level could be accounted for by changes consistent with a single genetic event i.e. 
point mutation or an insertion or deletion of DNA (Tenover et al., 1995; Ejrnaes et 
al., 2006). 
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Figure 3.1: Main procedural steps for pulsed-field gel electrophoresis of S. aureus 
isolates 
 
3.3.4 Bovine chondral explants 
For the experiment investigating the sensitivity of SZ chondrocytes to bacterial 
toxins, chondral (subchondral bone-free) explants were obtained.  This was achieved 
by flattening the angle of the number-24 scalpel blade upon engaging the articular 
surface.  Instead of a forward and backward rocking motion (as per the harvesting of 
osteochondral explants), the blade was simply pushed through the cartilage in a plane 
that was parallel to the bone-cartilage interface.  For all other experiments, 
osteochondral explants were harvested as previously described (see Chapter 2) 
 
3.3.5 Bacterial culture and pH studies 
For each experiment, osteochondral explants from each joint were placed into 
separate tissue culture flasks containing DMEM (5ml).  Thereafter, 25µl (2.5x103 
cfu) of a given bacterial aspirate was added to each flask.  A similar experiment was 
conducted whereby cartilage explants were cultured in non-infected DMEM at pH 
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values of 7.4, 6.4 or 5.4.  For a post-infection long-term chondrocyte viability study, 
explants were initially cultured with S. aureus 8325-4 for 40hrs.  The infected culture 
medium was then aspirated and the cartilage rinsed with normal saline in order to 
remove residual bacteria and their toxins.  Fresh DMEM containing penicillin (50 
U/ml) and streptomycin (50µg/ml) was then added, and the culture resumed for a 
further 14 days. The 8325-4 strain was known to be sensitive to penicillin (Figure 
3.2) and therefore would not grow in culture medium containing this antibiotic. 
 
3.3.6 Bacterial supernatant study 
The 40hr cultures of S. aureus 8325-4 were pooled and centrifuged (3400g; 10mins) 
to separate bacteria from toxins.  The supernatant, containing the toxins, was 
harvested and filter-sterilised (0.22µm filter). Subchondral bone-free explants were 
then exposed to the supernatant (37°C; 5% CO2) over a 6hr time-course. 
 
Figure 3.2: Confirmation of S. aureus 8325-4 sensitivity to penicillin 
(A) The presence of a penicillin-impregnated disc resulted in no bacterial growth in the immediate 
vicinity of the disc (red arrow), thereby confirming S. aureus 8325-4 sensitivity to penicillin.  (B) In 
comparison there was bacterial growth around a non-antibiotic loaded disc (white arrow) (scale 
bar=1cm). 
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3.3.7 Cartilage water content 
Cartilage explants were cultured with S. aureus 8325-4 or non-infected DMEM of 
pH7.4 or 5.4.  At 0, 24 and 40hrs, explants were aseptically retrieved from the flasks 
and excess moisture removed by placing the explants briefly between folded filter 
paper.  The explants were then placed in pre-weighed glass vials, weighed (total wet 
weight (a)) and dried at 60°C until constant weight (total dry weight (b)) (Huntley et 
al., 2005).  Water content was calculated as: ((a – b)/a) x 100%.  
 
3.3.8 Statistical analysis 
Parametric data were analysed using either one-way between-groups ANOVA 
(clinical isolate, cartilage water content and DMEM coronal studies), with post hoc 
Dunnett’s or Bonferroni tests, or paired and unpaired Student’s two-tailed t-tests 
(8325-4 versus DMEM axial study, post-infection viability study and SZ study).  
One-way between-groups Kruskal-Wallis ANOVA (pH study), with post hoc Dunn’s 
test, or Mann-Whitney U tests (8325-4 versus DMEM coronal study) were used to 
analyse non-parametric data.   
 
3.4 RESULTS 
3.4.1 S. aureus 8325-4 rapidly reduced in situ chondrocyte viability 
To test this bovine cartilage explant model of septic arthritis, in situ chondrocyte 
death was quantified in the axial plane using osteochondral explants cultured in the 
presence or absence (DMEM control) of S. aureus 8325-4.  In explants cultured with 
S. aureus 8325-4, chondrocyte death increased relatively slowly between 18 and 
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24hrs (Figure 3.3A).  However, between 24 and 40hrs there was a rapid reduction in 
chondrocyte viability with 88.3±21.3% chondrocyte death at 40hrs.  In comparison, 
there was negligible chondrocyte death at 40hrs in the control group (0.1±0.2%) with 
the difference in chondrocyte viability between the two groups at 40hrs being 
significant (p<0.001; Figure 3.3A and B).   
 
3.4.2 Reduced culture medium pH had a minimal effect on in situ chondrocyte 
viability 
During the above experiments, the culture medium became progressively acidic 
(Figure 3.4A), with pH values of approx. 6.4 and 5.4 being measured at 24 and 
40hrs, respectively.   There was the possibility that chondrocyte death might be due, 
in part, to acidic medium pH, induced by bacterial growth and metabolism (Smith, 
1991) rather than an action of bacterial toxins.  To assess the contribution of acidity 
on chondrocyte viability, explants were incubated in media of pH7.4, 6.4 and 5.4 in 
the absence of bacteria.  Although there was no difference in chondrocyte viability 
between the groups at 18hrs (p=0.18) and 24hrs (p=0.14), at 40hrs there was a small 
but significant increase in chondrocyte death in the explants exposed to pH5.4 
(4.7±7%; p<0.01) compared to pH6.4 (0.05±0.06%; Figure 3.4B).  The extent of 
chondrocyte death at pH5.4 (40hrs) was however considerably lower than that 
inflicted by S. aureus 8325-4 (Figure 3.3A) and therefore contributed no more than 
approx. 5% of the overall 40hr chondrocyte death induced by S. aureus 8325-4.  
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Figure 3.3: Increased in situ chondrocyte death by S. aureus 8325-4   
Line graph (A) shows chondrocyte death in the presence or absence (DMEM control group) of S. 
aureus 8325-4 (N=4[n=2]; p values represent 8325-4 versus DMEM control group by unpaired 
Student’s two-tailed t-test).  The CLSM images (B) display the marked difference between the S. 
aureus 8325-4 and DMEM control groups at 40hrs (scale bar=100µm).   
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Figure 3.4: Acidic culture medium induced a small decrease in in situ chondrocyte 
viability 
Reduced culture medium pH was noted during 40hr S. aureus 8325-4 culture, as depicted by a change 
in culture medium colour (DMEM contains phenol red which is pH sensitive and progresses through 
orange to yellow as the medium becomes more acidic) (A).  The bar graph (B) demonstrates in situ 
chondrocyte viability, in the absence of bacteria, in pH 7.4 (control), 6.4 and 5.4 culture medium 
(N=6[n=1]; numerical p values represent one-way between-groups Kruskal-Wallis ANOVA; ** 
p<0.01 pH5.4 versus pH6.4 by post hoc Dunn’s test).   
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3.4.3 PFGE typing demonstrated all S. aureus clinical isolates to be independent 
S. aureus strains 
In order to assess whether the S. aureus clinical isolates were the same S. aureus 
strain, clonally related or independent strains, PFGE was conducted.  Thereafter, the 
DNA restriction patterns (i.e. the ‘bands’ on the PFGE gel) of the clinical isolates 
and S. aureus 8325-4 were compared in order to determine their relatedness.  
Although there were some similarities between isolates, each isolate was sufficiently 
different (less than 85% similarity - see section 3.3.3) to be considered an 
independent strain (Figure 3.5).  In addition, each clinical strain was considerably 
different to S. aureus 8325-4.  Thus, the S. aureus clinical isolates will now be 
referred to as ‘strains’. 
 
Figure 3.5: PFGE of S. aureus clinical isolates and S. aureus 8325-4 
The PFGE patterns of each clinical isolate were sufficiently different (see section 3.3.3) to render each 
isolate an independent S. aureus strain.  MSS, molecular size standard. 
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3.4.4 Comparison between S. aureus clinical strains and S. aureus 8325-4 
In order to validate the use of S. aureus 8325-4 in the experimental model, its 
potency was compared with clinically relevant strains of S. aureus.  Although none 
of the clinical strains (Table 3.1) were as potent as S. aureus 8325-4, each clinical 
strain produced >45% chondrocyte death at 40hrs (Figure 3.6A).  In contrast, all the 
clinical strains had a more potent effect than S. aureus 8325-4 at 18 and 24hrs.  
There was, however, variation between the potencies of the clinical strains at 18 and 
24hrs (Figure 3.6A and B).  Statistical tests comparing the clinical strains with the 
DMEM control group demonstrated the 36V strain alone to be significantly different 
at 18hrs (31.3±10%; p<0.001), the 28G (58.4±22.2%; p<0.001) and 36V (47.5±12%; 
p<0.001) strains at 24hrs, and all strains at 40hrs (Figure 3.6A).  
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Figure 3.6: S. aureus clinical strains had a damaging effect on in situ chondrocyte 
viability 
The bar graph (A) displays a significant difference between the DMEM control group and the clinical 
strains from 18hrs onwards (N=4[n=2]; numerical p values represent one-way between-groups 
ANOVA; *** p<0.001 versus DMEM control group by post hoc Dunnett’s test).  The panels (B) 
show CLSM images of explants exposed to the clinical strains with marked chondrocyte death 
induced by all strains at 40hrs in comparison to the DMEM control group.  However, the potencies of 
the strains vary at 18 and 24hrs (scale bar=100µm).   
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3.4.5 Chondrocyte death induced by S. aureus 8325-4 commenced within the SZ 
of osteochondral explants and progressed to deeper zones 
In order to assess chondrocyte viability throughout articular cartilage following 
bacterial exposure, a separate population of explants was cultured in either the 
presence or absence of S. aureus 8325-4, but here they were imaged and quantified 
in the coronal plane (Figure 2.5B).  In the absence of bacteria, there was no change 
in chondrocyte viability over time (Figure 3.7A).  The chondrocyte death, which 
was present throughout, was due to the scalpel cut as previously reported (Amin et 
al., 2008).  Chondrocytes within the most superficial 100µm were more susceptible 
to cutting trauma than those within deeper layers.  With the exception of 18hrs, there 
was significantly more chondrocyte death within the superficial 100µm, compared to 
deeper intervals, at each time point (Figure 3.7A).  However, chondrocyte death did 
not exceed 13% within any of the intervals studied.  In comparison, there was 
progressive chondrocyte death in explants exposed to S. aureus 8325-4 (Figure 
3.7B) which commenced within the SZ and rapidly progressed to deeper layers 
(Figure 3.7B and C). 
 
It was hypothesised that the extensive chondrocyte death induced by S. aureus 8325-
4 at 40hrs (Figure 3.7B and C) might compromise cartilage integrity.  An early 
feature of cartilage degeneration is increased cartilage water content (Bollet and 
Nance, 1966; Buckwalter and Mankin, 1997b).  Accordingly, this was measured in 
explants cultured in the presence or absence of S. aureus 8325-4 at 24 and 40hrs.  In 
addition, explants incubated at pH5.4, previously shown to induce a small but 
significant decline in chondrocyte viability (Figure 3.4B), were also investigated.  
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There was no difference in the water content of the explants between the groups at 
24 (p=0.995) or 40hrs (p=0.46) (Figure 3.8), thereby indicating no immediate loss of 
cartilage integrity. 
 
3.4.6 Post-infection in situ chondrocyte viability study 
In order to assess the longer-term effects on chondrocyte viability following 
infection, cartilage explants were cultured with S. aureus 8325-4 for 40hrs prior to 
rinsing with normal saline.  Explants were then incubated in penicillin- and 
streptomycin-containing DMEM for a further 14 days.  Chondrocyte viability was 
determined in the coronal plane at 40hrs and 16 days as previously described.  The 
mean cell death throughout the analysed depth intervals at 40hrs was 87.1±21.3%, 
and this was not significantly different at 16 days (91.4±17.3%; p=0.16 by paired 
Student’s two-tailed t-test; N=4[n=2]) (Figures 3.9 and 3.10).  This demonstrated 
that the PI-stained chondrocytes at 40hrs were dead and incapable of labelling green 
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Figure 3.7: The zonal pattern of chondrocyte death with osteochondral explants 
following exposure to S. aureus 8325-4 
In the absence of bacteria (A), chondrocyte death at each time point was minimal and consistent 
within each depth interval.  Apart from 18hrs, there was significantly increased chondrocyte death 
within the first 100µm in comparison to deeper zones (N=4[n=2]; numerical p values represent one-
way between-groups ANOVA; * p<0.05; ** p<0.01; *** p<0.001 versus 0-100µm depth interval by 
post hoc Bonferroni test).  In those explants exposed to S. aureus 8325-4 (B), chondrocyte death 
commenced within the SZ and extended to deeper layers (N=4[n=2]; p<0.05 versus comparable depth 
interval in DMEM control group by Mann-Whitney U test).  The panels (C) display CLSM images of 
explants cultured in either the presence or absence of S. aureus 8325-4 and provide a visual 
representation of chondrocyte death commencing within the SZ and progressing (white arrows) to 
deeper layers (scale bar=100µm).   
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Figure 3.8: Cartilage dry weight study 
There was no change in cartilage water content following 40hrs culture in the presence of S. aureus 
8325-4 and pH5.4 culture medium (N=4[n=2]; p values represent one-way between-groups ANOVA).   
 
 
Figure 3.9: Post-infection long-term in situ chondrocyte viability 
Following 40hrs culture with S. aureus 8325-4, explants were irrigated with normal saline and 
transferred to fresh culture medium containing penicillin and streptomycin (see section 3.3.5 for 
details).  There was no significant change in chondrocyte viability between 40hrs and 16 days (14 
days post-irrigation) (N=4[n=2]).   
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Figure 3.10: CLSM images from the long-term post-infection chondrocyte viability 
study 
CMFDA- and PI-labelled explants from each foot at 40hrs and 16 days (14 days post-irrigation) are 
displayed.  There was no evidence of increased CMFDA staining at 16 days in any of the feet (scale 
bar=100µm). 
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3.4.7 SZ chondrocytes were more susceptible to S. aureus 8325-4 toxins than 
cells within deeper zones   
Chondrocyte death, following exposure to S. aureus 8325-4, commenced within the 
SZ (Figure 3.7B and C).  However, as osteochondral explants were utilised it could 
not be concluded that SZ chondrocytes were more susceptible to S. aureus 8325-4 
toxins as the subchondral bone may have acted as a diffusion barrier to bacterial 
toxins, thereby protecting DZ chondrocytes (Figure 3.11A).  In order to assess the 
susceptibility of SZ and DZ chondrocytes to S. aureus 8325-4 toxins, subchondral 
bone-free cartilage explants were exposed to S. aureus 8325-4 toxins for 6hrs and 
chondrocyte death analysed within the SZ and DZ (Figure 3.11A).  In the absence of 
subchondral bone, it would be expected that toxin exposure to chondrocytes within 
the SZ and DZ was equal (Figure 3.11A).  At 0hrs, chondrocyte death was 
comparable in the SZ and DZ (p=0.36) (Figure 3.11B and C).  However, after 6hrs 
incubation with S. aureus 8325-4 toxins, 49.1±2.5% of the SZ cells were dead 
compared to only 18.7±8.7% in the DZ (p<0.001).  There was significantly more 
chondrocyte death in the SZ at 6hrs compared to 0hrs (p<0.001).  In contrast, there 
was minimal difference in chondrocyte viability between 0 and 6hrs in the DZ 
(p=0.57).  These results therefore suggest that SZ chondrocytes were considerably 
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Figure 3.11: Increased susceptibility of SZ chondrocytes to S. aureus 8325-4 toxins 
Subchondral bone-free explants (A), which permitted exposure of both SZ and DZ chondrocytes to 
experimental challenge, were cultured with S. aureus 8325-4 toxins for 6hrs and chondrocyte viability 
was assessed within defined regions of interest (dashed yellow boxes).  The bar chart (B) 
demonstrates no difference in chondrocyte viability between the SZ and DZ at 0hrs (N=4[n=2]; 
p=0.36 by unpaired Student’s two-tailed t-test).  However, at 6hrs there was significantly more 
chondrocyte death within the SZ in comparison to the DZ (p<0.001).  The CLSM reconstructions (C) 
provide a clear visual representation of the increased susceptibility of SZ chondrocytes to S. aureus 
8325-4 toxins (scale bar = 100µm).   
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3.5 DISCUSSION 
This study utilised CLSM to determine changes to in situ chondrocyte viability 
during exposure to a laboratory strain and clinical isolates of S. aureus.  The results 
demonstrated that toxins released by S. aureus had a potent damaging effect on 
chondrocytes whereas the increased acidity occurring during bacterial culture had a 
minimal effect.  Chondrocyte death commenced in the SZ of cartilage, suggesting 
that these cells were more susceptible to the toxins compared to DZ chondrocytes.  
Furthermore, despite extensive chondrocyte death induced by S. aureus 8325-4 
toxins, cartilage water content was not significantly altered compared to non-infected 
controls.  
 
This study utilised S. aureus 8325-4 as it can induce severe septic arthritis in animal 
models (Gemmell et al., 1997; Nilsson et al., 1999).  To the author’s knowledge, no 
studies have measured the bacterial concentrations within the infected synovial fluid 
of humans presenting with S. aureus-induced septic arthritis.  Hence, it was difficult 
to match levels in the current experiments with those in a septic joint.  A low aspirate 
concentration and volume comparable to previous in vivo direct joint-inoculation 
studies (Riegels-Nielson et al., 1987) was therefore used.  The increase in 
chondrocyte death was dramatic, with approx. 90% cells dead at 40hrs (Figure 
3.3A).  However, the culture medium became more acidic (Figure 3.4A) raising the 
possibility that cell death may, in part, be due to elevated medium acidity.  
Nevertheless, control experiments established that there was a minimal effect on 
chondrocyte viability at reduced pH (Figure 3.4B).  This may reflect the membrane 
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transport adaptations present in articular chondrocytes required for survival in the 
relatively acidic environment of the ECM (Simpkin et al., 2007).  
 
Given that the experimental end-point of this study was chondrocyte death, one may 
question the importance of determining the mechanism of cell death i.e. necrosis 
versus apoptotosis.  The primary goal of the experimental work presented in this 
chapter was to assess the chondrocyte death-inducing potential of S. aureus toxins 
using an in vitro model of S. aureus-induced septic arthritis.  Chondrocyte death 
arising as a result of apoptosis or necrosis was therefore not the major focus, as the 
final outcome, irrespective of the cell death pathway, was chondrocyte death.  
Nevertheless, given the rate of cell death observed in the current study it is likely that 
it was necrotic in nature.  This is supported by the findings of Lee et al. (2001) who 
identified that isolated chondrocytes exposed to a high inocula of S. aureus 
underwent necrosis while chondrocytes exposed to a low inocula of S. aureus or its 
ultrafiltrate underwent apoptosis.        
 
One potential criticism of the use of S. aureus 8325-4 is that it may have become 
considerably distant, in terms of cartilage damaging potential, compared to strains of 
S. aureus currently isolated from patients presenting with septic arthritis.  However, 
it was demonstrated that although S. aureus 8325-4 was more potent than clinical 
strains at 40hrs, the latter still exerted a strong effect (>45% chondrocyte death) 
(Figure 3.6A).  Indeed, there were differences between all the clinical strains at each 
time point (Figure 3.6A and B) but this was expected, as different strains will have 
different growth curves and toxin production capabilities.   
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The S. aureus 8325-4 coronal study demonstrated that chondrocyte death 
commenced within the SZ and spread to deeper layers (Figure 3.7B and C).  This 
observation could potentially be explained by the diffusion of bacterial toxins from 
the articular surface through cartilage.  However, when chondrocytes within the SZ 
and DZ were exposed simultaneously to S. aureus 8325-4 toxins (Figure 3.11A) 
there was significantly more cell death in the surface compared to the deeper zones 
(Figure 3.11B and C), suggesting that SZ chondrocytes were inherently more 
sensitive to S. aureus toxins.  At present, there is no explanation for this observation 
but it could arise from differences in the permeability of the ECM to toxin diffusion, 
and/or properties of the resident chondrocytes in the various zones.  In any event, due 
to the proximity between the sensitive SZ chondrocytes and the cartilage/synovial 
fluid interface, rapid and thorough removal of bacteria and their toxins during 
surgical washout would be particularly important.  
 
At the end of the 40hr time-course experiments with S. aureus 8325-4, although 
there was almost complete chondrocyte death throughout the cartilage (Figure 3.7B 
and C), the tissue appeared macroscopically normal.  Furthermore, there was no 
significant change to cartilage water content after bacterial toxin exposure (Figure 
3.8) and no recovery in chondrocyte viability following rinsing with saline and 
antibiotic treatment (Figure 3.9 and 3.10).  Chondrocytes in cartilage do not 
normally divide once skeletal maturity is reached (Archer, 1994; Muir, 1995) and 
thus cartilage devoid of chondrocytes will likely become degenerate, as the 
maintenance of the ECM will be lost.  There is a risk therefore that following a 
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supposedly-treated episode of septic arthritis, radiographs without any joint space 
abnormality may be misinterpreted as showing normal, biomechanically competent 
cartilage whereas in fact the progressive degeneration and loss of this cartilage would 
be inevitable.  There are no published human studies investigating the time-course of 
cartilage loss in tissue devoid of chondrocytes.  However, Simon et al.(1976) 
investigating the long-term effect of localised cryotherapy-induced chondrocyte 
death in lapine articular cartilage in vivo, demonstrated histologically that the 
cartilage was structurally intact at 6 months despite the absence of living 
chondrocytes.  Nevertheless, by 12 months extensive cartilage fibrillation and 
softening were evident, which were considered to be amongst the first macroscopic 
changes associated with degenerative joint disease (Pearle et al., 2005).   
 
The interpretation of the current experiments had the benefit that the host immune 
response was not involved in chondrocyte death.  Following bacterial joint 
colonisation in vivo, inflammatory cytokines are released into the joint by synovial 
cells and there is an accompanying influx of host inflammatory cells (Shirtliff and 
Mader, 2002).  Through opsonisation and phagocytosis, the immune response 
ultimately acts to remove bacteria.  However, evidence from animal studies suggests 
that the immune response may paradoxically contribute further to cartilage 
destruction (Shirtliff and Mader, 2002; Tissi et al., 2004).  At present, it remains 
unknown as to what extent in vivo chondrocyte death and subsequent cartilage 
damage is due to bacteria and their products, and what is due to the immune 
response.  The findings from an in vivo lapine study of septic arthritis by Smith et al. 
(1987) support a significant role of bacteria and their soluble toxins by demonstrating 
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that the overall cartilage destruction, as measured by proteoglycan and collagen loss, 
declined the earlier antibiotics were administered.  From the current experiments, it 
was concluded that it was probable that bacterial toxins had a significant and rapid 
effect on chondrocyte viability in vivo.   
 
The finding that all acquired S. aureus clinical isolates, obtained from the joint 
aspirates of patients presenting with clinically and microbiologically confirmed 
septic arthritis, were independent S. aureus strains (Figure 3.5) was of further 
interest.  Although only 5 clinical isolates were investigated, the observation in the 
current study nevertheless provides convincing evidence that S. aureus-induced 
septic arthritis is not attributable to any one particular S. aureus strain.  Due to the 
likely interspecies polymorphism, in particular with regard to growth profiles, toxin 
production capabilities and antibiotic resistance, the finding also confirms that the 
treatment of S. aureus-induced septic arthritis will remain a challenge.  The 
emergence of multi-drug resistance strains further highlights this (Lowy, 2003; Kaatz 
et al., 2005; Appelbaum, 2007; Howden et al., 2011). 
 
This study has provided new insights into chondrocyte death following cartilage 
exposure to S. aureus and builds upon previous work highlighting damage to the 
ECM.  By identifying the factors that cause chondrocytes within some cartilage 
zones to be more susceptible to toxins than others and characterising the toxin-
induced cell death pathway, treatment strategies may be developed in order to protect 
these vulnerable cells with the ultimate goal of reducing the extent of cartilage 
destruction during and after an episode of septic arthritis.  
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CHAPTER 4 
THE INFLUENCE OF S. AUREUS ALPHA-, BETA- AND 
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4.1 INTRODUCTION 
Studies investigating a variety of S. aureus-related infections have implicated the 
exotoxins Hla, Hlb and Hlg as major virulence factors (Cunningham et al., 1996; 
O'Callaghan et al., 1997; Dajcs et al., 2002; Hayashida et al., 2009).  Interestingly, 
these studies suggest that Hla, Hlb and Hlg have varying destructive roles with 
regard to different S. aureus-related infections (Dajcs et al., 2002; Hayashida et al., 
2009; Katayama et al., 2013).  For example, Katayama et al. (2013) found that Hlb 
played an important role in S. aureus skin colonisation by specifically damaging 
keratinocytes while Bubeck-Wardenburg and Schneewind (2008) identified that Hla 
was key to S. aureus virulence in a murine model of pneumonia.  Whilst Hld also 
belongs to the same family of toxins, it is not currently believed to be a major S. 
aureus virulence factor (Dinges et al., 2000).    
 
Murine models of septic arthritis have implied that Hla and Hlg are key contributory 
factors to the cartilage destruction following joint infection, with little apparent role 
for Hlb (Gemmell et al., 1997; Nilsson et al., 1999).  However, there remains some 
uncertainty as to the exact role and contributions of each of these toxins to the 
overall pathological effect on cartilage.  Using similar murine models, Gemmell et 
al. (1997) concluded that Hla, in the presence of protein A, was the main damaging 
agent while Nilsson et al. (1999) found that Hla and Hlg in combination were 
required to exert a potent effect, with Hla alone being of minor importance.   
 
Although it is appreciated that animal models provide essential information, the 
influence of a complex host immune response can potentially produce results that 
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may be ambiguous and difficult to interpret.  The current study describes the 
influence of Hla, Hlb and Hlg on in situ chondrocyte viability using the in vitro 
bovine cartilage explant model of S. aureus-induced septic arthritis described in 
Chapter 3.  In order to determine the efficacy of Hla, Hlb and Hlg, a selection of 
isogenic S. aureus mutants, with respect to Hla, Hlb and Hlg expression (Table 4.1), 
originating from the laboratory ‘wild-type’ strain 8325-4 studied in Chapter 3 were 
utilised.  In situ chondrocyte viability was visualised and quantified by CLSM as 
previously described (see Chapter 2).    
 
4.2 HYPOTHESIS 
This study tested the hypothesis that Hla alone was the key damaging S. aureus toxin 
to in situ chondrocyte viability. 
	  
4.3 MATERIALS & METHODS 
4.3.1 Biochemicals and solutions 
The standard tissue culture medium used in this study was serum-free DMEM 
(Catalogue no. 41966; 340mOsm/Kg H2O; pH7.4) with L-glutamine (4mM), D-
glucose (25mM), sodium pyruvate (1mM) and sodium bicarbonate (44mM). 
Tetracycline (2µg/ml) and erythromycin (10µg/ml) were obtained from Sigma-
Aldrich (Gillingham, UK) and added to TSA and TSB depending on the antibiotic 
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4.3.2 Bacterial strains 
S. aureus 8325-4 and its associated isogenic mutants (Table 4.1) were kindly 
provided by Professor Timothy J. Foster, Dept. Microbiology, Trinity College, 
Dublin, Ireland.  The bacterial mutants contained combined mutations affecting Hla 
(hla::Emr), Hlb (hlb::φ42E) and Hlg (Δhlg::Tcr) synthesis.  The erythromycin and 
tetracycline resistance associated with the Hla and Hlg mutations respectively, 
enabled the selective growth of specific mutants in antibiotic-loaded culture media.  
Prior to experimentation, the toxin profile of the isogenic mutants was confirmed by 
plating each strain onto 5% v/v rabbit and sheep blood TSA plates, with or without 
tetracycline (2µg/ml) and erythromycin (10µg/ml) as appropriate, and assessing for 
haemolytic activity (Haque and Baldwin, 1964; Burnside et al., 2010; Herbert et al., 
2010).  Erythrocyte lysis in the immediate vicinity of the bacterial colonies, which 
manifested as clear regions in the blood agar, was indicative of haemolysis (Figure 
4.1).  Heparinised sheep blood was obtained from E&O Laboratories Ltd, 
Bonnybridge, UK, and heparinised rabbit blood was obtained from the Scottish 
National Blood Transfusion Service, Penicuik, UK. 
 
4.3.3 Statistical analysis 
Parametric data were analysed using one-way between-groups ANOVA with post 
hoc Dunnett’s test (40hr Hla-Hlb-Hlg- vs Hla-Hlb+Hlg+ vs Hla-Hlb-Hlg+ study, 40hr 
8325-4 (Hla+Hlb+Hlg+) vs Hla-Hlb-Hlg- v Hla+Hlb-Hlg- study and 6hr 8325-4 vs Hla-
Hlb-Hlg- vs Hla+Hlb-Hlg- vs Hla-Hlb+Hlg+ supernatant coronal study), and unpaired 
Student’s two-tailed t-tests (6hr 8325-4 (Hla+Hlb+Hlg+) vs Hla-Hlb+Hlg+ supernatant 
study). A Mann-Whitney U test (unpaired data; 40hr 8325-4 (Hla+Hlb+Hlg+) vs Hla-
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Hlb-Hlg- study and 6hr 8325-4 (Hla+Hlb+Hlg+) vs Hla-Hlb-Hlg- supernatant study) 
was used to analyse non-parametric data.  
 
 
S. aureus strain Genotype Phenotype Toxins Produced Given Name 
8325-4 Wild Type Hla+ Hlb+ Hlg+ Hla, Hlb & Hlg 8325-4 
DU5938 hlb::φ42E hla::Emr 
Δhlg::Tcr 
Hla- Hlb- Hlg- None Hla- Hlb- Hlg- 
DU5946 hlb::φ42E Δhlg::Tcr Hla+ Hlb- Hlg- Hla Hla+ Hlb- Hlg- 
DU1090 hla::Emr Hla- Hlb+ Hlg+ Hlb & Hlg Hla- Hlb+ Hlg+ 
DU5720 hla::Emr hlb::φ42E Hla- Hlb- Hlg+ Hlg Hla- Hlb- Hlg+ 
 
Table 4.1:  The isogenic S. aureus mutant strains, originating from S. aureus 8325-4, used in 
this study. The genotype, phenotype and toxins produced by each strain are shown (Tcr= 




4.4.1 Identification of toxin profiles of S. aureus isogenic mutant strains  
To test whether the isogenic mutant strains produced the designated toxin profiles 
(Table 4.1), strains were plated onto 5% rabbit and sheep blood TSA.  Hla is 
haemolytic to rabbit and sheep erythrocytes, Hlb is haemolytic to sheep erythrocytes 
only, whereas Hlg is haemolytic to rabbit erythrocytes only (Traber et al., 2008; 
Burnside et al., 2010).  Positive blood agar plate haemolysis was observed by the 
presence of distinct clear regions around the bacterial colonies (Figure 4.1A and B), 
which indicated erythrocyte lysis.  The 8325-4 (Hla+Hlb+Hlg+) and Hla+Hlb-Hlg- 
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strains induced potent rabbit erythrocyte haemolysis (Figure 4.1A).   However, 
minimal, but detectable, haemolysis was observed with the Hla-Hlb+Hlg+ and Hla-Hlb-
Hlg+ strains (Figure 4.1A).  There was no evidence of rabbit erythrocyte haemolysis 
with the Hla-Hlb-Hlg- strain (Figure 4.1A).  The 8325-4 (Hla+Hlb+Hlg+), Hla+Hlb-Hlg- 
and Hla-Hlb+Hlg+ strains were positive for sheep erythrocyte haemolysis whereas the 
Hla-Hlb-Hlg+ and Hla-Hlb- Hlg- strains were negative (Figure 4.1B).  All mutants 




Figure 4.1: Confirmation of the haemolytic properties of the isogenic mutant strains 
used in this study 
Each strain was plated onto 5% rabbit (A) and sheep (B) blood TSA and incubated for 24hrs.  
Haemolysis is shown by the presence of clear regions around the bacterial colonies (yellow arrows 
provide examples of haemolysis) (scale bar=1cm).  
 
4.4.2 S. aureus haemolysins induced in situ chondrocyte death  
In order to confirm that haemolysins contributed to in situ chondrocyte death, 
osteochondral explants were cultured in the presence of either the 8325-4 
(Hla+Hlb+Hlg+) or Hla-Hlb-Hlg- strains.  Chondrocyte death over 40hrs was then 
quantified in axial CLSM images of fluorescently-labelled chondrocytes as 
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previously described (see Chapter 2).  Thus, a strain producing Hla, Hlb and Hlg was 
compared with a strain that was unable to produce these toxins.  In the explants 
cultured with S. aureus 8325-4 (Hla+Hlb+Hlg+) there was significant chondrocyte 
death at each time point (Figure 4.2A).  Between 24 and 40hrs there was a rapid 
reduction in chondrocyte viability with 66.2±20.1% (p=0.029) of the chondrocyte 
population dying at 40hrs.  In comparison, there was only 6.7±8.9% chondrocyte 
death at 40hrs in those explants exposed to the Hla-Hlb-Hlg- strain (Figure 4.2A and 
B).  This was not significant however in comparison to the baseline level of 
chondrocyte death at 0hrs (N=4[n=2]; p=0.11 by Wilcoxon signed-rank test (paired 
data)).    
 
In order to assess the damaging potential of the 40hrs 8325-4 (Hla+Hlb+Hlg+) culture 
toxins independent of bacteria (i.e. to assess whether unspecified bacterial cell wall 
co-factors were required for haemolysins to exert their virulence), the bacteria were 
removed by both centrifugation and filter sterilisation leaving a toxin-rich 
supernatant in which toxin levels remained relatively unchanged.  Fresh 
osteochondral explants were subsequently exposed to either the 8325-4 
(Hla+Hlb+Hlg+) or Hla-Hlb-Hlg- supernatants.  In comparison to explants exposed to 
the Hla-Hlb-Hlg- supernatant, explants exposed to the 8325-4 (Hla+Hlb+Hlg+) 
supernatant demonstrated significant chondrocyte death at each time point (Figure 
4.2C and D).  Indeed, there was no measurable chondrocyte death at any time point 
in those explants exposed to the Hla-Hlb-Hlg- supernatant (Figure 4.2C). 
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Figure 4.2: Haemolysins played a key role in inducing in situ chondrocyte death  
Osteochondral explants cultured in the presence of the 8325-4 (Hla+Hlb+Hlg+) strain demonstrated 
significant chondrocyte death at each time point (A).  In comparison, chondrocyte death in the 
presence of the Hla-Hlb-Hlg- strain was minimal (N=4[n=2]; * p<0.05 8325-4 (Hla+Hlb+Hlg+) versus 
Hla-Hlb-Hlg- strain by Mann-Whitney U test).  The CLSM images display the marked difference 
between the two strains at 40hrs (B).  Osteochondral explants exposed to the 40hr 8325-4 
(Hla+Hlb+Hlg+) strain culture supernatant demonstrated rapid and significant chondrocyte death over a 
6hr time period in comparison to explants exposed to the Hla-Hlb-Hlg- strain supernatant (C) 
(N=4[n=2]; * p<0.05 8325-4 (Hla+Hlb+Hlg+) versus Hla-Hlb-Hlg- supernatant by Mann-Whitney U 
test).  The CLSM images (D) demonstrate the marked difference between the two supernatants at 6hrs 
(scale bar=100µm).   
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4.4.3 Hlb and Hlg induced minimal in situ chondrocyte death 
In order to assess the contributions of Hlb and Hlg, osteochondral explants were 
cultured with the Hla-Hlb+ Hlg+ and Hla-Hlb- Hlg+ strains.  The Hla-Hlb-Hlg- strain 
was used as a control as it had previously been shown to induce minimal 
chondrocyte death (Figure 4.2A) whilst producing similar changes to the culture 
medium as the 8325-4 (Hla+Hlb+Hlg+) strain.  Although there was significantly more 
chondrocyte death observed in those explants exposed to the Hla-Hlb-Hlg+ strain in 
comparison to the Hla-Hlb-Hlg- strain at 24hrs (p=0.027 by post hoc Dunnett’s test), 
the level of chondrocyte death was still extremely low (1.3±0.5%).  By 40hrs 
however there was no significant difference between the strains (p=0.12) (Figure 
4.3A and B).  The maximum chondrocyte death achieved was 4.1±3.4% by the Hla-
Hlb+Hlg+ strain (Figure 4.3A), which was not significant in comparison to the 
baseline level of chondrocyte death observed at 0hrs (p=0.14 by paired Student’s t-
test).  Additionally, this level of chondrocyte death was considerably less than that 
observed at the same time point with the 8325-4 (Hla+Hlb+Hlg+) strain (Figures 
4.2A and 4.3A) and also less than the chondrocyte death induced by the Hla-Hlb-
Hlg- strain during the initial 40hr 8325-4 (Hla+Hlb+Hlg+) vs Hla-Hlb-Hlg- strain 
experiment (Figure 4.2A).  Hla therefore appeared to be the key damaging toxin to 
in situ chondrocyte viability as the only difference between the 8325-4 
(Hla+Hlb+Hlg+) and Hla-Hlb+Hlg+ strains was the ability to produce Hla.  Hlb and 
Hlg thus had no significant role in inducing in situ chondrocyte death.  
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Figure 4.3: Hlb and Hlg had a minimal impact on in situ chondrocyte viability  
Osteochondral explants cultured in the presence of the Hla-Hlb-Hlg-, Hla-Hlb+Hlg+ and Hla-Hlb-Hlg+ 
strains exhibited minimal chondrocyte death at each time point (A) (N=4[n=2]; numerical p values 
represent probability from one-way ANOVA; * p<0.05 versus Hla-Hlb-Hlg- strain by post hoc 
Dunnett’s test).  The CLSM images (B) represent the chondrocyte death induced by each strain at 
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4.4.4 Hla induced significant and rapid in situ chondrocyte death 
In order to confirm that Hla alone was the key damaging toxin to in situ chondrocyte 
viability, explants were cultured in the presence of the following strains: 8325-4 
(Hla+Hlb+Hlg+), Hla+Hlb-Hlg- and Hla-Hlb-Hlg- (control).  Compared to the control 
group, explants exposed to the 8325-4 (Hla+Hlb+Hlg+) and Hla+Hlb-Hlg- strains 
exhibited significant chondrocyte death at each time point (Figure 4.4A and B).   
Although there was a significant difference between the 8325-4 (Hla+Hlb+Hlg+) and 
Hla+Hlb-Hlg- strains at 24hrs (p=0.01) there was no significant difference at 40hrs 
(p=0.2 by unpaired Student’s t-test). 
 
To confirm further that Hla was the main cause of chondrocyte death, explants were 
exposed to the 40hr culture supernatants of the 8325-4 (Hla+Hlb+Hlg+) and Hla-
Hlb+Hlg+ strains, where the only difference between the supernatants was the 
presence or absence of Hla, respectively. There was negligible chondrocyte death in 
the explants exposed to the Hla-Hlb+Hlg+ supernatant while there was significant 
chondrocyte death at each time point in those explants exposed to the 8325-4 
(Hla+Hlb+Hlg+) supernatant (Figure 4.5A and B).  These results therefore confirmed 
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Figure 4.4: The 8325-4 (Hla+Hlb+Hlg+) and Hla+Hlb-Hlg- strains had comparable 
potencies 
In comparison to the Hla-Hlb-Hlg- strain control group, the 8325-4 (Hla+Hlb+Hlg+) and Hla+Hlb-Hlg- 
strains induced similar chondrocyte death over the experimental period (A) (N=4[n=2]; numerical p 
values represent probability from one-way ANOVA; * p<0.05; ** p<0.01; *** p<0.001 versus Hla-
Hlb-Hlg- strain by post hoc Dunnett’s test).  The CLSM images (B) represent the chondrocyte death 
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Figure 4.5: Hla alone was the key damaging agent to the viability of in situ 
chondrocytes within bovine cartilage 
Osteochondral explants cultured with Hla-Hlb+Hlg+ supernatant were compared with explants cultured 
with 8325-4 (Hla+Hlb+Hlg+) supernatant.  The only difference between the two culture supernatants 
was the presence or absence of alpha-toxin.  There was significant chondrocyte death at each 
experimental time point in those explants exposed to the 8325-4 supernatant in comparison to those 
explants exposed to the Hla-Hlb+Hlg+ supernatant (A) (N=4[n=2]; * p<0.05; *** p<0.001 by unpaired 
Student’s two-tailed t-test). The CLSM images (B) display the influence of Hla on in situ chondrocyte 
viability (scale bar=100µm).  
 
 
4.4.5 Hla-induced chondrocyte death commenced within the SZ of cartilage 
All axial studies (see above) involved the imaging of osteochondral explants to a 
depth of approx. 100µm, thereby permitting quantification of chondrocyte death 
within the entirety of the SZ and a portion of the MZ (Figure 2.5).   In order to 
confirm (1) that Hla-induced chondrocyte death commenced within the SZ and (2) to 
ensure that Hlb and Hlg did not induce chondrocyte death within deeper layers of 
cartilage i.e. chondrocyte death that would not be detected upon axial imaging, 
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osteochondral explants were exposed to the Hla-Hlb-Hlg-, 8325-4 (Hla+Hlb+Hlg+), 
Hla+Hlb-Hlg- and Hla-Hlb+Hlg+ strain supernatants and imaged by CLSM in the 
coronal plane (Figure 2.5).  As observed previously (Figure 3.7), there was a dead 
cell artefact induced by the scalpel cut at 0hrs (Figure 4.6).  However, on this 
occasion there was no significant change in chondrocyte viability between depth 
intervals at 0hrs (p=0.17 by one-way ANOVA).  
 
Explants exposed to the Hla-Hlb-Hlg- strain (control) exhibited no significant 
chondrocyte death above 0hr values for each depth interval at 6hrs (p=0.07 by one-
way ANOVA) (Figure 4.6A).  Compared to the control group, explants exposed to 
the 8325-4 (Hla+Hlb+Hlg+) and Hla+Hlb-Hlg- supernatants demonstrated significant 
chondrocyte death (p<0.001) within the first depth interval (0-100µm) (Figure 4.6A, 
B and C).  In those explants exposed to the Hla-Hlb+Hlg+ supernatant, there was no 
change in chondrocyte viability within the first depth interval (p=0.28) or indeed 
throughout the analysed depth of cartilage (Figure 4.6D).  This further confirmed 
that Hlb and Hlg had no significant role in the induction of in situ chondrocyte death 
within the SZ but also that Hlb and Hlg did not specifically induce chondrocyte death 
within deeper layers, which would not have been detected upon axial imaging.   
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Figure 4.6: Hla-induced chondrocyte death commenced within the SZ of cartilage 
The depth-related pattern of chondrocyte death in osteochondral explants exposed to the 40hr Hla-Hlb-
Hlg-, 8325-4 (Hla+Hlb+Hlg+), Hla+Hlb-Hlg-, and Hla-Hlb+Hlg+ strain supernatants was assessed.  
Compared to the Hla-Hlb-Hlg- control group (A), there was significantly more chondrocyte death 
within the first 100µm of those explants exposed to the Hla-containing 8325-4 (Hla+Hlb+Hlg+) (B) 
and Hla+Hlb-Hlg- (C) supernatants.  There was no change in chondrocyte viability in those explants 
exposed to the Hla-Hlb+Hlg+ strain supernatant (D) (N=4[n=2]; numerical p values represent one-way 
ANOVA; * p<0.05; ** p<0.01; *** p<0.001 versus Hla-Hlb-Hlg- strain supernatant by post hoc 
Dunnett’s test).  The CLSM inserts (A-D) provide a visual representation of the zonal pattern of 
chondrocyte death following explant exposure to that particular strain’s 40hr culture supernatant 
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4.5 DISCUSSION 
This study has utilised CLSM to determine changes to the viability of in situ bovine 
chondrocytes following exposure to a variety of S. aureus isogenic mutants with 
differing haemolysin production capabilities (Table 4.1).  Compared to previous in 
vivo animal studies that used similar isogenic mutant strains to induce septic arthritis 
(Gemmell et al., 1997; Nilsson et al., 1999), the direct impact of Hla, Hlb and Hlg on 
in situ chondrocyte viability has been assessed in a bovine cartilage model, which did 
not have the complexities of a host immune response.  Two major findings emerge 
from this study.  Firstly, S. aureus Hla was unequivocally the key damaging toxin to 
in situ chondrocyte viability in this experimental model, with Hlb and Hlg having no 
significant role.  Secondly, Hla-induced chondrocyte death commenced within the 
SZ of cartilage.   
 
All the isogenic mutants investigated (Table 4.1) were created from the same mother 
strain (8325-4) by the controlled mutations of genes conferring production of 
particular haemolysins (O'Reilly et al., 1986; Nilsson et al., 1999).  By combining 
these mutations with defined antibiotic resistance cassettes i.e. tetracycline or 
erythromycin, it was possible to ensure that the correct mutant had grown in the 
presence of specific culture conditions i.e. TSA with tetracycline.  However, in order 
to confirm the toxin production profiles of the isogenic mutants (Table 4.1) prior to 
investigation, and to exclude the presence of spontaneous mutations, all mutants 
were tested for their ability to haemolyse rabbit and sheep blood agar (Figure 4.1).   
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The Hla and Hlb-producing mutants displayed the expected haemolytic activity on 
rabbit (Hla) and sheep (Hla & Hlb) blood agar plates (Traber et al., 2008; Burnside 
et al., 2010) (Figure 4.1A and B).  Hlg production however was more difficult to 
assess, as impurities in agar are known to have an inhibitory effect on its activity 
(Dinges et al., 2000; Burnside et al., 2010).  Indeed, previous studies using similar 
isogenic mutants only assessed for alpha- and beta-haemolytic activity (ability to 
haemolyse rabbit and sheep erythrocytes, respectively) (O'Callaghan et al., 1997; 
Nilsson et al., 1999).  However, in the presence of appropriate antibiotics, the 
inhibition of gamma haemolysis was used as a positive selection feature for the Hla-
Hlb-Hlg+ and Hla-Hlb+Hlg+ strains when cultured on rabbit blood agar.  As expected, 
the Hla-Hlb-Hlg- strain induced neither sheep nor rabbit erythrocyte haemolysis 
(Figure 4.1A and B).  All the mutant strains utilised in this study therefore exhibited 
the expected haemolysin production profiles thereby offering a useful and specific 
experimental model to test the potency of the various toxins.   
 
In order to establish whether haemolysins played a role in inducing in situ 
chondrocyte death, cell viability was assessed in explants exposed to either the 8325-
4 or Hla-Hlb-Hlg- strains, as strain 8325-4 produced Hla, Hlb and Hlg.  In contrast, 
the Hla-Hlb-Hlg- strain was unable to produce these toxins yet still produced all the 
other unspecified 8325-4 toxins i.e. they were both identical apart from the ability to 
produce Hla, Hlb and Hlg.  There was a significant difference between the 
chondrocyte-damaging potential of the two strains (Figures 4.2A and B) with the 
8325-4 (Hla+Hlb+Hlg+) and Hla-Hlb-Hlg- strains inducing approximately 66% and 
7% chondrocyte death at 40hrs, respectively.  This demonstrated that one, all, or a 
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combination of Hla, Hlb and Hlg was necessary to induce potent in situ chondrocyte 
death.  Although the 7% chondrocyte death induced by the Hla-Hlb-Hlg- strain was 
found not be significant, it likely represented chondrocyte death induced by the 
acidic culture medium conditions (see Chapter 3) and/or other non-specified S. 
aureus toxins.   In addition to Hla, Hlb and Hlg, S. aureus 8325-4 is known to 
produce a diverse array of potential virulence factors including exoenzymes, capsular 
polysaccharides, protein A and Hld (Cunningham et al., 1996).  As Hla-Hlb-Hlg- was 
derived directly from S. aureus 8325-4, the toxin profiles of both strains were 
identical apart from the ability to produce Hla, Hlb and Hlg i.e. whatever unspecified 
toxins were produced by S .aureus 8325-4 were also produced by the Hla-Hlb-Hlg- 
strain.  In addition, the Hla-Hlb-Hlg- strain established comparable culture conditions 
i.e. reduced culture medium pH with bacterial growth.  The Hla-Hlb-Hlg- strain was 
therefore considered a valid control for subsequent experiments.  
 
At present, S. aureus-induced septic arthritis is treated with a combination of 
intravenous antibiotics and joint lavage, which takes the form of either surgical 
washout or serial bedside aspirations.  Whilst antibiotics may adequately destroy the 
bacteria, there remains a concern with serial bedside aspirations that S. aureus toxins 
may remain within the joint.  Nevertheless, some animal models of S. aureus 
infection have suggested that the presence of bacterial cell-wall-anchored proteins, 
such as protein A, are required for certain haemolysins to exert their virulence 
(Gemmell et al., 1997).  Thus, with the knowledge that haemolysins play a key role 
in the induction of in vivo joint destruction (Gemmell et al., 1997; Nilsson et al., 
1999), the influence of isolated haemolysins on in situ chondrocyte viability was 
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assessed.  This was achieved by exposing cartilage explants to the 40hr culture 
supernatants of the 8325-4 (Hla+Hlb+Hlg+) and Hla-Hlb-Hlg- strains, whereby, in the 
absence of bacteria, relatively constant toxin concentrations were present throughout 
the experimental period.  In comparison to the Hla-Hlb-Hlg- supernatant, there was 
significant chondrocyte death in those explants exposed to the 8325-4 
(Hla+Hlb+Hlg+) supernatant at each experimental time point (Figures 4.2C and D).  
In contrast to the 40hr culture experiment, there was negligible chondrocyte death 
induced by the Hla-Hlb-Hlg- strain supernatant over 6hrs (Figures 4.2A and C).  A 
possible explanation for this finding may be that the acidity and/or non-specified 
toxins possibly accounting for the small degree of chondrocyte death over 40hrs was 
not apparent with the 6hr assay.  Taken together, the findings from this supernatant 
study demonstrated a destructive influence of haemolysins on chondrocyte viability 
in the absence of bacteria.  This advocates the prompt and thorough washout of all 
septic joints.  
 
In order to establish the individual roles of Hla, Hlb and Hlg, a series of experiments 
followed whereby in situ chondrocyte death induced by specific isogenic mutant 
strains over 40hrs were compared.  Hlb and Hlg had no significant role in inducing in 
situ chondrocyte death (Figures 4.3A and B).  However, Hla alone appeared to be 
the key damaging toxin as the Hla+Hlb-Hlg- strain was of a comparable potency to 
the 8325-4 (Hla+Hlb+Hlg+) strain (Figures 4.4A and B).  To confirm the destructive 
role of Hla further, a comparison was made between the 40hr 8325-4 (Hla+Hlb+Hlg+) 
and Hla-Hlb+Hlg+ supernatants, as the only difference between the two supernatants 
was the presence or absence of Hla, respectively.  In comparison to those explants 
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exposed to the 8325-4 (Hla+Hlb+Hlg+) supernatant, explants exposed to the Hla-
Hlb+Hlg+ supernatant exhibited negligible chondrocyte death throughout the 
experimental period (Figures 4.5A and B), thereby confirming the highly virulent 
nature of Hla.  
 
All the experiments that ultimately culminated in the identification of Hla as the key 
damaging S. aureus toxin to in situ chondrocyte viability involved the assessment of 
explants in the axial plane, whereby image acquisition was performed to a depth of 
approx. 100µm from the articular surface.  As the SZ of cartilage was considered to 
be up to 10% of the overall depth of cartilage from the articular surface (Jadin, 2005; 
Pearle et al., 2005) (bovine and human cartilage (Pedersen et al., 2013)), this 
permitted the estimation of chondrocyte viability within the entirety of the SZ and a 
portion of the MZ.  Given that chondrocytes within the SZ were closest to the 
synovial fluid harbouring the bacterial toxins in vivo, assessment of the sensitivity of 
these cells to Hla, Hlb and Hlg in the first instance was considered appropriate.  In 
addition, axial imaging allowed the quantification of chondrocytes within a region of 
cartilage that did not have any ‘cut-edge’ dead cell artifact  (Figure 2.5A).  
 
In order to assess whether Hla-induced chondrocyte death commenced within the SZ 
of cartilage and to ensure that Hlb and Hlg did not induce chondrocyte death within 
deeper layers of cartilage, the coronal assessment of osteochondral explants exposed 
to the Hla-Hlb-Hlg- (control), 8325-4 (Hla+Hlb+Hlg+), Hla+Hlb-Hlg- and Hla-
Hlb+Hlg+ supernatants was conducted.  Explant trimming was only performed at the 
time of fluorescent staining i.e. upon removal from the culture vessel containing the 
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bacterial supernatant, as the mechanical injury induced by the scalpel cut may have 
rendered some chondrocytes more susceptible to the toxins.  Thus, the imaged cut-
edge was never exposed to toxins directly.  The chondrocyte death observed within 
each depth interval at 0hrs (Figure 4.6) represented the previously observed (Figure 
3.7) background level of chondrocyte death induced by the ‘cut-edge’.  There was no 
significant difference in chondrocyte viability within any of the analysed depth 
intervals between 0 and 6hrs in those explants exposed to the Hla-Hlb-Hlg- 
supernatant (Figure 4.6A).  At 6hrs, explants cultured in the presence of the Hla-
containing 8325-4 and Hla+Hlb-Hlg- supernatants exhibited significant chondrocyte 
death within the first depth interval with no change in chondrocyte viability observed 
within deeper layers (Figures 4.6B and C).  In comparison, there was no significant 
change in chondrocyte viability throughout the analysed depth of cartilage in those 
explants exposed to the Hlb and Hlg-containing Hla-Hlb+Hlg+ supernatant (Figure 
4.6D).  This therefore confirmed that Hlb and Hlg had no significant role in inducing 
in situ chondrocyte death in our ex vivo model and that Hla-induced chondrocyte 
death commenced within the SZ of the osteochondral explants.  
 
There were several possible explanations for the observation of Hla-induced 
chondrocyte death commencing within the SZ.  Firstly, it may be that the 
subchondral bone (Figure 2.5B) acted as a barrier to Hla penetration, thereby 
protecting DZ chondrocytes, and thus the observed chondrocyte death within the SZ 
was simply due to the proximity of SZ chondrocytes to the culture medium 
containing Hla i.e. chondrocyte death was due to Hla diffusion through the ECM 
from the articular surface.  Secondly, it may be that SZ chondrocytes were inherently 
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more susceptible to Hla than chondrocytes within deeper layers.  Indeed, it has 
already been established that SZ chondrocytes have different properties in 
comparison to chondrocytes from deeper zones with regard to both metabolic 
activity and vulnerability to damage.  For example, Simpkin et al. (2007) (Simpkin et 
al., 2007) demonstrated that bovine SZ chondrocytes regulated pH through a 
bicarbonate-dependent mechanism that was not present in chondrocytes within 
deeper zones.  In a further study by Hauselmann et al. (1996), human SZ 
chondrocytes were found to be more susceptible to IL-1-induced damage than 
chondrocytes from deeper layers, with SZ chondrocytes being shown to have twice 
the number of high-affinity binding sites for IL-1 than DZ chondrocytes.  The 
receptor for Hla on eukaryotic cells has recently been identified as ‘A-disintegrin and 
metalloprotease 10’ (ADAM10) (Wilke and Bubeck-Wardenburg, 2010; Inoshima et 
al., 2011; Powers et al., 2012).  Another possibility therefore was that there are 
higher levels of ADAM10 expression in SZ chondrocytes in comparison to 
chondrocytes from deeper zones, thereby making them more susceptible to Hla.   
 
The increased susceptibility of SZ chondrocytes to Hla was of major concern.  It has 
previously been identified that SZ chondrocytes have unique characteristics with 
regard to ECM metabolism, which are essential for producing and maintaining the 
smooth surface of healthy articular cartilage (Siczkowski and Watt, 1990), a 
prerequisite to withstanding the mechanical stresses associated with normal joint 
activity (Buckwalter and Mankin, 1997a).  Damage to the SZ sets in motion a 
cascade of events that ultimately culminates in full thickness destruction of cartilage 
(Hollander et al., 1995).  It is therefore of critical importance that research should 
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focus on protecting these vulnerable yet key cellular building blocks of articular 
cartilage. 
 
The ex vivo findings presented in this chapter differed substantially from previous in 
vivo studies and it is important to consider possible explanations.  In a study by 
Gemmell et al. (1997), septic arthritis was established in mice using a variety of S. 
aureus mutants with varying deficiencies for protein A, Hla, Hlb, coagulase, 
clumping factor and accessory gene regulator.  The study concluded that Hla, in 
combination with protein A, was of major importance to the pathogenicity of S. 
aureus-induced septic arthritis.  In a further study by Nilsson et al. (1999), murine 
septic arthritis was induced utilising the same mutant strains as those used in the 
present study, in addition to others.  They concluded that the simultaneous presence 
of Hla and Hlg were crucial for the development and progression of S. aureus-
induced septic arthritis, with Hla alone being of minor importance.  A common 
finding between the present study and previous in vivo studies was the importance of 
Hla in the pathogenesis of S. aureus-induced septic arthritis.  In contrast, we have 
demonstrated that Hla, in the absence of both Hlb and Hlg, can exert a rapid and fatal 
action on in situ chondrocytes (Figure 4.4).  Protein A is a cell wall surface protein 
that aids S. aureus survival in the presence of a host immune response by binding the 
Fc portion of IgG and the Fc receptors of polymorphonuclear leukocytes, thereby 
preventing bacterial opsonisation and phagocytosis (Cunningham et al., 1996; Widaa 
et al., 2012).  However, the current experimental model had no immune response 
present.  Furthermore, it was unlikely that there was significant protein A production 
in the culture vessels as protein A synthesis is known to be very low in most complex 
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culture media (Nilsson et al., 1999).  In addition, protein A would not have been 
present in the supernatant studies, as bacteria were not present, yet there was still 
significant Hla-induced chondrocyte death.  Thus, it seems probable that the Hla-
induced chondrocyte death observed in the present study was independent of both 
Hlg and protein A.  
 
As previously discussed in Chapter 3, a potential limitation of the current study was 
that the S. aureus aspirate concentration used to inoculate the culture vessels, and 
subsequent bacterial and Hla levels during the incubation period thereafter, may not 
be in the physiological range in comparison to those found in vivo.  To the author’s 
knowledge, no studies have analysed bacterial toxin concentrations within infected 
synovial fluid in humans presenting with S. aureus-induced septic arthritis.  Hence, it 
was difficult to match levels in the current experiments with those in a septic joint. 
Thus, a further potential criticism of this study was that the time course in these 
experiments may differ considerably to those in vivo.  However, patients with ‘fight-
bite’ septic arthritis typically present between 18 and 24hrs post injury (i.e. they 
become symptomatic at this stage) (Kelly et al., 1996), which are time points in the 
current experimental model when chondrocyte death was detectable.  Fight-bite 
septic arthritis classically occurs when the metacarpophalangeal joint of a clenched 
fist is punctured by the tooth of another individual and is subsequently inoculated 
with contaminated saliva, most frequently with S. aureus (Perron et al., 2002; Talan 
et al., 2003).  In a small case series by Kelly et al. (1996), those patients presenting 
within 24hrs and adequately treated had a good functional outcome but those 
presenting beyond 24hrs had a poor outcome with longterm joint morbidity, likely 
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reflecting considerable chondrocyte death at the time of presentation.  Thus, the rate 
of Hla-induced chondrocyte death in the current in vitro model may be comparable 
to those in vivo albeit in the absence of a host immune response.  Regardless, the aim 
of this study was to investigate the impact of S. aureus Hla, Hlb and Hlg on in situ 
chondrocyte viability in the absence of the complexities of a host immune response 
and the aspirate concentration utilised during this study made this achievable.   
    
With S. aureus accounting for 40 to 65% of cases of septic arthritis (Kaandorp et al., 
1997a; Gupta et al., 2001), the data presented in this study may have clinical 
relevance for the treatment of septic arthritis.  The rapid and fatal action of Hla on in 
situ chondrocyte viability highlights the importance of rapid and thorough joint 
lavage in all patients presenting with septic arthritis, with surgical washout likely to 
offer the most comprehensive form of irrigation.  Although antibiotics may kill or 
inhibit the growth of bacteria within the infected joint, they do not have the ability 
actively to remove bacterial toxins i.e. Hla.  The findings of the current experiments 
have demonstrated that in the absence of viable bacteria, Hla caused significant 
chondrocyte death (Figure 4.5).  However, some studies have also suggested that 
Hla at sublethal levels may stimulate cells to produce pro-inflammatory cytokines 
(Bhakdi et al., 1989; Suttorp et al., 1993; Onogawa, 2002), thereby potentially 
worsening the immune mediated destruction of articular cartilage.  Therefore, 
antibiotic therapy alone should never be considered appropriate.    
 
The identification of a specific damaging toxin offered a potential future therapeutic 
target.  Firstly, by attempting to block the activity of Hla, for example by Hla-
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neutralising antibodies or selective blockade of ADAM10, it is possible that 
chondrocyte death may be significantly reduced during and after an episode of S. 
aureus-induced septic arthritis, thereby reducing the extent of subsequent cartilage 
loss.  Encouragingly, a murine study of S. aureus-induced pneumonia conducted by 
Bubeck-Wardenburg and Schneewind (2008) has demonstrated protection in those 
animals immunised with a mutant form of Hla (HlaH35L) that was unable to form 
pores i.e. it was unable to lyse cells.  In addition, the subsequent administration of 
Hla-specific antibodies to non-vaccinated animals also conferred protection.  A 
further potential therapeutic target is the Hla-induced cell death pathway following 
formation of the Hla pore on the plasma membrane.  However, a further 
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CHAPTER 5 
THE INFLUENCE OF RAISED CULTURE MEDIUM CALCIUM 
CONCENTRATION ON S. AUREUS ALPHA-HAEMOLYSIN-
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5.1 INTRODUCTION 
In Chapter 4, it was identified that S. aureus Hla, a ‘pore-forming’ exotoxin secreted 
by almost all strains of S. aureus (Bhakdi and Tranum-Jensen, 1991; Powers et al., 
2012; Thay et al., 2013), was the most potent agent affecting in situ chondrocyte 
viability.  It has been proposed that Hla-mediated destruction of sensitive cells, 
which includes bovine chondrocytes (see Chapter 4), relies on the formation of a 1- 
to 3-nm pore spanning the plasma membrane (Gray and Kehoe, 1984; Dinges et al., 
2000).  Hla is a chromosomally encoded toxin (Ragle and Bubeck-Wardenburg, 
2009) and is secreted as a water soluble 293-residue monomer (Bubeck-Wardenburg 
and Schneewind, 2008) with a molecular weight of 33kDa (Dinges et al., 2000).  
Following binding to the host cell membrane, monomers undergo a series of 
conformational changes and ultimately aggregate to form a heptameric β-barrel 
structure that penetrates the lipid bilayer of the plasma membrane (Figure 1.5) (Gray 
and Kehoe, 1984; Bhakdi and Tranum-Jensen, 1991; Dinges et al., 2000).  
Interaction of Hla monomers with the recently identified cell membrane receptor 
ADAM10 is thought to be a prerequisite to the initiation of the sequence of events 
that results in cytolytic pore formation (Wilke and Bubeck-Wardenburg, 2010; 
Inoshima et al., 2011).  It is currently believed that pore formation triggers 
alterations in ion gradients, the rapid egression of vital molecules such as adenosine 
triphosphate (ATP), activation of stress-signalling pathways, and loss of membrane 
integrity, culminating in eventual cell death (Suttorp et al., 1985; Bhakdi and 
Tranum-Jensen, 1991; Walev et al., 1993; Dinges et al., 2000).  
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It has been hypothesised that enhanced Ca2+ entry may play a key role in the Hla-
induced eukaryotic cell death pathway (Suttorp et al., 1985; Bhakdi and Tranum-
Jensen, 1991).  Whilst Ca2+ is essential for the maintenance of cellular life, it also, 
paradoxically, plays an important role in cell death (Berridge et al., 1998; 
Zhivotovsky and Orrenius, 2011).  This occurs when Ca2+ levels are irretrievably 
increased.  The intracellular Ca2+ concentration ([Ca2+]i) within chondrocytes is 
normally tightly controlled in the range of 80-100nM (Hall et al., 1996a; Yellowley 
et al., 1997; Wilkins et al., 2000; Sánchez et al., 2003).  In contrast, the extracellular 
Ca2+ concentration ([Ca2+]o) within the interstitial fluid of the ECM is estimated to be 
approximately 6-15mM (Urban, 1994).  A considerable concentration gradient 
therefore exists between the extracellular and intracellular spaces.  Hence, the 
presence of unregulated Ca2+-permeable pores spanning the plasma membrane may 
permit a markedly increased rate of diffusion of Ca2+ across the cell membrane.  It is 
possible therefore that the influx of Ca2+ through the Hla pore is the key upstream 
signal for the establishment of downstream death mechanisms that ultimately result 
in chondrocyte death.           
 
No studies have yet investigated the role of Ca2+ in S. aureus Hla-induced in situ 
chondrocyte death.  A further understanding of the mechanism through which this 
toxin causes chondrocyte death may provide an opportunity either to optimise 
current treatments or to develop novel therapeutic strategies with the aim of reducing 
the extent of chondrocyte death, and thus cartilage destruction, during and after an 
episode of septic arthritis.  As a first step towards clarifying the role of Ca2+ in the 
Hla-induced chondrocyte death pathway, the objective of this study was therefore to 
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determine the influence of [Ca2+]o on S. aureus Hla-induced in situ chondrocyte 
death using the previously described bovine cartilage explant model of septic 
arthritis (see Chapters 2 and 3).  The S. aureus laboratory ‘wild-type’ strain 8325-4 
along with a selection of isogenic mutants, with regard to Hla, Hlb and Hlg 
expression were utilised.  At designated time points, in situ chondrocyte viability was 
imaged and quantified within defined regions-of-interest in the axial plane of 
cartilage (i.e. within SZ of cartilage) as previously described (see Chapter 2). 
 
In order to assess the influence of raised [Ca2+]o on Hla-induced chondrocyte death, it 
was necessary to add CaCl2 to the culture media.  However, this also resulted in a 
simultaneous rise in culture medium osmolarity.  In situ chondrocytes are 
osmotically sensitive, responding to changes in extracellular osmolarity with 
reciprocal changes in cell volume (Bush and Hall, 2001a; Bush et al., 2005).  These 
changes are primarily the result of water movement across the plasma membrane, 
arising as a consequence of the differential osmotic pressure gradient (Hoffmann et 
al., 2009).  In almost all eukaryotic cells, including chondrocytes, water movement is 
extremely rapid with a corresponding change in cell volume occurring within 
seconds (McGann et al., 1988; Bush and Hall, 2001a).  However, it is important for 
chondrocytes to maintain constant cell volume in order optimise cellular function 
(Urban et al., 1993; Urban, 1994).  This is achieved through the activation of specific 
active membrane transporters that release or accumulate solutes in response to cell 
swelling or shrinkage, respectively (Hall et al., 1996a; Hall et al., 1996b; Bush et al., 
2010).  Nevertheless, such mechanisms typically take considerably longer (minutes 
to hours) than the initial response following osmotic challenge (Bush and Hall, 
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2001b; Hoffmann et al., 2009).  It was therefore deemed necessary to firstly assess 
the influence of raised culture medium osmolarity (through both sucrose and NaCl 
addition) per se on Hla-induced chondrocyte death.  To maintain experimental 
consistency in the [Ca2+]o studies thereafter, it was considered important to ensure 
that all solutions were osmotically balanced.   
 
Two commonly utilised osmolytes are NaCl and Sucrose (Urban et al., 1993; Amin 
et al., 2008; Amin et al., 2009a).  Following a series of experiments detailed within 
this chapter, sucrose was chosen to osmotically balance all culture media following 
the addition of CaCl2.  Although the metabolic effects on chondrocytes are similar 
for both osmolytes (Urban et al., 1993), sucrose was chosen for two reasons.  Firstly, 
it is known to maintain an extracellular osmotic pressure gradient without being 
metabolised by chondrocytes (Dingle et al., 1969).  Secondly, although raised 
osmolarity decreases cellular volume with both sucrose and NaCl, resulting in the 
subsequent concentration of intracellular contents, the use of NaCl may result in 
further perturbations to the intracellular ionic environment (Dingle et al., 1969).  For 
example, it has been suggested that raised extracellular Na+ concentrations may have 
an influence on intracellular Ca2+ concentrations through the presence of a Na+/Ca2+ 
exchange system on the plasma membrane of chondrocytes (Wilkins et al., 2000; 
Sánchez et al., 2006).  
 
5.2 HYPOTHESES 
The first hypothesis was that raised culture medium osmolarity had no influence on 
Hla-induced chondrocyte death. The second hypothesis was that increased [Ca2+]o,, 
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to the levels investigated in this study, did not influence S. aureus growth. The third 
hypothesis was that increasing the [Ca2+]o increased the rate of Hla-induced 
chondrocyte death.   
 
5.3 MATERIALS & METHODS 
5.3.1 Biochemicals and solutions 
Two distinct variants of DMEM were utilised during this study: 
1. DMEM (powder; Catalogue no. 12800-058) with L-glutamine (4mM), D-
glucose (25mM), sodium pyruvate (1mM), CaCl2 (1.8mM) was prepared in 
1litre of sterile de-ionized water.  4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES, 25mM) was added and the pH 
adjusted to 7.4 using HCl.  The osmolarity of the final prepared medium was 
300mOsm (measured).  
2. ‘Ca2+-free’ DMEM (aqueous medium, pH 7.4; Catalogue no. 21068-028) 
with D-glucose (25mM) and sodium bicarbonate (NaHCO3; 44mM), to which 
L-glutamine (4mM) and sodium pyruvate (1mM) were added.  The 
osmolarity of the final prepared medium was 300mOsm.  As this proprietary 
medium did not contain any added CaCl2 and was free of Ca2+-containing 
inorganic salts it has been referred to as Ca2+-free (0mM) DMEM in this 
chapter.  It is accepted however that a nominal amount of free Ca2+may still 
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5.3.2 Measuring and adjusting medium osmolarity 
The osmolarity of all solutions was measured using a freezing point osmometer 
(Advanced Micro Osmometer, Model 3300, Vitech Scientific Ltd, West Sussex, 
UK).  Three osmolarity measurements were taken for each prepared solution and the 
mean rounded to the nearest multiple of five.  For example, the osmolarity of DMEM 
(1) was measured using three different samples as 297 mOsm, 301 mOsm and 298 
mOsm.  The mean osmolarity of DMEM (1) was therefore 298.7 mOsm and is 
reported as 300 mOsm.  Medium osmolarity was increased by adding measured 
amounts of either sucrose or NaCl (sucrose and NaCl obtained from Sigma-Aldrich, 
Gillingham, UK).  
 
5.3.3 Varying medium Ca2+ concentration 
Medium Ca2+ concentration was varied between 0 and 20mM by adding CaCl2 (1M 
stock solution, VWR International Ltd., Lutterworth, UK).  The addition of CaCl2 
increased the osmolarity of the culture medium and, thus, to standardise osmolarity 
each solution was osmotically balanced to approx. 360mOsm with sucrose, as 
previously discussed (see section 5.1).  For the majority of experiments, DMEM with 
HEPES buffering was used in preference to NaHCO3-CO2 as the presence of HCO3- 
in the culture medium may have had the potential to reduce ionised Ca2+ 
concentrations through the precipitation of CaCO3.  However, Ca2+-free DMEM was 
only available with a NaHCO3-CO2 buffering system and therefore a separate study 
utilising this medium was conducted in order to investigate the influence of a Ca2+-
free medium on Hla-induced chondrocyte death.  
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5.3.4 Bacterial Strains 
S. aureus 8325-4 along with the following isogenic mutant strains were utilised for 
this study: DU5938 (Hla-Hlb-Hlg-), DU5946 (Hla+Hlb-Hlg-), DU1090 (Hla-
Hlb+Hlg+) (Table 4.1).  Aspirates were established as previously described (see 
Chapter 2) 
 
5.3.5 Bacterial counts and preparation of defined bacterial aspirates 
For the study investigating TSB bacterial growth in the presence of (1) elevated 
osmolarity (through sucrose addition) and (2) high Ca2+ (20mM), 10ml TSB was 
inoculated with approx. 5.0x103 cfu and incubated (37°C; 24hrs).  Thereafter, 
bacterial counts were conducted as previously described (see Chapter 2).  Bacterial 
growth in normal TSB acted as the control. 
 
5.3.6 High and low [Ca2+]o S. aureus 8325-4 supernatant study 
The 40hr cultures of S. aureus 8325-4 were pooled and centrifuged (3400g; 10mins) 
to separate bacteria from toxins.  The supernatant, containing the toxins, was 
harvested and filter-sterilised (0.22µm filter).  The supernatant was then equally 
divided in two.  CaCl2 was added to one half in order to raise the [Ca2+]o to 20mM 
while sucrose was added to the other half in order to osmotically balance the two 
groups.  The osmolarity of the high and low [Ca2+]o supernatants was 360mOsm.  
 
5.3.7 Statistical analysis 
Parametric data were analysed using either one-way between-groups ANOVA 
(bacterial growth, S. aureus isogenic mutant study and 0mM Ca2+ study), with post 
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hoc Bonferroni tests, or unpaired Student’s two-tailed t-tests (sucrose and NaCl 
osmolarity and S. aureus 8325-4 supernatant study).  A one-way between-groups 
Kruskal-Wallis ANOVA (extracellular Ca2+ sensitivity study), with post hoc Dunn’s 
test, was used to analyse non-parametric data.  For the study investigating S. aureus 
8325-4 growth in altered TSB culture medium conditions, N refers to the number of 
independent cultures per experimental group.  
 
5.4 RESULTS 
5.4.1 Raised culture medium osmolarity had no influence on S. aureus Hla-
induced in situ chondrocyte death 
Prior to assessing the influence of [Ca2+]o, preliminary experiments were conducted 
in order to assess the impact of raised culture medium osmolarity on Hla-induced in 
situ chondrocyte death i.e. to exclude the possibility that any observed changes in 
chondrocyte viability with raised [Ca2+]o were not simply due to the influence of 
elevated osmolarity.  Explants were cultured with S. aureus 8325-4 for 40hrs in the 
presence of low (300mOsm) or high (480mOsm; sucrose addition) osmolarity culture 
media.  There was no significant difference in chondrocyte death between the high 
and low osmolarity groups at each experimental time point (Figure 5.1A), with both 
groups reaching approx. 100% chondrocyte death at 40hrs.  To confirm further that 
osmolarity per se had no influence on Hla-induced chondrocyte death, the 
experiment was repeated but on this occasion NaCl was added to the culture medium 
in order to increase the osmolarity by the same amount.  Again, there was no 
significant difference between the high and low osmolarity groups at each time point 
(Figure 5.1B).  Additionally, there was no significant difference between the 
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480mOsm Sucrose and NaCl groups at 18 (p=0.052; unpaired Student’s two-tailed t-
test), 24 (p=0.2) and 40hrs (p=0.58). 
 
 
Figure 5.1: Raised culture medium osmolarity had no influence on S. aureus Hla-
induced in situ chondrocyte death   
The cell death in explants cultured with S. aureus 8325-4 at an osmolarity of 300mOsm were 
compared with those cultured at an osmolarity of 480mOsm.  There was no significant difference in 
chondrocyte death between the high and low osmolarity groups at any time point for both the sucrose 
(A) and NaCl (B) experiments (N=4[n=2] for both experiments; p values represent low versus high 
osmolarity by unpaired Student’s two-tailed t-test).   
 
5.4.2 A high culture medium Ca2+ concentration had no influence on S. aureus 
8325-4 growth 
Before assessing the influence of [Ca2+]o on Hla-induced chondrocyte death, it was 
important first of all to test whether increasing culture medium Ca2+ concentrations 
increased S. aureus growth.  TSB ([Ca2+]o=20mM; 380mOsm) was inoculated with 
S. aureus 8325-4 and incubated for 24hrs (N=3). TSB osmotically-balanced with 
sucrose ([Ca2+]o<1mM; 380mOsm) was utilised to assess the influence of osmolarity 
on bacterial growth.  Standard TSB ([Ca2+]o<1mM; 320mOsm) acted as the control 
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(N=3).  At 24hrs, the number of CFUs in the culture media were measured (Table 
5.1).  A one-way between-groups ANOVA demonstrated no significant difference 
(p=0.12) in the bacterial counts between the groups, thereby indicating that, in 
comparison to standard TSB (<1mM Ca2+), both raised [Ca2+]o and osmolarity, to the 
levels investigated in this study, had no significant effect on S. aureus 8325-4 
growth.    
 
TSB culture medium conditions (mOsm) 
    
24hr bacterial counts (CFU)  
Standard (320) 1.92x109 ± 0.28x109 
+ 20mM Calcium (380) 1.35x109 ± 0.26x109 
+ Sucrose (380) 1.93x109 ± 0.42x109 
 
Table 5.1: S. aureus 8325-4 growth in altered TSB culture medium conditions.   
The number of CFU in 10ml defined TSB following 24hrs incubation is displayed (N=3).  Values are 
means ± SD.   
 
5.4.3 An elevated [Ca2+]o had no influence on in situ chondrocyte viability in the 
absence of Hla 
In order to determine whether an elevated [Ca2+]o, to the level investigated in this 
study, had an impact on in situ chondrocyte viability, explants were cultured in high 
Ca2+ (20mM) culture medium with the following S. aureus isogenic mutants: 
Hla+Hlb-Hlg-, Hla-Hlb+Hlg+ and Hla-Hlb-Hlg- (control) (Table 4.1).  There was a 
significant difference between the strains at 24hrs (p<0.001), with subsequent post-
hoc testing demonstrating significantly increased chondrocyte death induced by the 
Hla+Hlb-Hlg- strain in comparison to the Hla-Hlb+Hlg+ (p<0.001) and Hla-Hlb-Hlg- 
(p<0.001) strains (Figure 5.2A and B).  There was no significant difference (p=1.0) 
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between the chondrocyte death induced by the Hla-Hlb+Hlg+ and the Hla-Hlb-Hlg- 
strains.  The minimal chondrocyte death observed in the explants exposed to the Hla-
Hlb+Hlg+ and Hla-Hlb-Hlg- isogenic mutants over the study period demonstrated, 
firstly, that a [Ca2+]o of 20mM had no significant impact on chondrocyte viability 
during the study period.  Secondly, Hlb and Hlg played no significant role in S. 
aureus-induced in situ chondrocyte death, thereby further confirming the findings 
presented in Chapter 4 (Figure 4.3). 
 
Figure 5.2: Minimal in situ chondrocyte death in the absence of Hla in high Ca2+ 
culture medium   
Chondrocyte death in osteochondral explants cultured for 24hrs with the Hla+Hlb-Hlg-, Hla-Hlb+Hlg+ 
and Hla-Hlb-Hlg- isogenic mutants in the presence of 20mM Ca2+ were compared (A).  There was 
significantly more chondrocyte death induced by the Hla+Hlb-Hlg- strain compared to the Hla-
Hlb+Hlg+ and Hla-Hlb-Hlg- strains (N=4[n=2]; numerical p value represents one-way between-groups 
ANOVA; *** p<0.001 Hla+Hlb-Hlg- versus Hla-Hlb+Hlg+ and Hla-Hlb-Hlg- strains by post hoc 
Bonferroni test).  The CLSM images (B) represent the chondrocyte death induced by each isogenic 
mutant at 24hrs (scale bar=100µm).   
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5.4.4 The rate of Hla-induced in situ chondrocyte death increased with raised 
culture medium [Ca2+]o 
In order to assess the influence of [Ca2+]o on Hla-induced in situ chondrocyte death, 
osteochondral explants were cultured with S. aureus 8325-4 for 40hrs in culture 
media with varying Ca2+ concentrations (Figure 5.3A).  The osmolarity of all media 
were maintained at 360mOsm (sucrose addition), which had previously been shown 
to have no influence on Hla-induced in situ chondrocyte death (Figure 5.1A).  There 
was a significant difference in chondrocyte viability between the experimental 
groups at 18 (p=0.01) and 24hrs (p=0.02) (Figure 5.3A and B).  Subsequent post-
hoc Dunn’s tests revealed that there was significantly more chondrocyte death in the 
10 and 20mM Ca2+ groups in comparison to the 1.8mM group at 18hrs and the 
20mM group alone to be significant at 24hrs.  There was no significant difference 
between the 10 and 20mM groups at 18hrs (p=1.0) or 24hrs (p=0.7).  By 40hrs there 
was no significant difference between the groups (p=0.45), with all groups reaching 
approx. 100% chondrocyte death (Figure 5.3A and B).  This experiment therefore 
demonstrated that in the presence of a raised culture medium Ca2+ concentration, the 
rate of Hla-induced in situ chondrocyte death increased.  However, given that there 
was no significant difference between the 10 and 20mM groups at each time point, 
there was the suggestion of a maximal Ca2+ level above which there was no 
significantly increased rate of chondrocyte death. 
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Figure 5.3: The influence of elevated [Ca2+]o on S. aureus Hla-induced in situ 
chondrocyte death 
Osteochondral explants were cultured with S. aureus 8325-4 in media over the range 1.8 to 20mM 
Ca2+ (A) with the osmolarity of media corrected to 360mOsm.  There was a significant difference in 
chondrocyte death between the groups at 18 and 24hrs (N=4[n=2]; numerical p values represent one-
way between-groups Kruskal-Wallis ANOVA; * p<0.05 10 and 20mM versus 1.8mM Ca2+ by post 
hoc Dunn’s test).  By 40hrs, chondrocyte death was comparable between the groups.  The CLSM 
images (B) represent the chondrocyte death at each time point in the presence of varying [Ca2+]o 
concentrations (scale bar=100µm).  
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5.4.5 Hla-induced chondrocyte death was still evident in the presence of 0mM 
Ca2+ culture medium 
In order to assess the influence of Ca2+-free culture medium on Hla-induced 
chondrocyte death, explants were cultured with S. aureus 8325-4 for 24hrs in culture 
media containing the following [Ca2+]o: 0, 1.8 and 10mM.  The osmolarity of each 
group was adjusted to 360mOsm (sucrose addition).  At 24hrs, there was significantly 
more chondrocyte death in those explants cultured in DMEM containing 10mM Ca2+ 
in comparison to those explants cultured in media containing 0 and 1.8mM (Figure 
5.4).  There was detectable chondrocyte death in both the 0 and 1.8mM groups.  
However, there was no significant difference between the 0 and 1.8mM groups at 
24hrs (p=1.0).  This experiment therefore further demonstrated increased chondrocyte 
death in the presence of an elevated [Ca2+]o.  It also demonstrated that some degree of 
chondrocyte death still occurred in the presence of Ca2+-free culture medium. 
 
5.4.6 Ca2+ played an important role in the Hla-induced chondrocyte death 
pathway 
In order to obtain further evidence to test the hypothesis that increasing the [Ca2+]o 
increased the rate of Hla-induced chondrocyte death, explants were cultured for 6hrs 
in high (20mM) or low (1.8mM) Ca2+ S. aureus 8325-4 supernatants.  The 
supernatants had identical Hla concentrations and this was achieved by equally 
dividing a 40hr S. aureus 8325-4 supernatant.  The osmolarity of each group was 
maintained at 360mOsm (sucrose addition).   At 6hrs there was significantly more 
chondrocyte death (p=0.015) in the explants exposed to the supernatant 
supplemented with Ca2+ ([Ca2+]o=20mM) in comparison to the low Ca2+-containing 
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supernatant ([Ca2+]o=1.8mM) (Figure 5.5A and B).  There was approx. twice as 
much death in the explants exposed to the high Ca2+ supernatant.  Taken together, 
these results suggest that Ca2+ played an important role in the cell death pathway 
mediated by Hla. 
 
 
Figure 5.4: The influence of 0mM Ca2+ culture medium on Hla-induced chondrocyte 
death 
Osteochondral explants were cultured with S. aureus 8325-4 in media over the range 0 to 10mM Ca2+ 
with the osmolarity of media corrected to 360mOsm.  There was a significant difference between the 
groups at 24hrs (N=4[n=2]; numerical p value represents one-way between-groups ANOVA; *** 
p<0.001 0mM and 1.8mM versus 10mM Ca2+ by post hoc Bonferroni test). Chondrocyte death in those 
explants cultured in the presence of 0mM was comparable to those explants cultured in 1.8mM.  
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Figure 5.5: A S. aureus 8325-4 supernatant supplemented with Ca2+ increased in situ 
chondrocyte death 
Osteochondral explants were exposed to either a high (20mM) or low (1.8mM) Ca2+ S. aureus 8325-4 
supernatant for 6hrs.  The supernatants were osmotically balanced and had comparable Hla 
concentrations.  There was significantly more chondrocyte death in the explants exposed to the high 
Ca2+ supernatant in comparison to those explants exposed to the low Ca2+ supernatant (A) (N=6[n=2]; 
p value represents the results from an unpaired Student’s two-tailed t-test).  The CLSM images (B) 
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5.5 DISCUSSION 
In this study, CLSM was used to determine changes to the viability of in situ bovine 
chondrocytes during exposure to S. aureus 8325-4 and associated isogenic mutants in 
the presence of altered culture medium conditions.  Several key findings emerge 
from this study.  Firstly, increased culture medium osmolarity had no significant 
effect on Hla-induced in situ chondrocyte death.  Secondly, a raised culture medium 
Ca2+ concentration, to the maximum level investigated in this study, had no 
significant effect on S. aureus 8325-4 growth.  Thirdly, in the absence of Hla, a high 
extracellular Ca2+ concentration had no influence on chondrocyte viability during the 
experimental period.  Finally, Hla-induced chondrocyte death increased in the 
presence of raised extracellular Ca2+ concentrations. 
 
The main objective of this study was to assess the influence of elevated [Ca2+]o on 
Hla-induced in situ chondrocyte death.  In order to achieve this goal, the addition of 
CaCl2 to culture media was required.  However, with the addition of CaCl2 the 
osmolarity of the medium rose (i.e. for every 1mM of added CaCl2, the osmolarity of 
the culture medium rose by 3mOsm).  Thus, assessing the influence of, for example, 
1.8 versus 20mM Ca2+ culture medium on Hla-induced in situ chondrocyte death 
would actually inadvertently assess two independent variables: (1) elevated Ca2+ and 
(2) elevated osmolarity.  It would therefore be impossible to determine whether any 
observed effects were due to elevated Ca2+, raised osmolarity or both.  It was thus 
necessary to first of all assess the influence of raised culture medium osmolarity on 
Hla-induced chondrocyte death prior to commencing any experiments investigating 
the influence of elevated Ca2+. 
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Using two separate osmolytes, sucrose and NaCl, no significant difference was 
identified in Hla-induced in situ chondrocyte death between high (480mOsm) and 
low (300mOsm) osmolarity culture media (Figure 5.1).  This finding enabled the 
confident osmotic adjustment of Ca2+ solutions for subsequent experiments.  Sucrose 
was chosen to increase the osmolarity of solutions, as previously discussed (see 
section 5.1).  Others may consider that MgCl2 would have been a more appropriate 
osmolyte, as it would have enabled the maintenance of a consistent divalent cation 
concentration between Ca2+ solutions.  However, studies have suggested increased S. 
aureus growth and toxin production in the presence of elevated culture medium Mg2+ 
concentrations (Ochiai, 2001) and, accordingly, it was not utilised in the current 
study. 
 
Before assessing the influence of elevated [Ca2+]o on Hla-induced chondrocyte death, 
it was considered important to assess the influence of raised Ca2+ concentrations on 
bacterial growth, as previous studies have highlighted an important role of Ca2+ for 
the growth of several bacterial species/strains (Onoda et al., 2000; Patrauchan, 2005; 
Cruz et al., 2012).  No other studies have specifically investigated the effect of Ca2+ 
on the growth of S. aureus 8325-4.  It was therefore possible that raised culture 
medium Ca2+ concentrations in this in vitro model may have stimulated S. aureus 
8325-4 growth, with an associated increase in Hla levels.  This would have provided 
a possible explanation for any observed differences in chondrocyte viability between 
the Ca2+ concentrations studied.  Nevertheless, there was no significant difference 
between the bacterial counts in high and low Ca2+ culture media (osmolarity of each 
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solution equal) at 24hrs (Table 5.1), indicating no influence of elevated Ca2+, to the 
maximum level studied, on S. aureus 8325-4 growth.  In addition, raised osmolarity 
per se also had no influence on bacterial growth (Table 5.1).  Given the various 
defined phases of bacterial growth (Harris et al., 2002), it is appreciated that this was 
a crude experimental strategy to assess S. aureus 8325-5 growth and future studies 
will therefore establish and compare growth curves during similar culture conditions.  
Furthermore, although 24hr bacterial counts were comparable in the current study, it 
was not possible to exclude the possibility that high Ca2+stimulated bacteria to 
produce more Hla.  A potential future experiment to address this question would be 
to compare Hla activity between high and low Ca2+ 24hr S. aureus 8325-4 cultures 
by conducting a rabbit red cell haemolytic titre (Nilsson et al., 1999).  
 
It has been hypothesised that the membrane-spanning pores established by Hla 
disturb the ionic equilibrium between the intra and extracellular compartments 
(Bhakdi and Tranum-Jensen, 1991).  Some studies have suggested that the influx of 
Na+ coupled with the efflux of K+ (Walev et al., 1993; Essmann et al., 2003) is a key 
event in the Hla-induced death pathway while other studies have suggested that an 
influx of Ca2+ is an important primary trigger (Suttorp et al., 1985; Bhakdi and 
Tranum-Jensen, 1991).  Prior to assessing the influence of Ca2+ on Hla-induced 
chondrocyte death, a preliminary experiment was conducted to assess whether a Ca2+ 
concentration of 20mM, which exceeds published ECM (6-15mM) (Urban, 1994) 
and synovial fluid (approx. 4mM) (Wan et al., 2008) levels, would influence in situ 
chondrocyte viability during the experimental period.  Hla-deficient isogenic mutants 
exhibited minimal, but detectable, chondrocyte death in comparison to an Hla-
	   159	  
producing mutant, which induced significant chondrocyte death (Figure 5.2).  This 
suggested that chondrocytes were capable of maintaining intracellular Ca2+ 
homeostasis, even in the presence of elevated extracellular levels.  Intracellular Ca2+ 
within chondrocytes is controlled tightly in the range of 80-100nM (Hall et al., 
1996a; Yellowley et al., 1997; Wilkins et al., 2000; Sánchez et al., 2003).  Transport 
systems in the endoplasmic reticulum, mitochondria and plasma membrane are 
believed to play a key role in maintaining the ionic [Ca2+]i equilibrium within 
eukaryotic cells (Berridge et al., 1998).  Given the large concentration gradient 
between the intra and extra-cellular compartments, it would thus appear that 
chondrocytes are uniquely adapted to regulating intracellular Ca2+ levels in the face 
of high extracellular levels.  The small, but detectable chondrocyte death observed in 
those explants exposed to the Hla-Hlb-Hlg- and Hla-Hlb+Hlg+ mutants may reflect 
Ca2+-induced enhanced potency of Hlb and Hlg and other S. aureus toxins.  
Regardless, this experiment further confirmed the destructive influence of Hla.   
 
With culture medium Ca2+ concentrations initially ranging from 1.8 to 20mM, 
elevated Hla-induced in situ chondrocyte death was identified with higher Ca2+ 
concentrations (Figure 5.3).  This experiment was conducted using culture medium 
containing a HEPES buffering system rather than a bicarbonate system, as there was 
concern that the presence of bicarbonate would precipitate calcium carbonate, 
thereby reducing the availability of free Ca2+.  Whilst the rate of Hla-induced 
chondrocyte death increased between 1.8 and 10mM, there was no significant 
difference between 10 and 20mM at each time point (Figure 5.3).  This finding 
suggested that there was a maximal Ca2+ level between 1.8 and 10mM above which 
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there was no significantly increased rate of chondrocyte death.  By 40hrs however 
there was almost complete chondrocyte death in each experimental group, thereby 
demonstrating potent Hla-induced chondrocyte death even at low medium Ca2+ 
concentrations.  Ultimately, this experiment demonstrated higher rates of Hla-
induced chondrocyte death in the presence of elevated Ca2+ concentrations. 
 
Given that elevated Ca2+ concentrations resulted in an increased rate of chondrocyte 
death, it was considered important to assess the influence of 0mM Ca2+ culture 
medium on Hla-induced chondrocyte death.  Unfortunately, 0mM Ca2+ culture media 
was only available with a bicarbonate buffer and therefore a further extracellular 
Ca2+ sensitivity experiment was conducted.  Whilst there was significantly more 
chondrocyte death in those explants exposed to 10mM at 24hrs there was still a 
detectable level of chondrocyte death in those explants cultured in 0mM Ca2+ 
medium, which was comparable to that of the 1.8mM Ca2+ group.  It was perhaps 
unsurprising that Hla-induced chondrocyte death still occurred in the presence of 
0mM culture medium as the negatively charged proteoglycans within the cartilage 
matrix have a strong affinity for cations such as Ca2+ and thus a reasonable Ca2+ 
concentration was likely to have been maintained within the ECM.  It is also possible 
that trace amounts of Ca2+ remained in the medium i.e. the medium wasn’t truly 
Ca2+-free.  The reduced chondrocyte death observed in the 1.8 and 10mM Ca2+ 
groups (during the study to assess the influence of 0mM Ca2+ culture medium on 
Hla-induced chondrocyte death) in comparison to the same experimental time point 
in the initial extracellular Ca2+ sensitivity experiment (Figures 5.3 and 5.4) possibly 
	   161	  
reflected the presence of bicarbonate in the culture medium i.e. reduced Ca2+ 
availability. 
 
One potential criticism of the extracellular Ca2+ sensitivity experiment was that the 
increased rate of Hla-induced chondrocyte death observed in the presence of elevated 
Ca2+ concentrations may have been due to Ca2+-induced stimulation of Hla 
production by S. aureus 8325-4.  To date, no studies have investigated the influence 
of raised extracellular Ca2+ concentrations on S. aureus Hla-production.  
Interestingly, in Pseudomonas aeruginosa Ca2+ has been identified to be an 
important regulatory ion that influences the production of extracellular enzymes and 
toxins (Patrauchan, 2005; Sarkisova et al., 2005).  However, when explants exposed 
to a high-Ca2+ S. aureus 8325-4 supernatant (bicarbonate-free) were compared with 
explants exposed to an osmotically balanced low-Ca2+ supernatant of identical Hla 
concentration, there was approx. twice as much chondrocyte death in those explants 
exposed to the high-Ca2+ supernatant (Figure 5.5).  In the absence of viable bacteria, 
this experiment therefore provided convincing experimental evidence that Ca2+ was 
involved in the Hla-induced chondrocyte death pathway.  
 
A further potential criticism of the findings presented in this chapter is that they 
provide no indication as to which stage of the Hla-induced chondrocyte death 
pathway Ca2+ is involved.  For example, Ca2+ may enter the chondrocyte through the 
membrane-spanning pores established by Hla with the resultant rise in intracellular 
Ca2+ concentrations triggering death pathways or, alternatively, Ca2+ may enter the 
cell as a result of loss of membrane integrity (i.e. at a later stage) and thereafter 
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accelerating established death pathways.  However, the goal of the current study was 
to identify if Ca2+ was indeed involved in the Hla-induced chondrocyte death 
pathway and this was achieved. 
 
To conclude, this study builds upon the knowledge obtained in Chapter 4 that Hla is 
critical to S. aureus-induced in situ chondrocyte death in a bovine cartilage explant 
model of septic arthritis by demonstrating an important role of extracellular Ca2+ in 
the Hla death pathway.  A further understanding of the role of Ca2+ in this pathway 
may enable future targeted therapeutic strategies to reduce the extent of chondrocyte 
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CHAPTER 6 
A DYNAMIC ASSESSMENT OF INTRACELLULAR CALCIUM 
FOLLOWING THE EXPOSURE OF IN SITU CHONDROCYTES 
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6.1 INTRODUCTION 
Alterations in intracellular Ca2+, Na+ and K+ concentrations have been hypothesised 
to be key events in the Hla-induced cell death pathway (Berube and Bubeck-
Wardenburg, 2013).  However, there remains some uncertainty as to the exact roles 
of these ions.  Some studies have suggested that the influx of Ca2+ through the 
membrane-spanning Hla pore is the main trigger of cellular death mechanisms 
(Suttorp et al., 1985) while other studies have suggested that Hla pores do not permit 
the passage of divalent cations and that the important primary trigger is the influx of 
Na+ coupled with the efflux of K+ (Walev et al., 1993; Valeva et al., 2000).  In 
Chapter 5, the rate of Hla-induced in situ chondrocyte death was found to have 
increased with elevated [Ca2+]o, thereby adding strength to the argument that Ca2+ 
plays a key role in the Hla-mediated chondrocyte death pathway.  In this chapter, the 
role of Ca2+ in the Hla-induced cell-death pathway has been further explored. 
 
The emergence of cytosolically-trapped fluorescent probes that change their 
emission/absorption spectra upon Ca2+-binding, coupled with advanced multi-track 
CLSM live-cell imaging systems, has enabled the characterisation and quantification 
of dynamic changes in [Ca2+]i within a variety of eukaryotic cells in response to 
external perturbations (Smith et al., 1991; Smith et al., 1992; Papadimitriou et al., 
1994; Trump and Berezesky, 1995).  Indeed, recent studies by Han et al. (2012) and 
Madden et al. (2014) utilised such methods to investigate chondrocyte Ca2+ 
signalling within osteochondral explants during dynamic loading conditions.  Both 
studies assessed changes in [Ca2+]i through a ‘ratiometric’ technique whereby 
chondrocytes were stained simultaneously with two Ca2+-sensitive fluorophores: 
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Fluo-4 and Fura Red.  As [Ca2+]i increases, the intensity of Fluo-4 fluorescence 
increases (Gee et al., 2000; Walczysko et al., 2000) whilst, paradoxically, the 
intensity of Fura Red fluorescence decreases.  Thus, a ratio can be established 
between the intensity of fluorescence of the two stains.  This ratio remains 
unchanged in the event of a shift in the focal plane or photobleaching and will only 
rise in the event of an increase in [Ca2+]i. 
 
Most fluorescent Ca2+ indicators are based on the Ca2+ chelators ethylene glycol 
tetraactetic acid (EGTA) or 1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic 
acid (BAPTA) modified to incorporate fluorescent reporter groups (Thomas et al., 
2000).  In this study, indicators with acetoxymethyl(AM)-ester linkage (Fluo-4 AM 
and Fura Red AM) have been used to introduce the indicators into living in situ 
chondrocytes, the AM-ester groups being cleaved by endogenous cytosolic esterases 
releasing the Ca2+-sensitive form of the indicator intracellularly.  Thereafter, 
alterations in [Ca2+]i within in situ chondrocytes were assessed following 
experimental challenge. 
 
This study aims to build on the knowledge obtained from the extracellular Ca2+ study 
detailed in the Chapter 5 by attempting to assess dynamic changes in [Ca2+]i within 
viable in situ chondrocytes following Hla exposure.  Live-cell CLSM coupled with 
Ca2+-sensitive fluorophores has been used to assess changes in [Ca2+]i, represented 
by changes in fluorophore fluorescence, following ionomycin and, thereafter, Hla 
exposure.  Exposure of in situ chondrocytes to ionomycin permitted validation of the 
dynamic experimental CLSM system prior to experimentation with Hla.  Ionomycin 
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is an effective and widely studied Ca2+ ionophore (a chemical that induces a rise in 
[Ca2+]i) that is produced by the bacterium Streptomyces conglobatus (Liu and 
Hermann, 1978).  It functions by both facilitating the transport of Ca2+ across the 
plasma membrane, through the creation of plasma membrane pores that are 
preferentially permeable to Ca2+, and also by stimulating the release of Ca2+ from 
intracellular stores (Himmel et al., 1990; Morgan and Jacob, 1994).  When 
administered in sufficiently high doses, ionomycin will induce cell death (Gwag et 
al., 1999).  
 
6.2 HYPOTHESES 
The first hypothesis was that Hla-induced chondrocyte death is associated with an 
overwhelming rise in [Ca2+]i.  The second hypothesis was that SZ chondrocytes more 
rapidly succumb to alterations in [Ca2+]i in comparison to chondrocytes from deeper 
zones.  
 
6.3 MATERIALS AND METHODS 
6.3.1 Biochemicals and Solutions 
Ionomycin was prepared as a 10mM stock solution in DMSO.  The following 
DMEM variants were used during this study: 
3. ‘Phenol red-free’ DMEM (aqueous medium, pH 7.4, 340mOsm; Catalogue 
no. 21063-029) with HEPES (25mM), L-glutamine (4mM), D-glucose 
(25mM) and CaCl2 (1.8mM).  A phenol red-free medium has been shown to 
improve sensitivity and ‘signal to noise’ ratio during CLSM imaging 
(Frigault et al., 2009) 
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4. ‘Bicarbonate-free’ DMEM (powder; Catalogue no. 12800-058) with L-
glutamine (4mM), D-glucose (25mM), sodium pyruvate (1mM), CaCl2 
(1.8mM) was prepared in 1litre of sterile de-ionized water.  HEPES (25mM) 
was added and the pH adjusted to 7.4 using HCl.  The osmolarity of the final 
prepared medium was 340mOsm (adjusted with sucrose).  
 
6.3.2 Fluorescent probes 
The following fluorescent probes were utilised for the experimental work presented 
in this chapter: 
1. LIVE CELLS: CMFDA was used to stain living cells as previously described 
in Chapter 2. 
2. DEAD CELLS: PI was used to stain dead or dying cells as previously 
described in Chapter 2.  
3. INTRACELLULAR Ca2+: the following two stains were used to assess 
dynamic changes in [Ca2+]i: 
1. Fluo-4 AM: passes freely through the plasma membrane of viable 
cells in a non-fluorescent form (Fluo-4 AM) and is cleaved by 
cytosolic esterases into the fluorescent ‘Fluo-4’.  Fluo-4 binds to 
intracellular free Ca2+ and fluoresces green following laser excitation 
(Paredes et al., 2008).  The level of fluorescence increases with Ca2+ 
binding (Gee et al., 2000) and thus as [Ca2+]i increases the intensity of 
Fluo-4 fluorescence also increases.  Fluo-4 AM (50µg) was prepared 
as a 1mM stock solution in DMSO. 
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2. Fura Red AM- passes freely through the plasma membrane of viable 
cells in a non-fluorescent form (Fura Red AM) and is cleaved by 
cytosolic esterases into the fluorescent ‘Fura Red’.  Fura-Red binds to 
free Ca2+ and fluoresces red following laser excitation (Kurebayashi et 
al., 1993).  In contrast to Fluo-4 however, the level of fluorescence 
decreases with Ca2+ binding (Walczysko et al., 2000) and therefore as 
[Ca2+]i increases the intensity of Fura Red fluorescence decreases.  
Fura Red AM (50µg) was prepared as a 1mM stock in 20% pluronic 
acid (v/w in DMSO; pluronic acid is believed to facilitate dye entry 
into cells (Pecze et al., 2013)). 
 
6.3.3 Bacterial supernatants 
S. aureus 8325-4 (Hla+Hlb+Hlg+)  and DU5938 (Hla-Hlb-Hlg-) were cultured with 
osteochondral explants in bicarbonate-free DMEM and the 40hr culture supernatants 
harvested as previously described in Chapter 2.  
 
6.3.4 Tissue culture 
Osteochondral explants were harvested as previously described in Chapter 2.  For all 
studies, explants were harvested into DMEM (phenol red-free) and incubated (37°C; 
5% CO2) for 24hrs prior to experimentation.  At the time of experimentation, 
explants were removed from the tissue culture flasks, trimmed as previously 
described (see Chapter 2) and stained with specified fluorescent stains.  For the cut-
edge study (see section 6.4.5 for study rationale), explants were transferred to culture 
vessels containing either fresh 340mOsm (‘normal’ osmolarity) or 600mOsm 
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(sucrose addition; ‘high’ osmolarity) phenol red-free DMEM and incubated for 2hrs 
(37°C) prior to trimming and staining.  This enabled the in situ chondrocytes to 
respond to the altered osmotic environment prior to scalpel wounding. 
 
6.3.5 Fluorescent stain combinations 
The following fluorescent stain combinations were utilised during this study: 
1. CMFDA and PI: explants were incubated (1hr; 21°C) in phenol red-
free DMEM with CMFDA (10µM) and PI (10µM). 
2. Fluo-4 and PI: explants were incubated (30mins at 37°C followed by 
30mins at 21°C) in phenol red-free DMEM with Fluo-4 (15µM) and 
PI (10µM).  For the cut-edge study, explants were stained in either 
high or normal osmolarity phenol red-free DMEM (see above). 
3. Fluo-4 and Fura Red: explants were incubated (30mins at 37°C 
followed by 30mins at 21°C) in phenol red-free DMEM with Fluo-4 
(15µM) and Fura Red (60µM).  
 
The staining of all explants was conducted in a Falcon tube (15ml).  For the staining 
of explants with Fluo-4, Fura Red or both, the stains were protected from excessive 
light exposure by wrapping the Falcon tube with tinfoil.  
 
6.3.6 Coverslip preparation and cartilage explant mounting 
Unless stated otherwise, all experiments presented in this chapter were conducted 
using an inverted microscope system and therefore, unlike in the previous chapters, 
all cartilage explants were mounted onto glass cover slips ‘articular-surface-down’ 
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(Figure 6.1A).  However, prior to the commencement of each experiment, three 
‘rows’ of clear nail varnish, measuring approx. 3 x 10mm with an approx. 5mm gap 
between each row, were established.  Upon drying, the viscous nature of the nail 
lacquer generated an approx. 1mm elevated platform.  The subsequent placement of 
each explant across the three elevated rows created a gap that enabled adequate 
exposure of the articular surface, and thus in situ chondrocytes, to the experimental 
fluid (Figure 6.1B).  Each explant was secured with Blu-Tack prior to submersion in 
a defined medium.  Upon cartilage mounting, the coverslip was placed into a 
POCmini-2 open tissue culture microscope chamber system (HemoGenix®, Inc., 
Colorado, USA) and, thereafter, the explant submerged in specified culture medium 
(Figure 6.1C). 
 
The pilot study to assess the rate of Hla-induced in situ chondrocyte death in a live-
cell system was conducted using the Zeiss LSM510 upright microscope and 
therefore the explants were mounted as previously described (see Chapter 2). 
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Figure 6.1: Coverslip preparation for imaging on Nikon A1 inverted CLSM system 
Osteochondral explants were placed ‘articular-surface-down’ between 3 rows of dried nail varnish and 
secured with 3 Blu-Tack balls (A).  The nail varnish rows, coupled with the Blu-Tack balls, permitted 
adequate exposure of the articular surface to the experimental culture medium whilst remaining 
sufficiently close to the glass cover slip for CLSM imaging (B).  Each coverslip was secured into a 
watertight POCmini-2 open tissue culture microscope chamber system and thereafter the explant was 
submerged in the designated experimental culture medium prior to CLSM imaging (C) (scale 
bar=1cm).  Images A and B kindly provided by Frances Greaney, Centre for Integrative Physiology, 
The University of Edinburgh. 
 
6.3.7 Live-cell studies 
The following dynamic live-cell studies were conducted: 
	   172	  
1. Ionomycin study: Explants stained with (1) Fluo-4 and PI and (2) Fluo-4 and 
Fura Red were submerged in pre-warmed phenol red-free DMEM (600µl; 
37°C) containing PI (15µM) and transferred to a pre-heated (37°C) and 
humidified microscope cage incubator (Okolab, Ottaviano, Italy).  For the 
Fluo-4 and PI study, images were acquired every 2mins over an initial 22min 
period.  At 22mins, 300µl DMEM was carefully removed from the 
experimental chamber and replaced with pre-warmed (37°C) DMEM 
containing ionomycin (100µM).  Thereafter, images were acquired every 
2mins for a further 46mins.  For the Fluo-4 and Fura Red ratiometric study, 
once the microscope settings had been optimised, 300µl DMEM was 
carefully removed from the experimental chamber and replaced with pre-
warmed (37°C) DMEM containing ionomycin (100µM) as per above.  
Thereafter, images were acquired every 10secs over a 5min period. The final 
concentration of ionomycin within the tissue culture microscope chamber for 
both studies was 50µM.  
2. Preliminary assessment of live-cell time course in the presence of Hla: 
Explants stained with CMFDA and PI were submerged in pre-warmed phenol 
red-free DMEM (5ml; 37°C) and transferred to a heated (37°C) microscope 
stage (Zeiss warm stage, Linkam Scientific Instruments, Surrey, UK).  
Thereafter, the DMEM was carefully removed and replaced with pre-warmed 
(37°C) S. aureus 8325-4 supernatant, to which was added PI (15µM).  Images 
of the same region of cartilage were acquired in the axial plane at 0, 2, 4 and 
6hrs with an upright Zeiss LSM510 microscope as previously described (see 
Chapter 2). 
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3. Hla study: Explants were stained with Fluo-4 and PI prior to submersion in 
either pre-warmed S. aureus 8325-4 (Hla+Hlb+Hlg+) or Hla-Hlb-Hlg- 
supernatant (1ml; 37°C) containing PI (10µM).  Thereafter, they were 
immediately transferred to the microscope cage incubator and images were 
acquired every 5mins for 6hrs. 
4. Cut-edge study (see section 6.4.5 for study rationale): Explants were 
trimmed as previously described and incubated (37°C) in high (600mOsm) 
and normal (340mOsm) osmolarity phenol red-free DMEM for 2hrs.  
Thereafter, they were stained with Fluo-4 and PI in phenol red-free DMEM 
of identical osmolarity.  Microscope settings were optimised and a single 
image was acquired. 
 
6.3.8 CLSM 
For the pilot study investigating the rate of Hla-induced in situ chondrocyte death in 
a live tissue model, axial images of CMFDA- and PI-labelled chondrocytes were 
acquired at 0, 2, 4 and 6hrs using an upright Zeiss LSM510 CLSM system as 
previously described in Chapter 2. 
 
For all remaining experiments, axial images were acquired with an inverted Nikon 
A1R CLSM system (Nikon UK, Kingston Upon Thames, Surrey, UK) using a 
x10/0.3 CFI Plan Fluor air objective lens (Figure 6.2).  Each optical section 
measured 921 x 921µm and had an image resolution of 512x512 pixels.  With the 
exception of the Fluo-4 and Fura Red ratiometric study, whereby a single z-slice was 
acquired every 10secs over a 5min time-course, the focal plane was moved through 
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the tissue in 10µm increments from the articular surface normally to a depth of 
100µm at defined time intervals over a designated time period (see above).  Only a 
single axial image was obtained for each explant in the cut-edge study.  
 
 
Figure 6.2: The Nikon A1R CLSM imaging system, with attached Perspex incubator 
chamber, that was utilised during this study for assessing alterations in [Ca2+]i within 
living in situ chondrocytes following experimental challenge  
 
For the experiments utilising a combination of Fluo-4 and PI, a channel series 
protocol for multicolour images was used in order to minimise ‘bleed-through’ 
(fluorescence emission overlap between two fluorophores), with the same high 
voltage gain and digital offset settings being applied to both control and treated 
samples.  Fluo-4 was excited at 488nm and signal (emitted light) collected from 500-
550nm while PI was excited at 561nm and signal collected from 570-620nm (band-
pass filters permitted the separation and capture of the fluorescence emitted from 
Fluo-4 and PI).  For the experiment utilising a combination of Fluo-4 and Fura Red, 
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a spectral scan of Fluo-4 emission from a Fluo-4 only loaded cartilage explant 
revealed a ‘red shift’ in the emission profile (i.e. a shift towards the Fura Red 
emission spectrum) compared to the published emission spectrum 
(www.lifetechnologies.com) (Figure 6.3).  In order to remove this red shifted Fluo-4 
signal from the Fura Red detection channel, a virtual filter (adjustable spectral 
grating) protocol was used.  Fluo-4 and Fura Red were excited at 488nm and 
detected between 504nm to 558nm and 642 to 696nm, respectively (Han et al, 2011); 
an optical configuration set-up was employed on the Nikon A1R in order to use the 
virtual filter sequentially.  This protocol minimised any ‘bleed-through’ of the Fluo-4 
signal into the Fura Red acquisition channel.  
 
Figure 6.3: Emitted fluorescence from Fluo-4- and Fura Red-loaded cells 
A spectral scan of Fluo-4 emission (excitation at 488nm) from Fluo-4-only loaded in situ 
chondrocytes revealed a ‘red-shift’ (indicated by black arrow) in the emission profile (i.e. a shift 
towards the Fura Red emission spectrum).  This necessitated the establishment of a ‘virtual filter’ 
protocol in order to minimise ‘bleed-through’ of the Fluo-4 signal into the Fura Red acquisition 
channel.  In situ chondrocyte Fluo-4 emission data kindly provided by Dr Trudi Gillespie, IMPACT 
facility, The University of Edinburgh. 
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6.3.9 Quantitative analysis 
The following quantitative analysis methodology was used for each experiment: 
1. Pilot study assessing the rate of Hla-induced in situ chondrocyte death in 
a live cartilage explant model: chondrocyte death was assessed within a 
50% ‘field-of-view’ ROI using Volocity 4 software as previously described 
in Chapter 2.  However, in order to ensure that the same region of cartilage 
was assessed at each designated time point, an explant corner i.e. a defined 
landmark was imaged and thus a small region of cut-edge was incorporated in 
the analysis. 
2. Fluo-4 and PI ionomycin study: for the initial Fluo-4 and PI ionomycin 
study, a 50% field-of-view ROI, identical in both placement and dimensions 
to those utilised in the previous chapters (Figure 6.4A), was established 
using Nikon NIS Elements version 4.0 software (Nikon UK, Kingston Upon 
Thames, Surrey, UK).  Thereafter, the percentage change in fluorescence 
intensity (%ΔF) of the Fluo-4 (%ΔFFluo-4) and PI (%ΔFPI) stains within this 
ROI (i.e. the global response of all cells within this ROI) from 0hrs (T0) over 
the experimental period was calculated as follows: ((F Tx – F T0)/F T0 x 100) 
(F T0 = arbitrary units (AU) of fluorescence at 0hrs; F Tx = arbitrary units of 
fluorescence at designated time point).  Given the potential differences in 
both Fluo-4 stain uptake and subsequent response between explants, 
calculation of  %ΔF enabled the standardised assessment of ΔF between 
explants. 
3. Fluo-4 and Fura Red ratiometric ionomycin study: the 50% field-of-view 
ROI utilised for the above Fluo-4 and PI ionomycin study was further 
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subdivided into quadrants (Figure 6.4B).  Thereafter, 3 cells within each 
quadrant were chosen by an impartial observer (12 cells in total per explant) 
and the %ΔFFluo-4 and %ΔFFura Red from T0 within each cell was assessed.  
This was achieved by creating a ‘Bezier’ ROI (a combination of linked 
curves around an object) around each chosen chondrocyte using the Nikon 
NIS Elements version 4.0 software (Figure 6.4C).  
4. Hla study: the %ΔFFluo-4 and %ΔFPI from T0 within individual cells following 
exposure to either an Hla-containing 8325-4 or Hla-Hlb-Hlg- supernatant was 
conducted using the same methodology as the above Fluo-4 and Fura Red 
ionomycin study.  
5. Cut-edge study (see section 6.4.5 for study rationale): ROIs measuring 
921x100x100µm (x-y-z axes, respectively), which were further subdivided 
into quadrants, were positioned at both the cut-edge and the distal margin of 
the field-of-view (i.e. as far away from the cut-edge as possible) (Figure 
6.4D).  Bezier ROIs were established around 3 cells per quadrant (12 cells 
per ROI; chosen by an impartial observer) and the mean Fluo-4 fluorescence 
(AU) within each cell was assessed.  
 
6.3.10 Statistical analysis 
Data were analysed using either paired or unpaired Student’s t-tests.  For all 
experiments, N refers to the number of feet from separate animals (independent 
experiments).  For the Fluo-4 and PI ionomycin and preliminary Hla live-cell studies, 
n refers to the number of cartilage explants analysed per foot for each experimental 
group.  For all other experiments, n refers to the number of cells analysed per 
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Figure 6.4: ROIs utilised for the intracellular Ca2+ imaging experiments  
A 50% ROI (demarcated by broken red line) (A), as previously described (see chapter 2), was initially 
utilised to assess alterations in [Ca2+]i within all cells contained within the ROI following exposure to 
ionomycin.  For the Fluo-4/Fura Red ionomycin ratiometric and 8325-4 (Hla+Hlb+Hlg+) vs Hla-Hlb-
Hlg- supernatant studies, the 50% ROI was further subdivided in quadrants (B) and 3 cells were 
analysed within each quadrant (12 cells in total per explant).  Single cell analysis was achieved by 
creating a ‘Bezier’ ROI (demarcated by solid red line) around each chosen chondrocyte (C). For the 
cut-edge study, ROIs measuring 921x100x100 (x-y-z axes, respectively), which were further 
subdivided into quadrants, were positioned at both the cut-edge and the distal margin of the field-of-
view (D) and 3 cells within each quadrant were analysed (scale bar A, B & D=100µm; scale bar 
C=10µm). 
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6.4 RESULTS 
 
6.4.1 Fluo-4 and PI ionomycin study 
In order to assess whether in situ chondrocytes could be loaded with Fluo-4, and a 
response i.e. a change in fluorescence visualised thereafter, preliminary experiments 
were conducted using the Ca2+ ionophore ionomycin.  These experiments confirmed 
the successful Fluo-4 loading of in situ chondrocytes (Figure 6.5).  When explants 
were sequentially imaged over a 22min control period (prior to the addition of 
ionomycin), the mean %ΔFFluo-4 and %ΔFPI was -3.7±6.2% and 0.75±1.2%, 
respectively, thereby indicating no adverse effects of sequential laser excitation on 
both the Fluo-4 stain and chondrocyte viability.  However, when ionomycin was 
administered there was a rapid and significant (p=0.02) rise in Fluo-4 fluorescence 
indicating a sharp rise in [Ca2+]i (Figure 6.5).  This was followed by a significant 
(p=0.02) rise in PI fluorescence indicating that the rise in [Ca2+]i was ultimately fatal 
to the chondrocytes (Figure 6.5).  This correlates with previously published findings 
that ionomycin, when administered in sufficiently high doses, will induce eukaryotic 
cell death (Gwag et al., 1999; Francis et al., 2013; Morotomi-Yano et al., 2014).  
 
6.4.2 Fluo-4 and Fura Red ratiometric study 
In order to confirm that the observed rise in Fluo-4 fluorescence in the above study 
did indeed represent a rise in [Ca2+]i, a further ionomycin experiment was conducted 
using a combination of Fluo-4 and Fura Red stains.  As previously discussed (see 
section 6.1), these two stains act in a paradoxical manner when [Ca2+]i rises (Figure 
6.6A and B) and thus a ratio of Fluo-4 and Fura Red fluorescence (RFluo-4/Fura Red) can 
be established.  In the absence of a rise in [Ca2+]i, a shift in the focal plane or 
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photobleaching stains, which could be visually represented by an apparent change in 
fluorescence, would result in a RFluo-4/Fura Red that remained unchanged.  However, if 
there was a rise in RFluo-4/Fura Red then one could be confident that the observed change 
in fluorescence was due to a rise in [Ca2+]i (Han et al., 2012; Madden et al., 2014).  
Prior to the administration of ionomycin, the mean RFluo-4/Fura Red was 0.54±0.07, 
which was comparable with previously published data in chondrocytes (Han et al., 
2012; Madden et al., 2014).  Following the administration of ionomycin, there was a 
rapid and significant (p=0.002) rise in the mean RFluo-4/Fura Red ratio to 2.02±0.56 
(Figure 6.6C and D), thereby confirming that the previously observed rise in Fluo-4 
fluorescence did indeed represent a rise in [Ca2+]i.  Thus, subsequent experiments 
utilising Fluo-4 could be performed with the confidence that any observed increase 
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Figure 6.5: Alterations in chondrocyte [Ca2+]i following the administration of 
ionomycin 
(A) Following ionomycin administration (represented by broken vertical black line), there was a 
significant rise in Fluo-4 fluorescence (green numeric p value) and thus [Ca2+]i in all explants.  This 
was followed by a significant rise in PI fluorescence (red numeric p value) suggesting cellular demise 
which appeared to follow the [Ca2+]i rise (N=4[n=1]; numerical p values represent mean %ΔF pre- 
versus post-ionomycin administration by paired Student’s two-tailed t-test). The CLSM images (B) 
represent changes in Fluo-4 and PI fluorescence following ionomycin administration (scale 
bar=100µm). 
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Figure 6.6: Ratiometric assessment of [Ca2+]i alterations in Fluo-4- and Fura Red-
loaded in situ chondrocytes 
Line graph (A) represents the typical response of a Fluo-4- and Fura Red-loaded in situ chondrocyte 
following ionomycin exposure (indicated by black arrow).  The CLSM images (B) demonstrate the 
paradoxical changes in the observed Fluo-4 and Fura Red fluorescence within the same sample 
population of cells following ionomycin administration (scale bar=100µm).  There was a significant 
rise in RFluo-4/Fura Red following ionomycin administration (C) (N=6[n=12]; numerical p values 
represent RFluo-4/Fura Red pre- versus post-ionomycin administration by paired Student’s two-tailed t-
test).  Line graph (D) provides an example of the RFluo-4/Fura Red change in an in situ chondrocyte 
following ionomycin exposure with the horizontal dashed line representing the ‘crossover point’ when 
Fluo-4 fluorescence intensity exceeded that of Fura Red.  
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6.4.3 Preliminary Hla live-cell study 
Prior to investigating the influence of Hla on in situ chondrocyte [Ca2+]i, a study was 
conducted in order to determine an appropriate experimental time period for the Hla 
Ca2+ imaging study.  Living in situ chondrocytes stained with CMFDA and PI were 
exposed to Hla-containing 8325-4 supernatant for 6hrs.  Chondrocyte death became 
apparent between 2 and 4hrs with 26.44±8.29% chondrocyte death observed at 6hrs 
(Figure 6.7).  Nevertheless, it was possible that alterations in [Ca2+]i  may have 
considerably preceded the emergence of chondrocyte death (PI stained cells) and 
therefore a 6hr experimental time course, imaging at 5 minute intervals from 0hrs, 




Figure 6.7: Preliminary live-cell viability assessment following Hla exposure 
In order to determine a suitable experimental time period for live-cell [Ca2+]i analysis following Hla 
exposure, CMFDA and PI loaded chondrocytes were exposed to an Hla-containing S. aureus 8325-4 
supernatant for 6hrs.  Chondrocyte death became apparent between 2 and 6hrs (A), thereby indicating 
that a 6hr experimental time period would be suitable for [Ca2+]i imaging (N=2[n=1]).  CLSM images 
(B) display progressive chondrocyte death following Hla exposure in a dynamic live-cell study (scale 
bar=100µm). 
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6.4.4 The influence of Hla on in situ chondrocyte [Ca2+]i 
When Fluo-4 and PI labelled chondrocytes were incubated in the presence of Hla-
containing 8325-4 supernatant , the maximum %ΔFFluo-4 and %ΔFPI encountered over 
the experimental time period was significantly elevated in comparison to those 
explants incubated in the presence of the Hla-Hlb-Hlg- supernatant (116.5±9.67% vs 
30.69±13.44% (Fluo-4) and 156.74±40.15% vs 25.57±7.92% (PI), respectively) 
(Figure 6.8A).  Thus, there was a significant rise in chondrocyte [Ca2+]i following 
Hla exposure that was associated with cellular demise given the significantly 
elevated PI fluorescence (Figure 6.8B and C).  
 
Further assessment of the change in Fluo-4 and PI fluorescence in Hla-exposed 
chondrocytes demonstrated a significantly elevated %ΔFPI at the point of maximum 
%ΔFFluo-4 (Figure 6.8B and 6.9A).  In addition, at the time point considered to 
represent the first detectable rise in Fluo-4 fluorescence, defined as an increase in 
%ΔFFluo-4 two standard deviations above the mean of the preceding values (baseline), 
there was also a detectable and significant rise in PI fluorescence (Figure 6.8B and 
6.9B).  Thus, there appeared to be a simultaneous rise in both Fluo-4 and PI 
fluorescence in Hla exposed in situ chondrocytes.  The mean time for the Ca2+ 
transient, defined as the time interval from the point of %ΔFFluo-4 rising two standard 
deviations above the baseline to falling two standard deviations below the baseline, 
was 22.71±9.51mins.  Finally, the mean %ΔFPI within chondrocytes exposed to the 
Hla-Hlb-Hlg- supernatant over the 6hr experimental period was 5.4±11.89% thereby 
further confirming no adverse effects of sequential laser excitation on cell viability, 
which has been reported previously (Knight et al., 2003). 
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Figure 6.8: Hla induced a rise in [Ca2+]i that was associated with chondrocyte death 
There was a significant rise in both Fluo-4 and PI fluorescence in those chondrocytes exposed to an 
Hla-containing S. aureus 8325-4 supernatant (A), indicating that a rise in [Ca2+]i is associated with 
Hla-induced chondrocyte death (N=4[n=12]; *** p<0.001 8325-4 (Hla+Hlb+Hlg+) versus Hla-Hlb-Hlg- 
by unpaired Student’s two-tailed t-test)  The line graphs (B) provide examples of the change in Fluo-4 
and PI fluorescence in chondrocytes exposed to the 8325-4 (Hla+Hlb+Hlg+) and Hla-Hlb-Hlg- strain 
supernatants, respectively.  The CLSM images (C) provide a visual representation of the progressive 
increase in Fluo-4 fluorescence, and thus [Ca2+]i, that precedes chondrocyte demise (scale bar=10µm).  
	   186	  
 
Figure 6.9: The rise in Fluo-4 fluorescence within in situ chondrocytes exposed to Hla 
was associated with a simultaneous rise in PI fluorescence   
PI fluorescence was significantly elevated at the point of peak Fluo-4 fluorescence in those 
chondrocytes exposed to Hla (N=4[n=12]; p values represent 8325-4 (Hla+Hlb+Hlg+) versus Hla-Hlb-
Hlg- by unpaired Student’s two-tailed t-test).  In all chondrocytes assessed, at the point of earliest 
detectable rise in Fluo-4 fluorescence there was also a significant rise in PI fluorescence, indicating a 
simultaneous rise in both Fluo-4 and PI fluorescence following Hla exposure (N=4[n=12]; p values 
represent change in PI fluorescence immediately pre- and post-Fluo-4 rise by paired Student’s two-
tailed t-test). 
 
6.4.5 An assessment of chondrocyte [Ca2+]i at the cut-edge 
The above study investigating alterations in chondrocyte [Ca2+]i following Hla 
exposure was conducted in the axial plane and therefore primarily assessed the 
response of in situ chondrocytes within the SZ of cartilage i.e. imaging was to a 
depth of approx. 100µm from the articular surface.  In order to embark upon the 
assessment of [Ca2+]i alterations within different cartilage zones following Hla 
exposure, coronal imaging would be required.  This presented a challenge as it 
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necessitated live-cell imaging through a scalpel-wounded cut-edge.  Indeed, a 
serendipitous observation during the ionomycin and 8325-4 vs Hla-Hlb-Hlg- 
supernatant axial studies was the apparent increased [Ca2+]i of chondrocytes located 
within the immediate vicinity of the cut-edge (Figure 6.10).  When the level of Fluo-
4 fluorescence within chondrocytes in the region of the cut-edge was compared with 
chondrocytes distant to the cut-edge in explants cultured in phenol red-free DMEM 
(340mOsm), there was approx. 4 times higher Fluo-4 fluorescence levels within 
chondrocytes in the region of the cut-edge (Figure 6.11A).   
 
Amin et al. (2008) previously demonstrated that exposure of a scalpel-induced cut-
edge to a hyperosmolar medium significantly reduced chondrocyte death and in a 
later study (Amin et al., 2009a) suggested that Ca2+ may play a role in early 
chondrocyte death arising as a result of mechanical trauma.  Therefore, in order to 
attempt to reduce the Ca2+ signal and thus the level of Fluo-4 fluorescence, 
osteochondral explants were exposed to a hyperosmolar medium (600mOsm) pre- 
and post-trimming.  However, the level of chondrocyte Fluo-4 fluorescence remained 
significantly elevated at the cut-edge despite exposure to the hyperosmolar medium 
(Figure 6.11B).  In addition, there was no significant difference in the level of Fluo-
4 fluorescence between chondrocytes exposed to 340 and 600mOsm media (p=0.69 
by unpaired Student’s t-test).  Therefore, given the ongoing significantly elevated 
Fluo-4 fluorescence within chondrocytes at the cut-edge despite attempted reduction 
strategies, it was considered unreasonable to pursue any further response of 
chondrocytes to Hla within different cartilage zones, given that the [Ca2+]i within 
these cells would already be elevated prior to the commencement of experimentation. 
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Figure 6.10: Increased Fluo-4 fluorescence within chondrocytes in the vicinity of the 
cut-edge 
It was noted during the axial studies presented in this chapter that there was an increased level of 
Fluo-4 fluorescence within chondrocytes in the region of the cut-edge (A).  The axial CLSM image 
represents an explant from the ionomycin study (see section 6.4.1) prior to the addition of ionomycin.  
Note the increased Fluo-4 fluorescence, and thus [Ca2+]i, at the cut-edge (*).  When the cut-edge of 
the same explant was imaged in the coronal plane (B), this confirmed increased chondrocyte Fluo-4 
fluorescence throughout the cut surface i.e. throughout the depth of cartilage (scale bar=100µm).   
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Figure 6.11: The influence of raised osmolarity on resting chondrocyte [Ca2+]i within 
the immediate vicinity of the cut-edge 
In explants cultured in phenol red-free DMEM (340mOsm) pre- and post-trimming, there was 
significantly elevated fluo-4 fluorescence in chondrocytes within the immediate vicinity of the cut 
edge (A).  Chondrocyte fluorescence within the cut-edge ROI remained significantly elevated when 
explants were cultured in hyperosmolar (600mOsm) DMEM (B) (N=3[n=12]; p values represent 
chondrocyte fluo-4 fluorescence within the cut-edge ROI vs chondrocyte fluorescence within the ROI 
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6.5 DISCUSSION 
In this study, Ca2+-sensitive fluorophores coupled with live-cell CLSM were used to 
assess alterations in [Ca2+]i within in situ chondrocytes following ionomycin and, 
thereafter, Hla exposure.  Whilst numerous studies investigating changes in [Ca2+]i 
within a variety of eukaryotic cells have used a similar experimental strategy, to the 
author’s knowledge it has not been used to investigate the pathology of S. aureus-
induced septic arthritis.  This study firstly demonstrated that alterations in Fluo-4 and 
Fura Red fluorescence within in situ chondrocytes could be successfully visualised 
and assessed following ionomycin administration.  Subsequent experimentation with 
Hla demonstrated a significant rise in chondrocyte [Ca2+]i that was associated with 
chondrocyte death.  A further incidental and serendipitous finding was the elevated 
[Ca2+]i within chondrocytes in the region of the scalpel-induced cut-edge. 
 
One of the major benefits of live- over fixed-tissue imaging was that in situ cells 
could be dynamically assessed within their native environment.  For straightforward 
experimental endpoints such as in situ cell viability assays, the assessment of fixed 
tissue was adequate but it would not be possible, for example, to assess alterations in 
[Ca2+]i within such specimens i.e. all the cells would be dead.  One disadvantage of 
the use of live-tissue imaging however was the potential for cellular phototoxicity 
arising as a result of prolonged periods of focused high intensity laser excitation of 
the tissue.  Indeed, a study by Knight et al. (2003) demonstrated that serial laser 
excitation of Fluo-4-loaded isolated chondrocytes imaged over a 1hr period (image 
acquisition every 10secs) induced Ca2+ oscillations, transients and a reduction in cell 
viability.  In contrast, no such adverse effects were encountered with regards to 
	   191	  
[Ca2+]i homeostasis or chondrocyte viability in the control samples of the current 
study, some of which were imaged for 6hrs (Figures 6.8 and 6.9).  Possible 
explanations may be the use of a refined and less intense laser in this study, more 
prolonged periods between image acquisition and a protective effect of the 
surrounding ECM. 
 
The primary objective of this study was to assess alterations in [Ca2+]i, depicted by 
changes in Ca2+-sensitive fluorophore fluorescence, following Hla exposure.  
Preliminary experiments utilising a Ca2+ ionophore were necessary in order to 
confirm that Fluo-4-loaded in situ chondrocytes could respond to a rise in [Ca2+]i.  
Ionomycin was chosen on the basis that it has previously been shown to reliably 
induce a rise in [Ca2+]i in many eukaryotic cell types (Liu and Hermann, 1978; 
Erdahl et al., 1994; Morgan and Jacob, 1994; Foerster et al., 2010).  This was indeed 
the case with in situ chondrocytes, with a rapid increase in Fluo-4 fluorescence being 
observed following ionomycin exposure, ultimately culminating in chondrocyte 
demise (Figure 6.5).  To obtain further confidence that the observed rise in Fluo-4 
fluorescence represented a true rise in [Ca2+]i and not just a shift in the focal plane or 
photobleaching, Fluo-4- and Fura Red-loaded chondrocytes were also challenged 
with ionomycin.  This resulted in a rapid and significant rise in RFluo-4/Fura Red (Figure 
6.6) thereby confirming a rise in [Ca2+]i.  One may argue that a Fluo-4 and Fura Red 
ratiometric analysis should have been used for the subsequent Hla studies.  However, 
Fura Red and PI have similar emission spectra (www.lifetechnologies.com) and 
therefore the two stains could not be used simultaneously.  One possible option for 
future studies would be to utilise the Ca2+-sensitive ratiometric fluorophore Fura-2 in 
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combination with PI.  Fura-2 has dual emission spectra following excitation at 
340nm and 380nm, repectively (www.lifetechnologies.com).  When excited at 
340nm, emitted fluorescence intensity increases as [Ca2+]i increases whilst when 
excited at 380nm, emitted fluorescence intensity decreases as [Ca2+]i increases 
(Malgaroli et al., 1987).  The use of Fura-2 was not explored in the current study, as 
the laser excitation sources available were unable to excite down to 340nm.  
Ultimately, the goal of this study was to assess whether Hla-induced chondrocyte 
death was associated with a rise in [Ca2+]i and this was achieved with a combination 
of Fluo-4 and PI.  
 
When in situ chondrocytes were exposed to the Hla-containing 8325-4 supernatant 
there was a significant rise in Fluo-4 fluorescence, and thus [Ca2+]i, in comparison to 
those explants exposed to the Hla-Hlb-Hlg- supernatant (Figure 6.8). The small 
change in Fluo-4 and PI fluorescence in those explants exposed to the Hla-Hlb-Hlg- 
supernatant may possibly be explained by either a slight shift in the focal plane 
during the initial experimental period or the influence of unspecified S. aureus 
toxins.  The Hla-induced Ca2+transient lasted between 20 and 25mins in the majority 
of cells analysed with cell death being witnessed in all cells thereafter.  Cellular 
demise following the Ca2+ transient was identified through the inability of the cells to 
contain plasma membrane-insoluble cytosolic Fluo-4 and persistently elevated 
nuclear PI fluorescence, both of which indicated catastrophic loss of plasma 
membrane integrity.  Given that images were acquired every 5mins, this was a fairly 
crude estimation of the Hla-induced intracellular Ca2+ transient dynamic and it was 
possible that it may have lasted longer or shorter in some of the cells analysed.  
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However, the primary goal of this study was to identify whether or not there was a 
rise in [Ca2+]i following Hla exposure and this was achieved.  Future experiments 
may refine the imaging interval in order to obtain a more detailed appreciation of the 
Hla-induced intracellular Ca2+ transient. 
 
Further assessment of the relationship between Fluo-4 and PI fluorescence in the 
presence of Hla demonstrated a significant rise in PI fluorescence that coincided with 
the first detectable rise in Fluo-4 fluorescence (Figure 6.9), thereby suggesting a 
simultaneous rise in Fluo-4 and PI fluorescence.  There were two possible 
explanations for this finding.  Firstly, membrane integrity had already been 
compromised prior to the start of the Ca2+ transient and that the observed transient 
simply represented the end-stage influx of Ca2+ down the considerable concentration 
gradient between the extra- and intracellular compartments i.e. Hla induced 
chondrocyte death was not triggered by the influx of Ca2+ through membrane-bound 
Hla pores.  Indeed, Walev et al. (1993) and Valeva et al. (2000) raised the possibility 
that divalent cations such as Ca2+ could not pass through Hla pores and that it was the 
influx of Na+ coupled with the efflux of K+ that initiated cell death.   
 
An alternative explanation may be that Hla pores permitted the passage of both Ca2+ 
and PI into the chondrocyte.  Interestingly, Jonas et al. (1994) identified that when 
isolated peripheral blood human T lymphocytes were exposed to a high 
concentration of Hla, the plasma membrane became permeabilised to both Ca2+  and 
PI.  However, when the cells were exposed to a low concentration of Hla, the plasma 
membrane was found to be impermeable to Ca2+ and PI, thereby suggesting that the 
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Hla pore size may be dependent on Hla concentration.  Additionally, studies 
conducted by Kennedy et al. (2009) and Knapp et al. (2010) investigating alpha-
toxin of Clostridium septicum, which was similar in both size and structure to S. 
aureus Hla, identified that the toxin permeabilised cell membranes to Ca2+ and PI, 
respectively.  In a further study by Koschinski et al. (2006) investigating alpha-
haemolysin of Escherichia coli, which was a similar pore-forming toxin to S. aureus 
Hla, identified that it also permeabilised cell membranes to Ca2+ and PI.  Moreover, 
following toxin washout the cells subsequently became impermeable to Ca2+ and PI. 
 
If the observed Ca2+ influx in the current study was simply due to diffusion down a 
concentration gradient established through the loss of membrane integrity then one 
would have expected the transient to be extremely rapid given the substantial 
difference between [Ca2+]i and [Ca2+]o in articular cartilage (Urban, 1994; Hall et al., 
1996a; Yellowley et al., 1997).  As the transient exceeded 20mins in the majority of 
cells and given the published literature to date on similar pore-forming toxins, it was 
likely that membrane-bound Hla pores permitted the passage of Ca2+, along with PI, 
into the chondrocyte and that this influx of Ca2+ was the primary trigger of cell death.  
In order to confirm that this was indeed the case, an experimental strategy whereby 
the assessment of [Ca2+]i and chondrocyte viability following Hla pore blockade 
would be required.  If Hla pore blockade inhibited both a rise in [Ca2+]i and 
chondrocyte death then this would provide convincing evidence that the passage of 
Ca2+ into the cell was predominantly via the Hla pore and that the rise in [Ca2+]i 
triggered cell death thereafter.  Whilst Hla-specific monoclonal antibodies have been 
shown to inhibit the activity of Hla in animal models (Bubeck-Wardenburg and 
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Schneewind, 2008; Ragle and Bubeck-Wardenburg, 2009), their mode of action has 
been identified as the inhibition of Hla heptamer formation (Tkaczyk et al., 2012) i.e. 
at a pre-pore conformational stage and thus would be unsuitable for the inhibition of 
mature membrane-spanning Hla pores.  However, the recent identification of β-
cyclodextrin derivatives as Hla pore-blocking agents may enable such a confirmatory 
experiment in the future (Karginov et al., 2007; McCormick et al., 2009; Ragle et al., 
2010; Inoshima et al., 2011; Yannakopoulou et al., 2011).  Encouragingly, Ragle et 
al. (2010) demonstrated that administration of a β-cyclodextrin compound in a 
murine model of S. aureus pneumonia both prevented and treated disease while a 
study by McCormick et al. (2009) demonstrated that the administration of methyl-β-
cyclodextrin-cholesterol in a murine model of S. aureus keratitis was effective in 
arresting corneal damage.  It was thus tempting to speculate that the administration 
of β-cyclodextrin compounds in a murine model of S. aureus-induced septic arthritis 
may be similarly advantageous. 
 
The study assessing chondrocyte [Ca2+]i alterations in response to Hla was conducted 
in the axial plane and predominantly assessed SZ chondrocytes to a depth of approx. 
100µm from the articular surface.  In order to assess whether alterations in [Ca2+]i 
varied between chondrocytes from different cartilage zones, and thus attempt to 
explain why SZ chondrocytes were previously shown to be more susceptible to Hla 
than chondrocytes from deeper cartilage zones (see Chapters 3 and 4), the coronal 
imaging of Fluo-4 loaded in situ chondrocytes would be necessary.  It was 
hypothesised that Hla-induced intracellular Ca2+ transients were more prolonged 
within chondrocytes from deeper zones in comparison to SZ chondrocytes.  
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However, a consistent observation during the experiments detailed within this 
chapter was increased Fluo-4 fluorescence within chondrocytes in the region of the 
cut-edge (Figure 6.10).  In some cells, the increased fluorescence was observed to be 
present for several hours prior to eventual cellular demise while in other cells it 
remained elevated for the duration of the experiment.  Whilst this was an interesting 
observation, the assessment of [Ca2+]i following mechanical trauma was not the goal 
of this study and it presented a challenge for the intended coronal imaging 
experiments as it would result in the assessment of cells in which [Ca2+]i was already 
considerably disturbed prior to Hla exposure. 
 
Amin et al. (2009a) previously identified that Ca2+ may play a role in early 
chondrocyte death following mechanical cutting trauma and also that exposure of a 
scalpel-induced cut-edge to a hyperosmolar medium significantly reduced 
chondrocyte death (Amin et al., 2008; Amin et al., 2010).  It was therefore 
hypothesised that exposure of the cut-edge to a hyperosmolar solution would reduce 
or prevent alterations in [Ca2+]i within cells in this region, thereby enabling the Hla 
coronal study to proceed.  However, despite being exposed to a hyperosmolar 
medium, [Ca2+]i remained significantly elevated within these cells and the 
experiment was thus abandoned.  A possible explanation for the raised [Ca2+]i within 
chondrocytes at the cut-edge may be that the cells were ‘sublethally’ damaged and 
the raised [Ca2+]i reflected intracellular reparative mechanisms.  Nevertheless, a 
potential future strategy to overcome the elevated [Ca2+]i at the cut-edge might 
involve the culture of trimmed explants in a hyperosmolar medium for several days 
prior to experimentation.  This may enable the disappearance of stain uptake in dying 
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cells and the recovery of damaged cells.  Alternatively, future studies could focus on 
alterations in [Ca2+]i within chondrocytes isolated from different cartilage zones i.e. 
isolated cells. 
 
To conclude, this in vitro live-cell imaging study has demonstrated that Hla-induced 
in situ chondrocyte death is associated with a rise in [Ca2+]i.  Future studies may 
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In this chapter, the experimental model utilised during this study to improve the 
current understanding of the articular cartilage destruction associated with S. aureus-
induced septic arthritis is discussed and novel aspects of the methodology 
highlighted.  The key study conclusions are presented and their translational 
relevance to current clinical practice and future scientific research are considered. 
 
7.1 A cartilage explant model of S. aureus-induced septic arthritis  
A key aim of this study was an attempt to model septic arthritis in a cartilage explant 
model.  In the clinical setting, establishment of infection involves a complex and 
dynamic interaction between pathogen and host.  The author is conscious of the fact 
that the current model used has inherent limitations in this regard and there is 
therefore no claim to mirror infection in vivo.   
 
One potential and important issue was the level of infection established, which may 
have been overly aggressive in the absence of the contributory influence in vivo of 
the host immune response or, in contrast, too weak as a consequence of the inoculum 
concentration used to establish infection.  Nevertheless, the concentration chosen 
produced a measurable degree of chondrocyte death within a reasonable time period 
that was neither overwhelming nor weak.  To date, the author is not aware of any 
studies that have measured the bacterial concentrations within the infected synovial 
fluid of humans presenting with S. aureus-induced septic arthritis.  Hence, it was 
exceedingly difficult to exactly match levels in the experimental model with those in 
a septic joint.  Ultimately, the goal of the current study was to assess the influence of 
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key S. aureus toxins on chondrocyte viability and the level of infection established 
within the experimental model enabled this to be achieved. 
 
One of the strengths of the in vitro cartilage explant model of septic arthritis 
presented in this study may paradoxically also be considered a limitation.  The 
absence of the complexities of a host immune response enabled the formulation of 
more accurate conclusions in regard to the chondrocyte-damaging potential of 
specific S. aureus toxins.  On the one hand, it could be considered that the 
destructive influence of such toxins would be significantly dampened in vivo by the 
host immune response.  Nevertheless, evidence from animal studies suggests that the 
immune response may paradoxically contribute further to the overall cartilage 
destruction (Shirtliff and Mader, 2002; Tissi et al., 2004).  It is currently entirely 
speculative as to what extent in vivo chondrocyte death and subsequent cartilage 
destruction is due to the bacterial toxin component and that due to the immune 
response engaged to ‘retaliate’ as a response, but it is likely that both contribute 
significantly. 
 
Bovine osteochondral explants (Figure 2.3) were utilised for all experiments unless 
stated otherwise as preliminary studies with cartilage explants devoid of subchondral 
bone had highlighted a major problem: the lack of a subchondral bone anchor 
resulted in marked ‘curling’ of the explants (author observation), rendering 
subsequent axial-plane CLSM image acquisition extremely difficult.  Furthermore, to 
achieve a more accurate representation of the in vivo environment, the assessment of 
articular cartilage bound to subchondral bone was considered important.   Indeed, the 
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observation by Amin et al. (2009b) that the presence of subchondral bone influenced 
chondrocyte survival in articular cartilage during explant culture further emphasised 
the importance of the use of osteochondral explants.  All oval (harvested form) 
osteochondral explants were trimmed to form rectangular explants immediately prior 
to fluorescent staining (Figure 2.4) in order to permit (1) a standardised method of 
CLSM imaging and quantification in the axial plane and (2) the capture of ‘flush’ 
coronal images.  In addition, it ensured that no coronal images were obtained of 
mechanically damaged chondrocytes that had been exposed to S. aureus toxins for 
the experimental period, as the cutting trauma may have rendered them more 
susceptible to S. aureus toxins. 
 
A further potential limitation of the use of the current bovine model is that a great 
degree of caution should be exercised before extrapolating conclusions to the clinical 
setting.  The sensitivity of in situ chondrocytes to S. aureus toxins may be 
considerably different in human articular cartilage.  However, there are significant 
practical problems with the use of human cartilage, namely it is extremely difficult to 
source a consistent and regular supply of non-degenerate human cartilage.  
Nevertheless, studies have demonstrated similar responses by bovine and human 
cartilage to a variety of experimental challenges (D'Lima et al., 2001; Démarteau et 
al., 2006), thereby supporting the use of bovine cartilage for experimental 
assessments.  Regardless, and despite the inherent challenges, ultimately it will be 
necessary to conduct experimental research with human osteochondral explants in 
order to assess the sensitivity of human chondrocytes to S. aureus haemolysins. 
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The role of cartilage explants to investigate the destructive roles of S. aureus on 
articular cartilage has been previously reported (Jasin, 1983; Williams et al., 1991) 
and their use in the current study was therefore not a novel experimental strategy.  
However, there were two major benefits to the use of cartilage explants in 
comparison to in vivo animal models and isolated chondrocytes: (1) as mentioned 
previously, there was the avoidance of the complexities of a host immune response 
and (2) cell-matrix interactions remained intact, thereby making any observed 
cellular responses more representative of those in vivo.   
 
Previous studies have primarily focused on S. aureus-induced damage to the ECM, 
assessing the release of matrix components and matrix-digesting enzymes as 
experimental endpoints, but gave no indication of chondrocyte viability following 
bacterial toxin exposure (Jasin, 1983; Smith and Schurman, 1983; Williams et al., 
1991).  Chondrocytes, the only cellular component of articular cartilage (Muir, 
1995), govern matrix turnover and thus a damaged matrix with large numbers of 
viable chondrocytes may have the capacity for repair.  As chondrocytes do not 
normally divide once skeletal maturity has been reached (Archer, 1994; Muir, 1995), 
a damaged matrix with a paucity of viable chondrocytes will ultimately degrade and 
the cartilage will inevitably become degenerate (Simon et al., 1976).  It was therefore 
considered important to analyse in situ chondrocyte viability following exposure to 
key S. aureus toxins and this was achieved through the modality of fluorescence-
mode CLSM.  Whilst CLSM is a well-established research tool, the author is not 
aware of its use for the assessment and subsequent characterisation of in situ 
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chondrocyte death following S. aureus toxin exposure and it therefore presented a 
novel and exciting investigative strategy within the field of septic arthritis research.  
 
7.2 Fluorescence-mode CLSM 
For the majority of experiments, low-power (x10) CLSM images of fluorescently 
labelled osteochondral explants (fixed and living specimens) were obtained in one of 
two orthogonal planes: axial or coronal.  A series of optical sections acquired in 
these planes were combined using imaging software (Volocity 4 and Nikon NIS 
Elements version 4.0) to produce 3-D reconstructions of the imaged volume of 
cartilage and defined analyses were conducted thereafter.  For the majority of 
experiments, images were acquired in the axial plane as it provided a more 
comprehensive evaluation of cells in the SZ (i.e. the articular surface) in comparison 
to that possible from thin coronal sections of cartilage.  The SZ was of particular 
interest as firstly, it harbours, in the majority of species (Pedersen et al., 2013), the 
highest cell density in cartilage and plays a key role in resisting both tensile and 
shearing forces (Buckwalter and Mankin, 1997a; Hunziker, 2002; Korhonen et al., 
2002) i.e. it plays a vital role in maintaining the overall integrity of the tissue.  
Secondly, as the articular surface was in close proximity to the infected synovial 
fluid in vivo, it followed that the response of SZ chondrocytes to defined S. aureus 
toxins should be of particular interest.  Given the zonal heterogeneity of articular 
cartilage, it was also considered important to investigate the response of in situ 
chondrocytes to S. aureus toxins throughout the depth of the tissue, an assessment 
that was not possible with axial imaging alone due to the limitations of stain 
penetration.   
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Success was achieved with coronal imaging, accepting that it did entail imaging 
through a scalpel-wounded cut-edge.  The small, but detectable degree of 
chondrocyte death induced by the scalpel blade (Figures 3.7 and 4.6) was minimised 
by trimming each explant immediately prior to staining.  
 
The technique of fluorescence-mode CLSM was central to this study and its use was 
advantageous for several reasons:  
 
1. Prior to CLSM, each specimen could be illuminated with an excitation light 
source (mercury lamp fitted within each CLSM system) and visualised 
thereafter to ensure that the region selected for CLSM imaging was indeed 
representative of the generalised cellular response to experimental challenge 
throughout the specimen.  In addition, it further enabled the identification and 
subsequent rejection of both microscopically degenerate explants, which 
were typically characterised by the presence of chondrocyte clusters, and 
iatrogenically injured explants.  
  
2. In comparison to conventional histology, where physical sectioning of the 
specimen is required and thus artefacts can be created, axial CLSM imaging 
permitted the assessment of undisturbed SZ chondrocytes.  Although the 
coronal imaging of chondrocytes within different cartilage zones necessitated 
the imaging through a cut-edge and hence disturbed cartilage, these ‘clean’ 
scalpel-induced edges, which were established well away from the ‘ragged’ 
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edges created at the time of explant harvesting, were only fashioned at the 
time of staining i.e. upon leaving the bacterial culture vessel and thus no 
toxins were present at this stage.  Therefore, the experimental fate of the cells 
was already established i.e. PI-labelled cells arising as a result of Hla-induced 
death were still labelled with PI post trimming.  It was accepted that the 
scalpel cut did induce a degree of dead-cell artefact, however this was 
consistently found to be minimal and did not significantly interfere with the 
analysis of coronal chondrocyte viability assays (Figures 3.7 and 4.6).  A 
possible solution to overcome the dead cell artifact would be to trim the 
explants post-fixation.  Unfortunately, this was not possible due to stain 
penetration limitations. 
 
3. As low powered CLSM was utilised, relatively large areas of cartilage were 
imaged (approx. 1mm x 1mm) thereby permitting the response of a large 
number of cells to be assessed simultaneously.  For axial images, the 50% 
field-of-view ROI typically contained approx. 3000 chondrocytes while there 
was in excess of 1000 cells within the combined ROIs for each coronal 
image.  For CMFDA- and PI-labelled specimens, subsequent quantitative 
analyses of chondrocyte viability based on such large numbers of cells 
ensured a more accurate representation of the overall response of articular 
cartilage to S. aureus toxins.   
 
4. As CLSM imaging was to a depth of approx. 100µm in both the axial and 
coronal planes, the imaged volume within CLSM reconstructions 
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considerably exceeded that of the fine sections used for conventional 
histology.  CLSM reconstructions therefore enabled the visualisation of 
cartilage in more detail, especially in coronal section (Figure 7.1).  
 
5. A unique feature of CLSM was that it had the capacity to image living tissue 
and thus in situ cells in fine morphological detail.  Moreover, dynamic 
responses within chondrocytes could be visualised and quantified in real 
time.  In Chapter 6, alterations in [Ca2+]i within living chondrocytes 
following Hla exposure took the imaging strategy to a level of sophistication 
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Figure 7.1: A comparison between the cellular detail of articular cartilage obtained 
with conventional histology and CLSM using a low power objective (x10) 
(A) A 10µm thick coronal section of haematoxylin and eosin stained bovine articular cartilage. (B) An 
approx. 100µm thick coronal section of CMFDA- and PI-labelled bovine articular cartilage.  Although 
both images demonstrated the full thickness of articular cartilage and thus provided an appreciation of 
the zonal heterogeneity, there was considerably more cellular detail in the image acquired through 
CLSM due to the greater imaged volume i.e. more cells are visualised (scale bar = 100µm).  Image 
(A) kindly provided by Dr Asima Karim, Centre for Integrative Physiology, The University of 
Edinburgh. 
 
As with any experimental technique, there were limitations associated with the use of 
fluorescence-mode CLSM.  Firstly, CLSM could only capture images from 
fluorescently labelled tissue and there was therefore a depth limitation to image 
acquisition that arose as a result of the limited ability of the fluorescent stains to 
penetrate cartilage.  Thus, with increasing depth the ability of the laser light to excite 
fluorescent stains decreased.  Secondly, there was the potential for adverse effects on 
cell viability (phototoxicity) as a result of sequential focused high power laser 
excitation of the tissue (Frigault et al., 2009).  Indeed, a study by Knight et al. (2003) 
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demonstrated that serial high-powered laser excitation was toxic to isolated 
chondrocytes.  Laser-induced toxicity was not a concern for the chondrocyte viability 
studies as the CMFDA- and PI-labelled explants were fixed in formaldehyde prior to 
imaging.  Regardless of laser power and exposure time it was not possible for 
chondrocyte viability to alter in these specimens, although fluorescence levels could 
decline with time (author observation).  Nevertheless, it was a potential issue for the 
live-cell intracellular Ca2+ imaging studies.  No such problems were encountered 
during these studies, perhaps reflecting reduced exposure time coupled with recent 
advances in CLSM laser technology or, alternatively, a protective influence of the 
ECM, which wasn’t present in the study by Knight et al. (2003) i.e. isolated 
chondrocytes were investigated.  
 
7.3. Quantification of in situ chondrocyte viability 
With the exception of the intracellular Ca2+ imaging studies detailed in Chapter 6 
(see this chapter for a detailed discussion on the CLSM assessment of alterations in 
chondrocyte [Ca2+]i), the majority of experiments detailed within this thesis involved 
the assessment of percentage chondrocyte death following experimental challenge.  
This was assessed by conducting automated cell viability counts on CMFDA- and 
PI-labelled chondrocytes within defined axial and coronal ROIs using Volocity 4 
software.  This was achieved by using a previously validated and reproducible 
algorithm based on thresholding percentage voxel intensity (Jomha et al., 2003; Lin 
et al., 2005; Amin et al., 2008), which minimised background noise whilst, at the 
same time, maximising the inclusion of cells despite signal attenuation.  Such a 
technique, which has both a high sensitivity and specificity (Jadin, 2005), and has 
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additionally been specifically validated for use with fluorophores used to label viable 
and non-viable chondrocytes (Jomha et al., 2003), enabled the rapid and accurate 
estimation of chondrocyte viability within large populations of cells.  
 
The use of CMFDA and PI is an accepted method utilised by many studies to 
fluorescently label living and dead cells, respectively (Jones and Senft, 1985; Bush 
and Hall, 2003; Lewis et al., 2003; Unal Cevik and Dalkara, 2003; Huntley et al., 
2005; Jones et al., 2005; Amin et al., 2008; Bubeck-Wardenburg and Schneewind, 
2008).  The question remained whether PI-labelled cells potentially represented 
membrane-damaged chondrocytes that, with time, could subsequently repair the 
membrane insult and, ultimately, survive.  The results from the long-term post-
infection chondrocyte viability study detailed in Chapter 3 demonstrated that PI-
labelled chondrocytes at 40hrs were incapable of labelling green with CMFDA to 
indicate that they had recovered viability (Figures 3.9 and 3.10).  This finding 
therefore provided confirmation that PI-labelled chondrocytes were indeed dead.  
 
7.4 Conclusions 
An in vitro bovine osteochondral explant model of S. aureus-induced septic arthritis 
was developed in this study.  Utilising fluorescence-mode CLSM, the model, which 
avoided the complexities of a host immune response, permitted an assessment of the 
following: (1) the spatial and temporal quantification of in situ chondrocyte viability 
following exposure to both a laboratory ‘wild-type’ (S. aureus 8325-4) and clinical 
strains of S. aureus; (2) the influence of S. aureus Hla, Hlb and Hlg on in situ 
chondrocyte viability through the use of specific ‘haemolysin-knockout’ mutant 
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strains; (3) the influence of altered culture medium osmolarity and [Ca2+]o on Hla-
induced in situ chondrocyte death; and (4) dynamic changes in [Ca2+]i within in situ 
chondrocytes following Hla exposure.  The key conclusions from the experiments 
are summarised below: 
 
1. S. aureus 8325-4 and S. aureus clinical strains rapidly reduced in situ 
chondrocyte viability (>45% chondrocyte death at 40hrs) (Figures 3.3 and 
3.6).  The increased acidity, observed during bacterial culture, had a minimal 
effect on chondrocyte viability (Figure 3.4).  Chondrocyte death commenced 
within the SZ of cartilage and rapidly progressed to the DZ (Figure 3.7).  
Simultaneous exposure of SZ and DZ chondrocytes to S. aureus 8325-4 
toxins, achieved with the use of subchondral bone-free explants, 
demonstrated that SZ chondrocytes were more susceptible to the toxins than 
DZ chondrocytes (Figure 3.11). 
 
2. When explants were cultured in the presence of a selection of isogenic S. 
aureus mutants, with varying Hla, Hlb and Hlg production capabilities (all 
originating from S. aureus 8325-4), Hla-producing mutants induced 
significant in situ chondrocyte death compared to a toxin-deficient control 
(Hla-Hlb-Hlg-) (Figures 4.2 and 4.4).  In contrast, mutants producing Hlb and 
Hlg in the absence of Hla were unable to induce significant chondrocyte 
death (Figure 4.3).  Hla alone was therefore identified as the key damaging 
toxin to in situ chondrocyte viability. 
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3. Raised culture medium osmolarity had no influence on Hla-induced in situ 
chondrocyte death (Figure 5.1).  In the absence of Hla, a high [Ca2+]o 
(20mM) had no influence on chondrocyte viability during the experimental 
period (Figure 5.2).  Hla-induced chondrocyte death increased in the 
presence of raised [Ca2+]o thereby confirming a role of Ca2+ in the 
chondrocyte death pathway (Figures 5.3, 5.4 and 5.5).  There was no 
significant difference between S. aureus growth in high and low Ca2+ culture 
media (Table 5.1), although the influence of raised [Ca2+]o on S. aureus Hla 
synthesis could not be excluded. 
 
4. When live osteochondral explants stained with the Ca2+-sensitive fluorophore 
Fluo-4 were cultured with an Hla-containing S. aureus supernatant (S. aureus 
8325-4 (Hla+Hlb+Hlg+)) there was a significant rise in [Ca2+]i in comparison 
to those explants exposed to a non-Hla-containing supernatant (S. aureus 
DU5938 (Hla-Hlb-Hlg-)) (Figures 6.8 and 6.9).  The Hla-induced Ca2+ 
transients, which lasted approx. 20mins, were always followed by 
chondrocyte death.  Thus, Hla-induced chondrocyte death was associated 
with a rise in [Ca2+]i. 
 
Figure 7.2 illustrates a simplified proposed model of S. aureus Hla-induced 
chondrocyte death based on the findings presented within this study.  The 
translational relevance of the above conclusions with regard to current clinical 
practice and future scientific research are now considered. 
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Figure 7.2: A proposed model of Hla-induced chondrocyte death 
Hla forms membrane-spanning heptameric pores on the chondrocyte that permit the unregulated 
influx of Ca2+ into the cell.  The resulting rise in intracellular Ca2+ culminates in chondrocyte death. 
 
7.5 Joint lavage and antibiotic selection 
The identification of rapid S. aureus-induced chondrocyte death firstly advocates the 
prompt and thorough removal of both bacteria and their associated toxins from 
infected joints; treatment with antibiotics alone should never be considered 
appropriate.  Two common forms of joint lavage include serial bedside aspirations 
and surgical washout, with the most common irrigation solution being normal saline 
(Gredlein et al., 2000; Klinger et al., 2010).  Whilst there is currently no evidence to 
suggest that one irrigation strategy is superior (Manadan and Block, 2004; Ravindran 
et al., 2009), it has been posited that surgical washout provides a more 
comprehensive evacuation of bacteria and their toxins from the joint.  In addition, 
given the observation that Ca2+ was associated with Hla-induced chondrocyte death 
then the use of Ca2+-free irrigation solutions may be beneficial. 
 
The finding that S. aureus-induced chondrocyte death was primarily mediated by Hla 
may challenge the appropriateness of current antibiotics.  When patients present with 
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suspected septic arthritis, the joint in question is initially aspirated to enable 
microbiological assessment of the infected synovial fluid.  An urgent gram stain may 
alert the clinician as to the likely causative organism but the full microbiological 
profile may take 24-48hrs.  Patients are therefore empirically commenced on broad-
spectrum intravenous antibiotics, commonly flucloxacillin and benzyl penicillin 
(Goldenberg, 1998; Shirtliff and Mader, 2002; Mathews et al., 2008).  In some 
circumstances several hours may pass between the commencement of antibiotics and 
formal joint lavage i.e. lack of operating theatre availability, thereby making initial 
antibiotic selection a potential key stage in the successful treatment of septic arthritis.  
At present, there is a lack of scientific evidence on which to base the choice of first-
line antibiotic treatment (Mathews et al., 2008).  
 
Flucloxacillin and benzyl penicillin are classed as bactericidal antibiotics in that their 
ultimate mode of action is bacterial lysis (Bergeron et al., 1976; Elliott et al., 1979).  
Whilst this process kills the bacteria, there is the potential for the inadvertent release 
of intracellular contents, including bacterial toxins i.e. Hla, into the immediate 
surrounding environment (Pankey and Sabath, 2004).  In vivo, it is possible and 
likely that Hla secreted into the synovial fluid prior to clinical presentation may have 
resulted in some degree of chondrocyte death.  The bacterial rupture induced by 
bactericidal antibiotics may result in a ‘pulse’ of potent Hla that could cause 
additional chondrocyte death over and above that produced when the bacteria were 
alive.  Minimising chondrocyte death during an episode of septic arthritis is likely to 
be pivotal to ensuring a satisfactory long-term outcome i.e. reducing the chance of 
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long-term problems such as early onset osteoarthritis.  The choice of first-line 
antibiotics could therefore be crucial. 
 
In contrast to bactericidal antibiotics, bacteriostatic antibiotics act by inhibiting 
bacterial growth (Kohanski et al., 2010).  The bacteria remain intact and are removed 
in a controlled manner by the host immune response (Varley et al., 2009).  In theory, 
there should be considerably lower levels of Hla released into the joint following 
their administration in comparison to bactericidal antibiotics.  There has been 
exciting and encouraging experimental data that the bacteriostatic antibiotic 
Linezolid has the ability to suppress Hla synthesis by S. aureus intrinsically 
(Gemmell, 2002; Bernardo et al., 2004), thereby making it a potential ideal first-line 
antibiotic for the treatment of septic arthritis.  A proposed future study may therefore 
utilise the model of S. aureus-induced septic arthritis detailed within this thesis to 
assess in situ chondrocyte viability following treatment with a variety of commonly 
used bacteriostatic and bactericidal antibiotics. 
 
7.6 Improved diagnosis of septic arthritis 
Given the potential catastrophic consequences of a missed diagnosis of septic 
arthritis (outlined in Chapter 1), it is of critical importance that a diagnosis is quickly 
established in all cases.  Sometimes the diagnosis can be challenging, as 
inflammatory markers may not be always be significantly elevated and the urgent 
gram stain is frequently inconclusive (Mathews et al., 2010).  In addition, current 
imaging studies, which include plain radiographs, CT, MRI and Ultrasonography, do 
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not have a high sensitivity or specificity for the diagnosis of septic arthritis (Shirtliff 
and Mader, 2002; Chander and Coakley, 2011).   
 
Nuclear medicine could make an important future contribution to the diagnosis of 
ambiguous cases.  Recent studies have investigated the role of radiolabelled 
antimicrobial peptides (AMPs) for infection detection.  AMPs are a unique and 
varied group of primitive molecules that are considered to be part of the host innate 
immune response, the principal defence system for the majority of living organisms 
ranging from prokaryotes to humans (Boman, 1995; Zasloff, 2002; Giuliani et al., 
2007).  They are small, positively charged, amphipathic molecules, possessing both 
hydrophobic and hydrophilic regions, that typically contain less than 100 amino acid 
residues (Peters et al., 2010).  They are mobilised shortly after infection and act 
rapidly to neutralise a broad range of microorganisms including bacteria, fungi, 
protozoa and viruses (Shai, 2002; Klotman and Chang, 2006; Peters et al., 2010).  To 
date, more than 800 AMPs have been isolated from a wide range of organisms 
(Peters et al., 2010).  In humans and other mammals, the two main AMP families, 
produced predominantly by the cells of the immune system, are cathelicidins and 
defensins (Bals and Wilson, 2003; Ganz, 2003; Zanetti, 2003; Lehrer, 2004).  
 
The exact mechanism through which AMPs kill microorganisms is not yet fully 
understood although it is hypothesised that AMPs cause microbial membrane 
permeation with the subsequent disruption to transmembrane electrochemical 
gradients and, ultimately, cellular demise (Shai, 2002).  AMPs utilise a fundamental 
difference between the design of microbial and multicellular organism membranes to 
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target invading microorganisms selectively (Zasloff, 2002).  The organisation of the 
bacterial membrane is such that the outermost leaflet of the bilayer i.e. the surface 
exposed to the external environment, is heavily populated by lipids with negatively 
charged phospholipid head groups (Epand and Vogel, 1999; Matsuzaki, 1999; Shai, 
1999).  In contrast, the outer leaflet of the plasma membrane of mammalian cells is 
composed principally of lipids with no net charge; the majority of lipids with 
negatively charged head groups are contained within the inner leaf i.e. facing the 
cytoplasm (Zasloff, 2002).  Thus, the positively charged AMPs are attracted to the 
negatively charged bacterial membrane only.  
 
The preferential binding of AMPs to bacterial cell membranes has offered a potential 
target for the development of novel radiopharmaceuticals in order to expedite the 
diagnosis of septic arthritis in ambiguous cases.  Ubiquicidin 29-41 (UBI 29-41), an 
AMP that was originally isolated from murine macrophages (Akhtar et al., 2004), 
has been the subject of recent investigation.  In an in vivo study by Welling et al. 
(2000), whereby mice were intramuscularly infected with a variety of bacteria, 
99mTc-labelled UBI 29-41 was able to detect both gram-positive and gram-negative 
bacteria 5-30mins after injection.  It was also found to be able to discriminate 
between bacterial infection and sterile inflammatory processes.  Interestingly, a small 
clinical pilot study by Akhtar et al. (2005), investigating 18 individuals with 
suspected bone, soft tissue or prosthesis infection, has demonstrated encouraging 
results.  The reported sensitivity, specificity and overall diagnostic accuracy of 
99mTc-labelled UBI 29-41 for infection localisation were 100, 80 and 94.4%, 
respectively, with no adverse reactions observed during or after image acquisition.  
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Although subsequent small pilot studies have continued to show promising results 
(Beiki et al., 2013; Saeed et al., 2013), further large-scale studies are required to 
validate the routine use of 99mTc-labelled UBI 29-41 in clinical practice.  In the 
meantime, for all ambiguous cases of septic arthritis, the ‘if in doubt, washout’ 
approach is often most appropriate.  
 
7.7 Strategies to inhibit the activity of Hla 
The identification of Hla alone as the key damaging toxin to in situ chondrocyte 
viability (Figures 4.4 and 4.5), with its destructive action being associated with a 
rise in [Ca2+]i, stimulates the concept of a future potential therapeutic target to reduce 
the extent of cartilage destruction during and after an episode of septic arthritis.   
 
The process of Hla pore-formation on eukaryotic cells is summarised as follows: (1) 
Hla is secreted as soluble monomers by S. aureus; (2) monomeric Hla molecules 
bind to a cell surface receptor, recently identified as ADAM10 (Inoshima et al., 
2011); (3) the Hla monomers undergo oligomerisation into a heptameric prepore on 
the cell surface and finally; (4) the heptameric prepore undergoes a conformational 
change leading to the formation of a 14-stranded transmembrane β-barrel (Gouaux, 
1998).  There are two key stages where activity of Hla could be inhibited: (1) pre- 
and (2) post-pore formation.   
 
Inhibition at a pre-pore stage would necessitate the prevention of Hla cellular binding 
either through direct neutralisation or competitive inhibition.  Interestingly, potent 
anti-Hla monoclonal antibodies have recently been identified and have been shown 
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to reduce lesion size significantly in a murine model of S. aureus-induced 
dermonecrosis (skin necrosis arising as a result of S. aureus infection) (Tkaczyk et 
al., 2012).  Tkaczyk et al. (2012) subsequently identified that these inhibitory 
monoclonal antibodies acted by blocking Hla hepatamer formation.  Another 
potential strategy would be to attempt to develop high affinity antibodies for 
ADAM10 that would competitively inhibit the activity of Hla. 
 
Once the membrane-spanning Hla pore has been established, it is unlikely that it will 
be amenable to antibody targeting and the focus therefore shifts to blocking the Hla 
pore.  A recent exciting development in the field of Hla research is the ability of β-
cyclodextrin derivatives to block Hla pores specifically (Karginov et al., 2007; 
McCormick et al., 2009; Ragle et al., 2010; Inoshima et al., 2011; Yannakopoulou et 
al., 2011).  Encouragingly, Ragle et al. (2010) demonstrated that administration of a 
β-cyclodextrin compound in a murine model of S. aureus pneumonia both prevented 
and treated disease while a study by McCormick et al. (2009) demonstrated that the 
administration of methyl-β-cyclodextrin-cholesterol in a murine model of S. aureus 
keratitis was effective in arresting corneal damage.  It is possible that the 
administration of β-cyclodextrin compounds in a murine model of S. aureus-induced 
septic arthritis may be similarly advantageous. 
 
7.8 Future studies 
The experimental model of S. aureus-induced septic arthritis developed during this 
study will now be used for further investigations including: (1) the detailed study of 
intracellular Ca2+ pathways associated with Hla-induced chondrocyte death; (2) the 
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assessment of in situ chondrocyte viability during infection and following treatment 
with a variety of commonly used bacteriostatic and bactericidal antibiotics and; (3) 
the assessment of the chondroprotective potential of Hla-inhibiting agents such as 
Hla-specific monoclonal antibodies and β-cyclodextran compounds.   
 
Studies will ultimately need to move to an animal model of septic arthritis in order to 
ascertain the chondrocyte-damaging role of the host immune response in vivo.  The 
S. aureus ‘haemolysin-knockout’ mutant strains utilised in the current study may 
make such an experiment achievable.   Any in vivo chondrocyte death observed 
following the establishment of septic arthritis with the Hla-Hlb-Hlg- mutant will 
likely be due to the host immune response.  The extent of chondrocyte death present 
at the time of clinical presentation in humans is currently unknown.  However, this 
could be estimated using an animal model to assess chondrocyte viability at the point 
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APPENDIX II 
Reprint of a published paper based on the work presented in 
Chapter 3 
 
 
